<!DOCTYPE html> <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Topical antimicrobial agents for treating foot ulcers in people with diabetes - Dumville, JC - 2017 | Cochrane Library</title> <meta property="og:title" content="Topical antimicrobial agents for treating foot ulcers in people with diabetes - Dumville, JC - 2017 | Cochrane Library" /> <meta property="og:url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011038.pub2/references" /> <meta property="og:type" content="article" /> <meta property=”og:image” content=”https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png” /> <meta content="initial-scale=1.0, width=device-width" name="viewport" /> <meta name="dc.identifier" scheme="DOI" content="10.1002/14651858.CD011038.pub2" /> <meta name="citation_title" content="Topical antimicrobial agents for treating foot ulcers in people with diabetes" /> <meta name="citation_author" content="Jo C Dumville" /> <meta name="citation_author_institution" content="University of Manchester, Manchester Academic Health Science Centre" /> <meta name="citation_author_email" content="jo.dumville@manchester.ac.uk" /> <meta name="citation_author" content="Benjamin A Lipsky" /> <meta name="citation_author_institution" content="Green Templeton College, University of Oxford" /> <meta name="citation_author" content="Christopher Hoey" /> <meta name="citation_author_institution" content="VA Puget Sound Health Care System Medical Center" /> <meta name="citation_author" content="Mario Cruciani" /> <meta name="citation_author_institution" content="Azienda ULSS9 Scaligera" /> <meta name="citation_author" content="Marta Fiscon" /> <meta name="citation_author_institution" content="University of Verona" /> <meta name="citation_author" content="Jun Xia" /> <meta name="citation_author_institution" content="The Ingenuity Centre, The University of Nottingham" /> <meta name="citation_journal_title" content="Cochrane Database of Systematic Reviews" /> <meta name="citation_publisher" content="John Wiley &amp; Sons, Ltd" /> <meta name="citation_issue" content="6" /> <meta name="citation_doi" content="10.1002/14651858.CD011038.pub2" /> <meta name="citation_date" content="2017" /> <meta name="citation_online_date" content="2017/06/14" /> <meta name="citation_abstract_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011038.pub2/abstract" /> <meta name="citation_fulltext_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011038.pub2/full" /> <meta name="citation_pdf_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011038.pub2/pdf/CDSR/CD011038/CD011038.pdf" /> <meta name="citation_issn" content="1465-1858" /> <meta name="citation_language" content="en" /> <meta name="citation_keywords" content="Administration, Topical; Anti‐Bacterial Agents [*administration &amp; dosage, adverse effects]; Bacterial Infections [complications, *drug therapy, epidemiology]; Bandages, Hydrocolloid; Diabetic Foot [complications, *drug therapy]; Foot Ulcer [drug therapy]; Incidence; Intercellular Signaling Peptides and Proteins [administration &amp; dosage]; Randomized Controlled Trials as Topic [statistics &amp; numerical data]; Wound Healing [drug effects]" /> <script type="text/javascript" src="//script.crazyegg.com/pages/scripts/0056/6375.js" async="async"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <script type="text/javascript">var o={auth:{customerIds:["P#DRAAEAC","EAL00000056729","DRAA3TITLES","TSINGH009S","EAL0001468","EAL00000045347"],individualId:null,brandedCustomer:"EAL0001468",roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=UTF-8" http-equiv="content-type" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/favicon.ico" rel="Shortcut Icon" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" rel="canonical" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-CN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh_TW&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-TW" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;hr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="hr-HR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="x-default" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="en-US" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fr-FR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;de&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="de-DE" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ja&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ja-JP" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ko&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ko-KR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ms&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ms-MY" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fa&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fa-IR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pl&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pl-PL" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pt&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pt-PT" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ru&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ru-RU" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;es&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="es-ES" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ta&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ta-IN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;th&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="th-TH" rel="alternate" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581422282000" rel="stylesheet" type="text/css" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;aui&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581422282000" rel="stylesheet" type="text/css" /> <link href="&#x2f;html&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1513680834000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581718173000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581718256000" rel="stylesheet" type="text/css" /> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 13},getRevision:function(){return"605.1"},getVersion:function(){return"13.0"},isAir:function(){return false},isChrome:function(){return false},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return false},isMac:function(){return true},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="EfT7x5RD";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dreferences\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011038\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011038\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011038\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011038\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article References"},article:{availableLanguage:["en","de","ru","th","ms","fr","zh"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011038.pub2",title:"Topical antimicrobial agents for treating foot ulcers in people with diabetes",firstPublishedDate:"Jun 14, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Wounds Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;custom&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581422282000" rel="stylesheet" type="text/css" /> <style type="text/css"></style> <script src="//assets.adobedtm.com/6e626c9ec247e474f6b98eb15a79a185cf7e26a5/satelliteLib-b0f13d7a13ebe8b0b1b00a9f0730a084926e292f.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1581422282000" type="text/javascript"></script> <![endif]--> </head> <body class=" yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div id="js-cookie-message" class="cookie-message cookie-message--hidden system-message-container"> <div class="container"> <a href="#" class="fa fa-times js-cookie-close pull-right" aria-label="Close cookies message"></a> <div class="system-message-wrapper container"> <i class="fa fa-exclamation-triangle" aria-hidden="true"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7XGCZUQPW4C675JNSTYTLUDN7XB/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a href="#" class="btn secondary js-cookie-close js-cookie-accept">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/"> <span class="brand-name">The Cochrane Library</span> <img class="brand-logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_logo.png" alt="Cochrane Library logo" title="Cochrane Library" /> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="owel__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=EfT7x5RD&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011038.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011038.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a href="/en/browse-by-topic" class="btn secondary">Browse</a>
<a href="/en/advanced-search" class="btn primary advanced-search-button">Advanced search</a>
</div>
</div>
<a href="#" class="toggle-menu-switch"><i class="fa fa-bars" aria-hidden="true"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<p class="auxiliary-menu-item access">Access provided by: <strong>Tsinghua University</strong></p>
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="bvrs__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="language-selector-modal-content" style="display: none;" data-modal-title="Language selection" data-size="large"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div> <a href="/en/cdsr/doi/10.1002/14651858.CD011038.pub2/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD011038.pub2/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <button class="btn primary btn-cancel" type="button">Cancel</button> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011038.pub2%2Freferences" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
</a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
<div class="access-provider-mobile">
<p class="access">Access provided by: <strong>Tsinghua University</strong></p>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
 <li class=" nav-root-item parent">
<a href="#">Cochrane Reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_14" role="presentation">
<a aria-labelledby="layout_14" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews" role="menuitem">
Search Reviews (CDSR)
</a>
</li>
<li class=" child-nav-item" id="layout_15" role="presentation">
<a aria-labelledby="layout_15" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews&#x2f;topics" role="menuitem">
Browse Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_18" role="presentation">
<a aria-labelledby="layout_18" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;table-of-contents" role="menuitem">
Issues
</a>
</li>
<li class=" child-nav-item" id="layout_17" role="presentation">
<a aria-labelledby="layout_17" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;editorials" role="menuitem">
Editorials
</a>
</li>
<li class=" child-nav-item" id="layout_19" role="presentation">
<a aria-labelledby="layout_19" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;special-collections" role="menuitem">
Special Collections
</a>
</li>
<li class=" child-nav-item" id="layout_20" role="presentation">
<a aria-labelledby="layout_20" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;supplements" role="menuitem">
Supplements
</a>
</li>
<li class=" child-nav-item" id="layout_13" role="presentation">
<a aria-labelledby="layout_13" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;about-cdsr" role="menuitem">
About the CDSR
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_22" role="presentation">
<a aria-labelledby="layout_22" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central" role="menuitem">
Search Trials (CENTRAL)
</a>
</li>
<li class=" child-nav-item" id="layout_114" role="presentation">
<a aria-labelledby="layout_114" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central&#x2f;about-central" role="menuitem">
About CENTRAL
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_29" role="presentation">
<a aria-labelledby="layout_29" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca" role="menuitem">
Browse Clinical Answers
</a>
</li>
<li class=" child-nav-item" id="layout_91" role="presentation">
<a aria-labelledby="layout_91" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca&#x2f;about" role="menuitem">
About Clinical Answers
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_116" role="presentation">
<a aria-labelledby="layout_116" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-library" role="menuitem">
About the Cochrane Library
</a>
</li>
<li class=" child-nav-item" id="layout_34" role="presentation">
<a aria-labelledby="layout_34" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochrane&#x2e;org&#x2f;about-us" role="menuitem">
About Cochrane
</a>
</li>
<li class=" child-nav-item" id="layout_121" role="presentation">
<a aria-labelledby="layout_121" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-reviews" role="menuitem">
About Cochrane Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_92" role="presentation">
<a aria-labelledby="layout_92" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;author-information" role="menuitem">
Information for authors
</a>
</li>
<li class=" child-nav-item" id="layout_188" role="presentation">
<a aria-labelledby="layout_188" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;releases" role="menuitem">
What&#039;s new
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_177" role="presentation">
<a aria-labelledby="layout_177" href="https&#x3a;&#x2f;&#x2f;www&#x2e;wiley&#x2e;com&#x2f;network&#x2f;cochranelibrarytraining" role="menuitem">
Cochrane Library Training
</a>
</li>
<li class=" child-nav-item" id="layout_44" role="presentation">
<a aria-labelledby="layout_44" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;access" role="menuitem">
Access options
</a>
</li>
<li class=" child-nav-item" id="layout_150" role="presentation">
<a aria-labelledby="layout_150" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;permissions" role="menuitem">
Permissions and reprints
</a>
</li>
<li class=" child-nav-item" id="layout_93" role="presentation">
<a aria-labelledby="layout_93" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;media" role="menuitem">
Media information
</a>
</li>
<li class=" child-nav-item" id="layout_97" role="presentation">
<a aria-labelledby="layout_97" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;contact-us" role="menuitem">
Contact us
</a>
</li>
<li class=" child-nav-item" id="layout_125" role="presentation">
<a aria-labelledby="layout_125" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;terms-and-conditions" role="menuitem">
Terms and conditions
</a>
</li>
<li class=" child-nav-item" id="layout_176" role="presentation">
<a aria-labelledby="layout_176" href="https&#x3a;&#x2f;&#x2f;hub&#x2e;wiley&#x2e;com&#x2f;docs&#x2f;cochrane-library&#x2f;cochrane-library-known-issues-DOC-16221&#x3f;referrer&#x3d;cochrane" role="menuitem">
Known issues
</a>
</li>
</ul>
</li>
<li class="about-link"><a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img id="etlj__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <section class="content-language-banner system-message-container" data-content-language="en" data-portal-language="en" style="display: none"> <div class="container"> <a href="#0" class="fa fa-times content-language-banner-close pull-right" aria-label="Close"></a> <i class="fa fa-globe" aria-hidden="true"></i> <div class="system-message-title">Content Language Selection</div> <div class="system-message-description">Your language preference is set to <strong class="language">English</strong>. Where translations are available, article sections will display in this language. Return to <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=reset-content-language&p_p_cacheability=cacheLevelPage" class="language secondary">English</a>.</div> </div> </section> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div id="content" class="">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="rjus__column1__0" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools"> <li class="cdsr-nav-link pulldown-menu readcube-menu closed"> <a href="#0" class="pulldown-menu-trigger"> <i class="icon fa fa-file-pdf-o"></i>View PDF <i aria-hidden="true" class="fa fa-caret-up"></i> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/pdf/full/en" class="download media pdf-link-full pdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/epdf/full/en" class="download media pdf-link-full readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/pdf/standard/en" class="download media pdf-link-standard pdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/epdf/standard/en" class="download media pdf-link-standard readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/pdf/abstract/en" class="download media pdf-link-abstract pdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/epdf/abstract/en" class="download media pdf-link-abstract readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="cdsr-nav-link cite-article-link" data-article-id="CD011038.PUB2" data-modal-title="Cite this Review"> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/#"> <i class="icon fa fa-share"></i>Cite this Review </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-english-only-message="Please note, that requesting permissions is available in English only. Apologies for any inconvenience." href="/cdsr/doi/10.1002/14651858.CD011038.pub2/#" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false"> <span class="request-permissions-icon"></span> Request Permissions </a> </li> <li class="cdsr-nav-link comment-on-review"> <a id="comment-on-review" class="js-old-version-modal-trigger" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/comment" data-new-version="" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience."> <i class="icon fa fa-comment"></i>Comment on Review </a> </li> <li class="cdsr-nav-link comment-on"> <span>Read comments on this Review(0)</span> </li> </ul> <ul class="share clearfix"> <li class="cdsr-nav-link print-cdsr-link" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011038.pub2/print" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;za&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Data and analysis&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;}]}]"> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/#"> <i class="icon fa fa-print"></i>Print </a> </li> <li class="cdsr-nav-link share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011038.pub2/full"> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/#"> <i class="icon fa fa-share-alt"></i>Share </a> </li> <li class="cdsr-nav-link"> <a href="/c/portal/login" class="article-not-followed cochrane-link signin"> <span class="article-follow-display"><i class="icon fa fa-plus"></i>Follow</span> </a> </li> </ul> <ul id="linked-articles" data-type="cdsr" class="linked-content tools clearfix linked-content-trigger"> <li> <a href="#0"> <span class="linked-to-this"> Linked to this Review <span class="linked-content-count"></span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> </li> </ul> <ul class="linked-content-dropdown"> <li data-type="cca" class="linked-cca"> <p>Cochrane Clinical Answers</p> </li> <li data-type="editorial" class="linked-editorials"> <p>Editorials</p> </li> <li data-type="podcast" class="linked-podcasts"> <p>Podcasts</p> </li> <li data-type="sc" class="linked-sc"> <p>Special Collections</p> </li> </ul> <ul class="nav-long-form"> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-sec1-0007"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-sec1-0001"> Summary of findings </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-sec1-0002"> Background </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-sec1-0003"> Objectives </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-sec1-0004"> Methods </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-sec1-0005"> Results </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-sec1-0006"> Discussion </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/appendices#CD011038-sec1-0012"> Appendices </a> </li> </ul> <ul> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/information"> Information </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/information#authors"> Authors </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/information#history"> History </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/information#keywords"> Keywords </a> </li> </ul> <ul> <li class="cdsr-nav-link bold-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/#"> <i class="icon fa fa-globe"></i>Translation notes </a> </li> </ul> <ul> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references"> References </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#dataAndAnalyses"> Data and analyses </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/#"> <i class="icon fa fa-line-chart"></i>Figures and tables </a> </li> <li class="cdsr-nav-link download-stats-data-link " data-download-href="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/table_n/CD011038StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/table_n/CD011038StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <i class="icon fa fa-download"></i>Download statistical data </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i>Related content <span class="note podcast-indicator">Podcast available</span> </a> </li> </ul> </nav> </div> <article class="information" data-article-id="CD011038.PUB2"> <header> <h1 class="publication-title"><h1 lang="en" class="publication-title">Topical antimicrobial agents for treating foot ulcers in people with diabetes</h1></h1> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div><h2 class="title section-collapse-title"> References <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <section class="references bibliographies" id="references"> <section> <div class="section-header" id="CD011038-bbs1-0001"> <h3 class="title">References to studies included in this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD011038-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0003">studies awaiting assessment</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0004">ongoing studies</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0005">additional references</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0006">other published versions</a></li> </ul> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0001"> <div class="reference-title-banner"> <h4 class="title">Ahmed 2014 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0001"> <div class="citation-journal">Ahmed A, Ahmed MI. <span class="citation-title">A comparison of efficacy of topical use of phenytoin and Vaseline gauze dressing with Vaseline gauze dressing alone in healing of diabetic foot ulcers</span>. <span class="citation"> Journal of Postgraduate Medical Institute </span><span class="pubYear">2014</span>;<span class="volume">28</span>(3):297‐302. <a class="crsref citation-link central-link" data-crsref="5747943" href="" ref="info:x-wiley/crsRef/5747943" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparison+of+efficacy+of+topical+use+of+phenytoin+and+Vaseline+gauze+dressing+with+Vaseline+gauze+dressing+alone+in+healing+of+diabetic+foot+ulcers+&author=A+Ahmed&author=MI+Ahmed&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0002"> <div class="reference-title-banner"> <h4 class="title">Apelqvist 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0002"> <div class="citation-journal">Apelqvist J, Ragnarson‐Tennvall G. <span class="citation-title">Cavity foot ulcers in diabetic patients: a comparative study of cadexomer iodine ointment and standard treatment. An economic analysis alongside a clinical trial</span>. <span class="citation"> Acta Dermato‐Venereologica </span><span class="pubYear">1996</span>;<span class="volume">76</span>(3):231‐5. <a class="crsref citation-link central-link" data-crsref="5747945" href="" ref="info:x-wiley/crsRef/5747945" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8800307" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Cavity+foot+ulcers+in+diabetic+patients:+a+comparative+study+of+cadexomer+iodine+ointment+and+standard+treatment.+An+economic+analysis+alongside+a+clinical+trial+&author=J+Apelqvist&author=G+Ragnarson%E2%80%90Tennvall&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0003"> <div class="reference-title-banner"> <h4 class="title">Bergqvist 2016 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0003"> <div class="citation-journal">Bergqvist K, Almhöjd U, Herrmann I, Eliasson B. <span class="citation-title">The role of chloramines in treatment of diabetic foot ulcers: an exploratory multicentre randomised controlled trial</span>. <span class="citation"> Clinical Diabetes and Endocrinology </span><span class="pubYear">2016</span>;<span class="volume">2</span>(6):1‐7. <a class="crsref citation-link central-link" data-crsref="5747947" href="" ref="info:x-wiley/crsRef/5747947" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/28702237" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+role+of+chloramines+in+treatment+of+diabetic+foot+ulcers:+an+exploratory+multicentre+randomised+controlled+trial+&author=K+Bergqvist&author=U+Almh%C3%B6jd&author=I+Herrmann&author=B+Eliasson&publication_year=2016&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0004"> <div class="reference-title-banner"> <h4 class="title">Bowling 2011 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0004"> <div class="citation-journal">Bowling FL, Crews RT, Salgami E, Armstrong DG, Boulton AJ. <span class="citation-title">The use of superoxidized aqueous solution versus saline as a replacement solution in the Versajet lavage system in chronic diabetic foot ulcers</span>. <span class="citation"> Journal of the American Podiatric Medical Association </span><span class="pubYear">2011</span>;<span class="volume">101</span>(2):124‐6. <a class="crsref citation-link central-link" data-crsref="5747949" href="" ref="info:x-wiley/crsRef/5747949" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21406695" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+use+of+superoxidized+aqueous+solution+versus+saline+as+a+replacement+solution+in+the+Versajet+lavage+system+in+chronic+diabetic+foot+ulcers+&author=FL+Bowling&author=RT+Crews&author=E+Salgami&author=DG+Armstrong&author=AJ+Boulton&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0005"> <div class="reference-title-banner"> <h4 class="title">Gottrup 2013 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0005"> <div class="citation-journal">Gottrup F, Cullen BM, Karlsmark T, Bischoff‐Mikkelsen M, Nisbet L, Gibson MC. <span class="citation-title">Randomized controlled trial on collagen/oxidized regenerated cellulose/silver treatment</span>. <span class="citation"> Wound Repair and Regeneration </span><span class="pubYear">2013</span>;<span class="volume">21</span>:1‐10. <a class="crsref citation-link central-link" data-crsref="5747951" href="" ref="info:x-wiley/crsRef/5747951" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/23126632" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Randomized+controlled+trial+on+collagen/oxidized+regenerated+cellulose/silver+treatment&author=F+Gottrup&author=BM+Cullen&author=T+Karlsmark&author=M+Bischoff%E2%80%90Mikkelsen&author=L+Nisbet&author=MC+Gibson&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0006"> <div class="reference-title-banner"> <h4 class="title">He 2016 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0006"> <div class="citation-journal">He WQ, Luo WH, Li L, Jiang L. <span class="citation-title">Effects of silver ions dressing for diabetic foot ulcers: a randomized controlled trial</span> [银离子敷料治疗糖尿病足溃疡的疗效观察]. <span class="citation"> Chinese Journal of Evidence‐Based Medicine </span><span class="pubYear">2016</span>;<span class="volume">5</span>:510‐2. <a class="crsref citation-link central-link" data-crsref="5747953" href="" ref="info:x-wiley/crsRef/5747953" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+silver+ions+dressing+for+diabetic+foot+ulcers:+a+randomized+controlled+trial+&author=WQ+He&author=WH+Luo&author=L+Li&author=L+Jiang&publication_year=2016&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0007"> <div class="reference-title-banner"> <h4 class="title">Hwang 2010 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0007"> <div class="citation-journal">Hwang JH, Kim KS, Lee SY. <span class="citation-title">Hydrofibre dressings with silver in the management of diabetic foot ulcers</span>. <span class="citation"> EWMA Journal </span><span class="pubYear">2010</span>;<span class="volume">10</span>(2):136. [Abstract P57]<a class="crsref citation-link central-link" data-crsref="5747955" href="" ref="info:x-wiley/crsRef/5747955" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Hydrofibre+dressings+with+silver+in+the+management+of+diabetic+foot+ulcers&author=JH+Hwang&author=KS+Kim&author=SY+Lee&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0008"> <div class="reference-title-banner"> <h4 class="title">Imran 2015 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0008"> <div class="citation-journal">Imran M, Hussain MB, Baig M. <span class="citation-title">A randomized, controlled clinical trial of honey‐impregnated dressing for treating diabetic foot ulcer</span>. <span class="citation"> Journal of the College of Physicians and Surgeons ‐ Pakistan </span><span class="pubYear">2015</span>;<span class="volume">25</span>:721‐5. <a class="crsref citation-link central-link" data-crsref="5747957" href="" ref="info:x-wiley/crsRef/5747957" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/26454386" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized,+controlled+clinical+trial+of+honey%E2%80%90impregnated+dressing+for+treating+diabetic+foot+ulcer+&author=M+Imran&author=MB+Hussain&author=M+Baig&publication_year=2015&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0009"> <div class="reference-title-banner"> <h4 class="title">Jacobs 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0009"> <div class="citation-journal">Jacobs AM, Tomczak R. <span class="citation-title">Evaluation of Bensal HP for the treatment of diabetic foot ulcers</span>. <span class="citation"> Advances in Skin &amp; Wound Care </span><span class="pubYear">2008</span>;<span class="volume">21</span>(10):461‐5. <a class="crsref citation-link central-link" data-crsref="5747959" href="" ref="info:x-wiley/crsRef/5747959" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18836324" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Evaluation+of+Bensal+HP+for+the+treatment+of+diabetic+foot+ulcers&author=AM+Jacobs&author=R+Tomczak&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0010"> <div class="reference-title-banner"> <h4 class="title">Jeffcoate 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0010"> <div class="citation-journal">Jeffcoate WJ, Price PE, Phillips CJ, Game FL, Mudge E, Davies S, et al. <span class="citation-title">Randomised controlled trial of the use of three dressing preparations in the management of chronic ulceration of the foot in diabetes</span>. <span class="citation"> Health Technology Assessment </span><span class="pubYear">2009</span>;<span class="volume">13</span>(54):1‐86. <a class="crsref citation-link central-link" data-crsref="5747961" href="" ref="info:x-wiley/crsRef/5747961" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19922726" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Randomised+controlled+trial+of+the+use+of+three+dressing+preparations+in+the+management+of+chronic+ulceration+of+the+foot+in+diabetes+&author=WJ+Jeffcoate&author=PE+Price&author=CJ+Phillips&author=FL+Game&author=E+Mudge&author=S+Davies&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0011"> <div class="reference-title-banner"> <h4 class="title">Jude 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0011"> <div class="citation-journal">Jude EB, Apelqvist J, Spraul M, Martini J, Silver Dressing Study Group. <span class="citation-title">Prospective randomized controlled study of Hydrofiber dressing containing ionic silver or calcium alginate dressings in non‐ischaemic diabetic foot ulcers</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2007</span>;<span class="volume">24</span>(3):280‐8. <a class="crsref citation-link central-link" data-crsref="5747963" href="" ref="info:x-wiley/crsRef/5747963" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17305788" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prospective+randomized+controlled+study+of+Hydrofiber+dressing+containing+ionic+silver+or+calcium+alginate+dressings+in+non%E2%80%90ischaemic+diabetic+foot+ulcers+&author=EB+Jude&author=J+Apelqvist&author=M+Spraul&author=J+Martini&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0012"> <div class="reference-title-banner"> <h4 class="title">Khandelwal 2013 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0012"> <div class="citation-journal">Khandelwal S, Chaudhary P, Poddar DD, Saxena N, Singh RA, Biswal UC. <span class="citation-title">Comparative study of different treatment options of grade III and IV diabetic foot ulcers to reduce the incidence of amputations</span>. <span class="citation"> Clinics and Practice </span><span class="pubYear">2013</span>;<span class="volume">3</span>(1):20‐4. <a class="crsref citation-link central-link" data-crsref="5747965" href="" ref="info:x-wiley/crsRef/5747965" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparative+study+of+different+treatment+options+of+grade+III+and+IV+diabetic+foot+ulcers+to+reduce+the+incidence+of+amputations+&author=S+Khandelwal&author=P+Chaudhary&author=DD+Poddar&author=N+Saxena&author=RA+Singh&author=UC+Biswal&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0013"> <div class="reference-title-banner"> <h4 class="title">Landsman 2011 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0013"> <div class="citation-journal">Landsman A, Blume PA, Jordan DA, Vayser D, Gutierrez A. <span class="citation-title">An open‐label, three‐arm pilot study of the safety and efficacy of topical Microcyn Rx wound care versus oral levofloxacin versus combined therapy for mild diabetic foot infections</span>. <span class="citation"> Journal of the American Podiatric Medical Association </span><span class="pubYear">2011</span>;<span class="volume">101</span>(6):484‐96. <a class="crsref citation-link central-link" data-crsref="5747967" href="" ref="info:x-wiley/crsRef/5747967" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/22106196" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=An+open%E2%80%90label,+three%E2%80%90arm+pilot+study+of+the+safety+and+efficacy+of+topical+Microcyn+Rx+wound+care+versus+oral+levofloxacin+versus+combined+therapy+for+mild+diabetic+foot+infections+&author=A+Landsman&author=PA+Blume&author=DA+Jordan&author=D+Vayser&author=A+Gutierrez&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0014"> <div class="reference-title-banner"> <h4 class="title">Lipsky 2008a {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0014"> <div class="citation-journal">Lipsky BA, Holroyd KJ, Zasloff M. <span class="citation-title">Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double‐blinded, multicenter trial of Pexiganan cream</span>. <span class="citation"> Clinical Infectious Diseases </span><span class="pubYear">2008</span>;<span class="volume">47</span>(12):1537‐45. <a class="crsref citation-link central-link" data-crsref="5747969" href="" ref="info:x-wiley/crsRef/5747969" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18990064" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Topical+versus+systemic+antimicrobial+therapy+for+treating+mildly+infected+diabetic+foot+ulcers:+a+randomized,+controlled,+double%E2%80%90blinded,+multicenter+trial+of+Pexiganan+cream+&author=BA+Lipsky&author=KJ+Holroyd&author=M+Zasloff&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0015"> <div class="reference-title-banner"> <h4 class="title">Lipsky 2008b {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0015"> <div class="citation-journal">Lipsky BA, Holroyd KJ, Zasloff M. <span class="citation-title">Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double‐blinded, multicenter trial of Pexiganan cream</span>. <span class="citation"> Clinical Infectious Diseases </span><span class="pubYear">2008</span>;<span class="volume">47</span>(12):1537‐45. <a class="crsref citation-link central-link" data-crsref="5747971" href="" ref="info:x-wiley/crsRef/5747971" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18990064" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Topical+versus+systemic+antimicrobial+therapy+for+treating+mildly+infected+diabetic+foot+ulcers:+a+randomized,+controlled,+double%E2%80%90blinded,+multicenter+trial+of+Pexiganan+cream+&author=BA+Lipsky&author=KJ+Holroyd&author=M+Zasloff&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0016"> <div class="reference-title-banner"> <h4 class="title">Lipsky 2012a {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0016"> <div class="citation-journal">Lipsky BA, Kuss M, Edmonds M, Reyzelman A, Sigal F. <span class="citation-title">Topical application of a gentamicin‐collagen sponge combined with systemic antibiotic therapy for the treatment of diabetic foot infections of moderate severity: a randomized, controlled, multicenter clinical trial</span>. <span class="citation"> Journal of the American Podiatric Medical Association </span><span class="pubYear">2012</span>;<span class="volume">102</span>(3):223‐32. <a class="crsref citation-link central-link" data-crsref="5747973" href="" ref="info:x-wiley/crsRef/5747973" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/22659765" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Topical+application+of+a+gentamicin%E2%80%90collagen+sponge+combined+with+systemic+antibiotic+therapy+for+the+treatment+of+diabetic+foot+infections+of+moderate+severity:+a+randomized,+controlled,+multicenter+clinical+trial+&author=BA+Lipsky&author=M+Kuss&author=M+Edmonds&author=A+Reyzelman&author=F+Sigal&publication_year=2012&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0017"> <div class="reference-title-banner"> <h4 class="title">Martinez‐De Jesus 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0017"> <div class="citation-journal">Martinez‐De Jesus FR, Ramos‐De la Medina A, Remes‐Troche JM, Armstrong DG, Wu SC, Lazaro Martinez JL, et al. <span class="citation-title">Efficacy and safety of neutral pH superoxidised solution in severe diabetic foot infections</span>. <span class="citation"> International Wound Journal </span><span class="pubYear">2007</span>;<span class="volume">4</span>:353‐62. <a class="crsref citation-link central-link" data-crsref="5747975" href="" ref="info:x-wiley/crsRef/5747975" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17953678" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+neutral+pH+superoxidised+solution+in+severe+diabetic+foot+infections&author=FR+Martinez%E2%80%90DeJesus&author=A+Ramos%E2%80%90DelaMedina&author=JM+Remes%E2%80%90Troche&author=DG+Armstrong&author=SC+Wu&author=JL+LazaroMartinez&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0018"> <div class="reference-title-banner"> <h4 class="title">Ramos Cuevas 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0018"> <div class="citation-journal">Ramos Cuevas F, Velazquez Mendez AA, Castaneda Andrade I. <span class="citation-title">Zinc hyaluronate effects on ulcers in diabetic patients</span>. <span class="citation"> Gerokomos </span><span class="pubYear">2007</span>;<span class="volume">18</span>(2):91‐101. <a class="crsref citation-link central-link" data-crsref="5747977" href="" ref="info:x-wiley/crsRef/5747977" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Zinc+hyaluronate+effects+on+ulcers+in+diabetic+patients&author=F+RamosCuevas&author=AA+VelazquezMendez&author=I+CastanedaAndrade&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0019"> <div class="reference-title-banner"> <h4 class="title">Shukrimi 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0019"> <div class="citation-journal">Shukrimi A, Sulaiman AR, Halim AY, Azril A. <span class="citation-title">A comparative study between honey and povidone iodine as dressing solution for Wagner Type II diabetic foot ulcers</span>. <span class="citation"> Medical Journal of Malaysia </span><span class="pubYear">2008</span>;<span class="volume">63</span>(1):44‐6. <a class="crsref citation-link central-link" data-crsref="5747979" href="" ref="info:x-wiley/crsRef/5747979" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18935732" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparative+study+between+honey+and+povidone+iodine+as+dressing+solution+for+Wagner+Type+II+diabetic+foot+ulcers+&author=A+Shukrimi&author=AR+Sulaiman&author=AY+Halim&author=A+Azril&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0020"> <div class="reference-title-banner"> <h4 class="title">Tom 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0020"> <div class="citation-journal">Tom WL, Peng DH, Allaei A, Hsu D, Hata TR. <span class="citation-title">The effect of short‐contact topical tretinoin therapy for foot ulcers in patients with diabetes</span>. <span class="citation"> Archives of Dermatology </span><span class="pubYear">2005</span>;<span class="volume">141</span>(11):1373‐7. <a class="crsref citation-link central-link" data-crsref="5747981" href="" ref="info:x-wiley/crsRef/5747981" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16301384" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+short%E2%80%90contact+topical+tretinoin+therapy+for+foot+ulcers+in+patients+with+diabetes+&author=WL+Tom&author=DH+Peng&author=A+Allaei&author=D+Hsu&author=TR+Hata&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0021"> <div class="reference-title-banner"> <h4 class="title">Ullal 2014 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0021"> <div class="citation-journal">Ullal S, Adhikari P. <span class="citation-title">Efficacy of honey in healing diabetic ulcers: a pilot study</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2014</span>;<span class="volume">106</span>(1 Suppl):S63‐4. [Poster PO037]<a class="crsref citation-link central-link" data-crsref="5747983" href="" ref="info:x-wiley/crsRef/5747983" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+honey+in+healing+diabetic+ulcers:+a+pilot+study&author=S+Ullal&author=P+Adhikari&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD011038-bbs2-0022"> <div class="reference-title-banner"> <h4 class="title">Viswanathan 2011 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0022"> <div class="citation-journal">Viswanathan V, Kesavan R, Kavitha KV, Kumpatla S. <span class="citation-title">A pilot study on the effects of a polyherbal formulation cream on diabetic foot ulcers</span>. <span class="citation"> Indian Journal of Medical Research </span><span class="pubYear">2011</span>;<span class="volume">134</span>(2):168‐73. <a class="crsref citation-link central-link" data-crsref="5747985" href="" ref="info:x-wiley/crsRef/5747985" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21911968" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+pilot+study+on+the+effects+of+a+polyherbal+formulation+cream+on+diabetic+foot+ulcers&author=V+Viswanathan&author=R+Kesavan&author=KV+Kavitha&author=S+Kumpatla&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD011038-bbs1-0002"> <h3 class="title">References to studies excluded from this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD011038-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0003">studies awaiting assessment</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0004">ongoing studies</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0005">additional references</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0006">other published versions</a></li> </ul> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0023"> <div class="reference-title-banner"> <h4 class="title">Abidia 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0023"> <div class="citation-journal">Abidia A, Laden G, Kuhan G, Johnson BF, Wilkinson AR, Renwick PM, et al. <span class="citation-title">The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial</span>. <span class="citation"> European Journal of Vascular and Endovascular Surgery </span><span class="pubYear">2003</span>;<span class="volume">25</span>(6):513‐8. <a class="crsref citation-link central-link" data-crsref="5747987" href="" ref="info:x-wiley/crsRef/5747987" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12787692" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+role+of+hyperbaric+oxygen+therapy+in+ischaemic+diabetic+lower+extremity+ulcers:+a+double%E2%80%90blind+randomised%E2%80%90controlled+trial+&author=A+Abidia&author=G+Laden&author=G+Kuhan&author=BF+Johnson&author=AR+Wilkinson&author=PM+Renwick&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0024"> <div class="reference-title-banner"> <h4 class="title">Ajmeer 2015 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0024"> <div class="citation-journal">Ajmeer AS, Dudhamal TS, Gupta SK. <span class="citation-title">Management of Madhumehajanya Vrana (diabetic wound) with Katupila (Securinega leucopyrus (Willd) Muell.) Kalka</span>. <span class="citation"> AYU </span><span class="pubYear">2015</span>;<span class="volume">36</span>(3):351‐5. <a class="crsref citation-link central-link" data-crsref="5747989" href="" ref="info:x-wiley/crsRef/5747989" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/27313426" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Management+of+Madhumehajanya+Vrana+(diabetic+wound)+with+Katupila+(Securinega+leucopyrus+(Willd)+Muell.)+Kalka+&author=AS+Ajmeer&author=TS+Dudhamal&author=SK+Gupta&publication_year=2015&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0025"> <div class="reference-title-banner"> <h4 class="title">Al‐Ebous 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0025"> <div class="citation-journal">Al‐Ebous AD, Hiasat B, Sarayrah M, Al‐Jahmi M, Al‐Zuriqat AN. <span class="citation-title">Management of diabetic foot in a Jordanian hospital</span>. <span class="citation"> Eastern Mediterranean Health Journal </span><span class="pubYear">2005</span>;<span class="volume">11</span>(3):490‐3. <a class="crsref citation-link central-link" data-crsref="5747991" href="" ref="info:x-wiley/crsRef/5747991" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16602471" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Management+of+diabetic+foot+in+a+Jordanian+hospital&author=AD+Al%E2%80%90Ebous&author=B+Hiasat&author=M+Sarayrah&author=M+Al%E2%80%90Jahmi&author=AN+Al%E2%80%90Zuriqat&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0026"> <div class="reference-title-banner"> <h4 class="title">Alzahrani 2013 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0026"> <div class="citation-journal">Alzahrani H, Bedir Y, Al‐Hayani A. <span class="citation-title">Efficacy of shellac, a natural product, for the prevention of wet gangrene</span>. <span class="citation"> Journal of International Medical Research </span><span class="pubYear">2013</span>;<span class="volume">41</span>(3):795–803. <a class="crsref citation-link central-link" data-crsref="5747993" href="" ref="info:x-wiley/crsRef/5747993" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/23637276" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+shellac,+a+natural+product,+for+the+prevention+of+wet+gangrene&author=H+Alzahrani&author=Y+Bedir&author=A+Al%E2%80%90Hayani&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0027"> <div class="reference-title-banner"> <h4 class="title">Bahar 2015 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0027"> <div class="citation-journal">Bahar A, Saeedi M, Kshi Z, Davoodi M. <span class="citation-title">The effect of Aloe vera and honey gel in healing diabetic foot ulcers</span>. <span class="citation"> Journal of Mazandaran University of Medical Sciences </span><span class="pubYear">2015</span>;<span class="volume">25</span>(128):110‐4. <a class="crsref citation-link central-link" data-crsref="5747995" href="" ref="info:x-wiley/crsRef/5747995" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+Aloe+vera+and+honey+gel+in+healing+diabetic+foot+ulcers&author=A+Bahar&author=M+Saeedi&author=Z+Kshi&author=M+Davoodi&publication_year=2015&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0028"> <div class="reference-title-banner"> <h4 class="title">Belcaro 2010 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0028"> <div class="citation-journal">Belcaro G, Cesarone MR, Errichi BM, Ricci A, Dugall M, Pellegrini L, et al. <span class="citation-title">Venous and diabetic ulcerations: management with topical multivalent silver oxide ointment</span>. <span class="citation"> Panminerva Medica </span><span class="pubYear">2010</span>;<span class="volume">52</span>(2 Suppl 1):37‐42. <a class="crsref citation-link central-link" data-crsref="5747997" href="" ref="info:x-wiley/crsRef/5747997" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/20657533" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Venous+and+diabetic+ulcerations:+management+with+topical+multivalent+silver+oxide+ointment+&author=G+Belcaro&author=MR+Cesarone&author=BM+Errichi&author=A+Ricci&author=M+Dugall&author=L+Pellegrini&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0029"> <div class="reference-title-banner"> <h4 class="title">Braumann 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0029"> <div class="citation-other">Braumann C, Pirlich M, Menenakos C, Lochs H, Mueller JM. <span class="citation-title">Implementation of the clean and close concept for treatment of surgical and chronic wounds in three university centres in Berlin Germany</span>. old.ewma.org/fileadmin/user_upload/EWMA/pdf/conference_abstracts/2008/oral/44._pdf.pdf (accessed 3 February 2017). <a class="crsref citation-link central-link" data-crsref="5747999" href="" ref="info:x-wiley/crsRef/5747999" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0030"> <div class="reference-title-banner"> <h4 class="title">Braumann 2011 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0030"> <div class="citation-journal">Braumann C, Guenther N, Menenakos C, Muenzberg H, Pirlich M, Lochs H, et al. <span class="citation-title">Clinical experiences derived from implementation of an easy to use concept for treatment of wound healing by secondary intention and guidance in selection of appropriate dressings</span>. <span class="citation"> International Wound Journal </span><span class="pubYear">2011</span>;<span class="volume">8</span>(3):253‐60. <a class="crsref citation-link central-link" data-crsref="5748001" href="" ref="info:x-wiley/crsRef/5748001" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21401884" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Clinical+experiences+derived+from+implementation+of+an+easy+to+use+concept+for+treatment+of+wound+healing+by+secondary+intention+and+guidance+in+selection+of+appropriate+dressings+&author=C+Braumann&author=N+Guenther&author=C+Menenakos&author=H+Muenzberg&author=M+Pirlich&author=H+Lochs&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0031"> <div class="reference-title-banner"> <h4 class="title">Dalla Paola 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0031"> <div class="citation-journal">Dalla Paola L, Brocco E, Senesi A, Ninkovic S, Merico M, Vido D. <span class="citation-title">Use of Dermacyn, a new antiseptic agent, for the local treatment of diabetic foot ulcers</span>. <span class="citation"> Journal of Wound Healing </span><span class="pubYear">2005</span>;<span class="volume">2</span>:201. <a class="crsref citation-link central-link" data-crsref="5748003" href="" ref="info:x-wiley/crsRef/5748003" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Use+of+Dermacyn,+a+new+antiseptic+agent,+for+the+local+treatment+of+diabetic+foot+ulcers+&author=L+DallaPaola&author=E+Brocco&author=A+Senesi&author=S+Ninkovic&author=M+Merico&author=D+Vido&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0032"> <div class="reference-title-banner"> <h4 class="title">Della Marchina 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0032"> <div class="citation-journal">Della Marchina M, Renzi G. <span class="citation-title">A new antiseptic preparation used for the disinfection of cutaneous distrophic ulcers</span>. <span class="citation"> Chronica Dermatologica </span><span class="pubYear">1997</span>;<span class="volume">7</span>(6):873‐85. <a class="crsref citation-link central-link" data-crsref="5748005" href="" ref="info:x-wiley/crsRef/5748005" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+new+antiseptic+preparation+used+for+the+disinfection+of+cutaneous+distrophic+ulcers&author=M+DellaMarchina&author=G+Renzi&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0033"> <div class="reference-title-banner"> <h4 class="title">Driver 2015 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0033"> <div class="citation-journal">Driver VR, Lavery LA, Reyzelman AM, Dutra TG, Dove CR, Kotsis SV, et al. <span class="citation-title">A clinical trial of Integra Template for diabetic foot ulcer treatment</span>. <span class="citation"> Wound Repair and Regeneration </span><span class="pubYear">2015</span>;<span class="volume">23</span>(6):891‐900. <a class="crsref citation-link central-link" data-crsref="5748007" href="" ref="info:x-wiley/crsRef/5748007" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/26297933" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+clinical+trial+of+Integra+Template+for+diabetic+foot+ulcer+treatment&author=VR+Driver&author=LA+Lavery&author=AM+Reyzelman&author=TG+Dutra&author=CR+Dove&author=SV+Kotsis&publication_year=2015&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0034"> <div class="reference-title-banner"> <h4 class="title">Dwivedi 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0034"> <div class="citation-other">Dwivedi KN, Shukla VK, Ojha JK. <span class="citation-title">Role of plant extract in non‐healing diabetic foot ulcers</span>. 10th Conference of the European Wound Management Association; 2000 May 18‐20; Stockholm, Sweden. <span class="pubYear">2000</span>:27. <a class="crsref citation-link central-link" data-crsref="5748009" href="" ref="info:x-wiley/crsRef/5748009" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Role+of+plant+extract+in+non%E2%80%90healing+diabetic+foot+ulcers&author=KN+Dwivedi&author=VK+Shukla&author=JK+Ojha&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0035"> <div class="reference-title-banner"> <h4 class="title">Gao 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0035"> <div class="citation-journal">Gao L, Xu GX, Zhou HB. <span class="citation-title">Efficacy evaluation of diabetic foot ulceration treated with iodophors dressings therapy</span>. <span class="citation"> Journal of Clinical Nursing </span><span class="pubYear">2007</span>;<span class="volume">6</span>:21‐2. <a class="crsref citation-link central-link" data-crsref="5748011" href="" ref="info:x-wiley/crsRef/5748011" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+evaluation+of+diabetic+foot+ulceration+treated+with+iodophors+dressings+therapy&author=L+Gao&author=GX+Xu&author=HB+Zhou&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0036"> <div class="reference-title-banner"> <h4 class="title">Gibbons 2015 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0036"> <div class="citation-journal">Gibbons GW. <span class="citation-title">Grafix, a cryopreserved placental membrane, for the treatment of chronic/stalled wounds</span>. <span class="citation"> Advances in Wound Care </span><span class="pubYear">2015</span>;<span class="volume">4</span>(9):534‐44. <a class="crsref citation-link central-link" data-crsref="5748013" href="" ref="info:x-wiley/crsRef/5748013" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/26339532" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Grafix,+a+cryopreserved+placental+membrane,+for+the+treatment+of+chronic/stalled+wounds&author=GW+Gibbons&publication_year=2015&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0037"> <div class="reference-title-banner"> <h4 class="title">Hadi 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0037"> <div class="citation-journal">Hadi SF, Khaliq T, Bilal N, Sikandar I, Saaiq M, Aurangzeb S. <span class="citation-title">Treating infected diabetic wounds with superoxidized water as antiseptic agent: a preliminary experience</span>. <span class="citation"> Journal of the College of Physicians and Surgeons ‐ Pakistan </span><span class="pubYear">2007</span>;<span class="volume">17</span>(12):740‐3. <a class="crsref citation-link central-link" data-crsref="5748015" href="" ref="info:x-wiley/crsRef/5748015" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18182139" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treating+infected+diabetic+wounds+with+superoxidized+water+as+antiseptic+agent:+a+preliminary+experience+&author=SF+Hadi&author=T+Khaliq&author=N+Bilal&author=I+Sikandar&author=M+Saaiq&author=S+Aurangzeb&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0038"> <div class="reference-title-banner"> <h4 class="title">Kamaratos 2014 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0038"> <div class="citation-journal">Kamaratos AV, Tzirogiannis KN, Iraklianou SA, Panoutsopoulos GI, Kanellos IE, Melidonis AI. <span class="citation-title">Manuka honey‐impregnated dressings in the treatment of neuropathic diabetic foot ulcers</span>. <span class="citation"> International Wound Journal </span><span class="pubYear">2014</span>;<span class="volume">11</span>(3):259‐63. <a class="crsref citation-link central-link" data-crsref="5748017" href="" ref="info:x-wiley/crsRef/5748017" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/22985336" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Manuka+honey%E2%80%90impregnated+dressings+in+the+treatment+of+neuropathic+diabetic+foot+ulcers&author=AV+Kamaratos&author=KN+Tzirogiannis&author=SA+Iraklianou&author=GI+Panoutsopoulos&author=IE+Kanellos&author=AI+Melidonis&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0039"> <div class="reference-title-banner"> <h4 class="title">Kapur 2011 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0039"> <div class="citation-journal">Kapur V, Marwaha AK. <span class="citation-title">Evaluation of effect and comparison of superoxidised solution (Oxum) vs povidone iodine (Betadine)</span>. <span class="citation"> Indian Journal of Surgery </span><span class="pubYear">2011</span>;<span class="volume">73</span>(1):48‐53. <a class="crsref citation-link central-link" data-crsref="5748019" href="" ref="info:x-wiley/crsRef/5748019" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/22211038" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Evaluation+of+effect+and+comparison+of+superoxidised+solution+(Oxum)+vs+povidone+iodine+(Betadine)+&author=V+Kapur&author=AK+Marwaha&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0040"> <div class="reference-title-banner"> <h4 class="title">Kastelan 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0040"> <div class="citation-journal">Kastelan M, Brajac I, Gruber F. <span class="citation-title">Treatment of leg ulcers with autologous heparinized blood</span>. <span class="citation"> Acta Dermato‐Venereologica </span><span class="pubYear">1998</span>;<span class="volume">7</span>:30‐4. <a class="crsref citation-link central-link" data-crsref="5748021" href="" ref="info:x-wiley/crsRef/5748021" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treatment+of+leg+ulcers+with+autologous+heparinized+blood&author=M+Kastelan&author=I+Brajac&author=F+Gruber&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0041"> <div class="reference-title-banner"> <h4 class="title">Lázaro‐Martínez 2014 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0041"> <div class="citation-journal">Lázaro‐Martínez JL, Aragón‐Sánchez J, García‐Morales E. <span class="citation-title">Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2014</span>;<span class="volume">37</span>(3):789‐95. <a class="crsref citation-link central-link" data-crsref="5748023" href="" ref="info:x-wiley/crsRef/5748023" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/24130347" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Antibiotics+versus+conservative+surgery+for+treating+diabetic+foot+osteomyelitis:+a+randomized+comparative+trial+&author=JL+L%C3%A1zaro%E2%80%90Mart%C3%ADnez&author=J+Arag%C3%B3n%E2%80%90S%C3%A1nchez&author=E+Garc%C3%ADa%E2%80%90Morales&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0042"> <div class="reference-title-banner"> <h4 class="title">Li 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0042"> <div class="citation-journal">Li HM, Liang ZQ, Meng CY, Li DH. <span class="citation-title">The efficacy and safety of recombinant human epidermal growth factor in 4 types of wounds</span>. <span class="citation"> Chinese Journal of New Drugs </span><span class="pubYear">2004</span>;<span class="volume">13</span>(11):1048‐50. <a class="crsref citation-link central-link" data-crsref="5748025" href="" ref="info:x-wiley/crsRef/5748025" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+efficacy+and+safety+of+recombinant+human+epidermal+growth+factor+in+4+types+of+wounds+&author=HM+Li&author=ZQ+Liang&author=CY+Meng&author=DH+Li&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0043"> <div class="reference-title-banner"> <h4 class="title">Li 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0043"> <div class="citation-journal">Li Y, Song Z‐Q, Ren H‐Z. <span class="citation-title">Alprostadil combined with deproteinized calf blood extractives injection for treatment of diabetic foot</span>. <span class="citation"> Journal of Clinical Rehabilitative Tissue Engineering Research </span><span class="pubYear">2008</span>;<span class="volume">12</span>(50):9970‐2. <a class="crsref citation-link central-link" data-crsref="5748027" href="" ref="info:x-wiley/crsRef/5748027" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Alprostadil+combined+with+deproteinized+calf+blood+extractives+injection+for+treatment+of+diabetic+foot+&author=Y+Li&author=Z%E2%80%90Q+Song&author=H%E2%80%90Z+Ren&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0044"> <div class="reference-title-banner"> <h4 class="title">Li 2011 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0044"> <div class="citation-journal">Li FL, Deng H, Wang HW, Xu R, Chen J, Wang YF, et al. <span class="citation-title">Effects of external application of Chinese medicine on diabetic ulcers and the expressions of β‐catenin, c‐myc and K6</span>. <span class="citation"> Chinese Journal of Integrative Medicine </span><span class="pubYear">2011</span>;<span class="volume">17</span>(4):261‐6. <a class="crsref citation-link central-link" data-crsref="5748029" href="" ref="info:x-wiley/crsRef/5748029" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21509668" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+external+application+of+Chinese+medicine+on+diabetic+ulcers+and+the+expressions+of+%CE%B2%E2%80%90catenin,+c%E2%80%90myc+and+K6+&author=FL+Li&author=H+Deng&author=HW+Wang&author=R+Xu&author=J+Chen&author=YF+Wang&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0045"> <div class="reference-title-banner"> <h4 class="title">Lipsky 2015 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0045"> <div class="citation-journal">Lipsky BA, Cannon CM, Ramani A, Jandourek A, Calmaggi A, Friedland HD, et al. <span class="citation-title">Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experience</span>. <span class="citation"> Diabetes/Metabolism Research and Reviews </span><span class="pubYear">2015</span>;<span class="volume">31</span>(4):395‐401. <a class="crsref citation-link central-link" data-crsref="5748031" href="" ref="info:x-wiley/crsRef/5748031" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Ceftaroline+fosamil+for+treatment+of+diabetic+foot+infections:+the+CAPTURE+study+experience&author=BA+Lipsky&author=CM+Cannon&author=A+Ramani&author=A+Jandourek&author=A+Calmaggi&author=HD+Friedland&publication_year=2015&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0046"> <div class="reference-title-banner"> <h4 class="title">Lishner 1985 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0046"> <div class="citation-journal">Lishner M, Lang R, Kedar I, Ravid M. <span class="citation-title">Treatment of diabetic perforating ulcers (mal perforant) with local dimethylsulfoxide</span>. <span class="citation"> Journal of the American Geriatrics Society </span><span class="pubYear">1985</span>;<span class="volume">33</span>(1):41‐3. <a class="crsref citation-link central-link" data-crsref="5748033" href="" ref="info:x-wiley/crsRef/5748033" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3880781" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treatment+of+diabetic+perforating+ulcers+(mal+perforant)+with+local+dimethylsulfoxide&author=M+Lishner&author=R+Lang&author=I+Kedar&author=M+Ravid&publication_year=1985&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0047"> <div class="reference-title-banner"> <h4 class="title">Londahl 2013 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0047"> <div class="citation-other">Londahl M, Sjoberg S, Apelqvist J. <span class="citation-title">Monochromatic phototherapy enhances healing rate in diabetic foot ulcers</span>. EWMA Journal<span class="pubYear">2013</span>; Vol. 13, issue 1 Suppl:54. [Abstract 70]<a class="crsref citation-link central-link" data-crsref="5748035" href="" ref="info:x-wiley/crsRef/5748035" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Monochromatic+phototherapy+enhances+healing+rate+in+diabetic+foot+ulcers&author=M+Londahl&author=S+Sjoberg&author=J+Apelqvist&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0048"> <div class="reference-title-banner"> <h4 class="title">Mahmoud 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0048"> <div class="citation-journal">Mahmoud SM, Mohamed AA, Mahdi SE, Ahmed ME. <span class="citation-title">Split‐skin graft in the management of diabetic foot ulcers</span>. <span class="citation"> Journal of Wound Care </span><span class="pubYear">2008</span>;<span class="volume">17</span>(7):303‐6. <a class="crsref citation-link central-link" data-crsref="5748037" href="" ref="info:x-wiley/crsRef/5748037" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18705232" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Split%E2%80%90skin+graft+in+the+management+of+diabetic+foot+ulcers&author=SM+Mahmoud&author=AA+Mohamed&author=SE+Mahdi&author=ME+Ahmed&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0049"> <div class="reference-title-banner"> <h4 class="title">Martinez‐Sanchez 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0049"> <div class="citation-journal">Martínez‐Sánchez G, Al‐Dalaina SM, Menéndez S, Rec L, Giuliani A, Candelario‐Jalila E, et al. <span class="citation-title">Therapeutic efficacy of ozone in patients with diabetic foot</span>. <span class="citation"> European Journal of Pharmacology </span><span class="pubYear">2005</span>;<span class="volume">523</span>:151‐61. <a class="crsref citation-link central-link" data-crsref="5748039" href="" ref="info:x-wiley/crsRef/5748039" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16198334" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Therapeutic+efficacy+of+ozone+in+patients+with+diabetic+foot&author=G+Mart%C3%ADnez%E2%80%90S%C3%A1nchez&author=SM+Al%E2%80%90Dalaina&author=S+Men%C3%A9ndez&author=L+Rec&author=A+Giuliani&author=E+Candelario%E2%80%90Jalila&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0050"> <div class="reference-title-banner"> <h4 class="title">Mikhaloĭko 2014 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0050"> <div class="citation-journal">Mikhaloĭko II, Sabadosh RV, Kovalenko AL, Skripko VD. <span class="citation-title">Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries</span>. <span class="citation"> Khirurgiia </span><span class="pubYear">2014</span>;<span class="volume">12</span>:36‐40. <a class="crsref citation-link central-link" data-crsref="5748041" href="" ref="info:x-wiley/crsRef/5748041" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rationale+of+application+of+the+drug+Cytoflavin+in+complex+treatment+of+patients+with+diabetic+foot+syndrome+with+mediacalcification+arteries+&author=II+Mikhalo%C4%ADko&author=RV+Sabadosh&author=AL+Kovalenko&author=VD+Skripko&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0051"> <div class="reference-title-banner"> <h4 class="title">Minatel 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0051"> <div class="citation-journal">Minatel DG, Frade MA, França SC, Enwemeka CS. <span class="citation-title">Phototherapy promotes healing of chronic diabetic leg ulcers that failed to respond to other therapies</span>. <span class="citation"> Lasers in Surgery and Medicine </span><span class="pubYear">2009</span>;<span class="volume">41</span>(6):433‐41. <a class="crsref citation-link central-link" data-crsref="5748043" href="" ref="info:x-wiley/crsRef/5748043" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19588536" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Phototherapy+promotes+healing+of+chronic+diabetic+leg+ulcers+that+failed+to+respond+to+other+therapies+&author=DG+Minatel&author=MA+Frade&author=SC+Fran%C3%A7a&author=CS+Enwemeka&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0052"> <div class="reference-title-banner"> <h4 class="title">Monami 2012 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0052"> <div class="citation-journal">Monami M, Genovese S, Anichini R, Fondelli C, Romagnoli F, Bartoli N, et al. <span class="citation-title">Randomised, double‐blind versus placebo, proof of concept clinical trial to evaluate efficacy and safety of g.68.y/etoh in diabetic infected foot ulcers (DANTE study)</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2012</span>;<span class="volume">55</span>(1 Suppl):S476. <a class="crsref citation-link central-link" data-crsref="5748045" href="" ref="info:x-wiley/crsRef/5748045" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Randomised,+double%E2%80%90blind+versus+placebo,+proof+of+concept+clinical+trial+to+evaluate+efficacy+and+safety+of+g.68.y/etoh+in+diabetic+infected+foot+ulcers+(DANTE+study)+&author=M+Monami&author=S+Genovese&author=R+Anichini&author=C+Fondelli&author=F+Romagnoli&author=N+Bartoli&publication_year=2012&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0053"> <div class="reference-title-banner"> <h4 class="title">Morley 2012 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0053"> <div class="citation-journal">Morley S, Griffiths J, Philips G, Moseley H, O'Grady C, Mellish K, et al. <span class="citation-title">Phase IIa randomized, placebo‐controlled study of antimicrobial photodynamic therapy in bacterially colonized, chronic leg ulcers and diabetic foot ulcers: a new approach to antimicrobial therapy</span>. <span class="citation"> British Journal of Dermatology </span><span class="pubYear">2013</span>;<span class="volume">168</span>(3):617‐24. <a class="crsref citation-link central-link" data-crsref="5748047" href="" ref="info:x-wiley/crsRef/5748047" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/23066973" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Phase+IIa+randomized,+placebo%E2%80%90controlled+study+of+antimicrobial+photodynamic+therapy+in+bacterially+colonized,+chronic+leg+ulcers+and+diabetic+foot+ulcers:+a+new+approach+to+antimicrobial+therapy+&author=S+Morley&author=J+Griffiths&author=G+Philips&author=H+Moseley&author=C+O'Grady&author=K+Mellish&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0054"> <div class="reference-title-banner"> <h4 class="title">Motta 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0054"> <div class="citation-journal">Motta GJ, Milne CT, Corbett LQ. <span class="citation-title">Impact of antimicrobial gauze on bacterial colonies in wounds that require packing</span>. <span class="citation"> Ostomy/Wound Management </span><span class="pubYear">2004</span>;<span class="volume">50</span>(8):48‐62. <a class="crsref citation-link central-link" data-crsref="5748049" href="" ref="info:x-wiley/crsRef/5748049" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Impact+of+antimicrobial+gauze+on+bacterial+colonies+in+wounds+that+require+packing&author=GJ+Motta&author=CT+Milne&author=LQ+Corbett&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0055"> <div class="reference-title-banner"> <h4 class="title">Münter 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0055"> <div class="citation-journal">Münter KC, Beele H, Russell L, Crespi A, Gröchenig E, Basse P, et al. <span class="citation-title">Effect of a sustained silver‐releasing dressing on ulcers with delayed healing: the CONTOP study</span>. <span class="citation"> Journal of Wound Care </span><span class="pubYear">2006</span>;<span class="volume">15</span>(5):199‐206. <a class="crsref citation-link central-link" data-crsref="5748051" href="" ref="info:x-wiley/crsRef/5748051" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16711173" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+a+sustained+silver%E2%80%90releasing+dressing+on+ulcers+with+delayed+healing:+the+CONTOP+study+&author=KC+M%C3%BCnter&author=H+Beele&author=L+Russell&author=A+Crespi&author=E+Gr%C3%B6chenig&author=P+Basse&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0056"> <div class="reference-title-banner"> <h4 class="title">Otvos 2015 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0056"> <div class="citation-journal">Otvos L, Ostorhazi E. <span class="citation-title">Therapeutic utility of antibacterial peptides in wound healing</span>. <span class="citation"> Expert Review of Anti‐infective Therapy </span><span class="pubYear">2015</span>;<span class="volume">13</span>(7):871‐81. <a class="crsref citation-link central-link" data-crsref="5748053" href="" ref="info:x-wiley/crsRef/5748053" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/25835521" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Therapeutic+utility+of+antibacterial+peptides+in+wound+healing&author=L+Otvos&author=E+Ostorhazi&publication_year=2015&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0057"> <div class="reference-title-banner"> <h4 class="title">Panahi 2015 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0057"> <div class="citation-journal">Panahi Y, Izadi M, Sayyadi N, Rezaee R, Jonaidi‐Jafari N, Beiraghdar F, et al. <span class="citation-title">Comparative trial of Aloe Vera/olive oil combination cream versus phenytoin cream in the treatment of chronic wounds</span>. <span class="citation"> Journal of Wound Care </span><span class="pubYear">2015</span>;<span class="volume">24</span>(10):459‐65. <a class="crsref citation-link central-link" data-crsref="5748055" href="" ref="info:x-wiley/crsRef/5748055" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/26488737" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparative+trial+of+Aloe+Vera/olive+oil+combination+cream+versus+phenytoin+cream+in+the+treatment+of+chronic+wounds+&author=Y+Panahi&author=M+Izadi&author=N+Sayyadi&author=R+Rezaee&author=N+Jonaidi%E2%80%90Jafari&author=F+Beiraghdar&publication_year=2015&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0058"> <div class="reference-title-banner"> <h4 class="title">Paquette 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0058"> <div class="citation-journal">Paquette D, Badiavis E, Falanga V. <span class="citation-title">Short‐contact topical tretinoin therapy to stimulate granulation tissue in chronic wounds</span>. <span class="citation"> Journal of the American Academy of Dermatology </span><span class="pubYear">2001</span>;<span class="volume">45</span>(3):382‐6. <a class="crsref citation-link central-link" data-crsref="5748057" href="" ref="info:x-wiley/crsRef/5748057" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11511834" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Short%E2%80%90contact+topical+tretinoin+therapy+to+stimulate+granulation+tissue+in+chronic+wounds+&author=D+Paquette&author=E+Badiavis&author=V+Falanga&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0059"> <div class="reference-title-banner"> <h4 class="title">Piaggesi 2010 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0059"> <div class="citation-journal">Piaggesi A, Goretti C, Mazzurco S, Tascini C, Leonildi A, Rizzo L, et al. <span class="citation-title">A randomized controlled trial to examine the efficacy and safety of a new super‐oxidized solution for the management of wide postsurgical lesions of the diabetic foot</span>. <span class="citation"> International Journal of Lower Extremity Wounds </span><span class="pubYear">2010</span>;<span class="volume">9</span>(1):10‐5. <a class="crsref citation-link central-link" data-crsref="5748059" href="" ref="info:x-wiley/crsRef/5748059" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/20207618" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized+controlled+trial+to+examine+the+efficacy+and+safety+of+a+new+super%E2%80%90oxidized+solution+for+the+management+of+wide+postsurgical+lesions+of+the+diabetic+foot+&author=A+Piaggesi&author=C+Goretti&author=S+Mazzurco&author=C+Tascini&author=A+Leonildi&author=L+Rizzo&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0060"> <div class="reference-title-banner"> <h4 class="title">Reyzelman 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0060"> <div class="citation-journal">Reyzelman A, Crews RT, Moore JC, Moore L, Mukker JS, Offutt S, et al. <span class="citation-title">Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study</span>. <span class="citation"> International Wound Journal </span><span class="pubYear">2009</span>;<span class="volume">6</span>(3):196‐208. <a class="crsref citation-link central-link" data-crsref="5748061" href="" ref="info:x-wiley/crsRef/5748061" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19368581" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Clinical+effectiveness+of+an+acellular+dermal+regenerative+tissue+matrix+compared+to+standard+wound+management+in+healing+diabetic+foot+ulcers:+a+prospective,+randomised,+multicentre+study+&author=A+Reyzelman&author=RT+Crews&author=JC+Moore&author=L+Moore&author=JS+Mukker&author=S+Offutt&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0061"> <div class="reference-title-banner"> <h4 class="title">Rhaiem 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0061"> <div class="citation-journal">Rhaiem BB, Ftouhi B, Brahim SB, Mekaouer A, Kanoun F, Abde'nnebi A, et al. <span class="citation-title">A comparative study of saccharose use in the treatment of cutaneous lesions in diabetic patients: about 80 cases</span> [Essai comparatif de l'utilisation du saccharose dans le traitement des lésions cutanées chez le diabétique à propos de 80 cas]. <span class="citation"> Tunisie Médicale </span><span class="pubYear">1998</span>;<span class="volume">76</span>(3):19‐23. <a class="crsref citation-link central-link" data-crsref="5748063" href="" ref="info:x-wiley/crsRef/5748063" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9844527" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparative+study+of+saccharose+use+in+the+treatment+of+cutaneous+lesions+in+diabetic+patients:+about+80+cases+&author=BB+Rhaiem&author=B+Ftouhi&author=SB+Brahim&author=A+Mekaouer&author=F+Kanoun&author=A+Abde'nnebi&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0062"> <div class="reference-title-banner"> <h4 class="title">Santomauro 2015 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0062"> <div class="citation-journal">Santomauro AC, Tardivo JP, Mascarenhas BM, Ramiro RE, Santomauro AT, Correa JA. <span class="citation-title">A new proposal for the treatment of patients with diabetic foot ‐ photodynamic therapy</span>. <span class="citation"> Diabetes </span><span class="pubYear">2015</span>;<span class="volume">64</span>(1 Suppl):A185‐6. <a class="crsref citation-link central-link" data-crsref="5748065" href="" ref="info:x-wiley/crsRef/5748065" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+new+proposal+for+the+treatment+of+patients+with+diabetic+foot+%E2%80%90+photodynamic+therapy&author=AC+Santomauro&author=JP+Tardivo&author=BM+Mascarenhas&author=RE+Ramiro&author=AT+Santomauro&author=JA+Correa&publication_year=2015&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0063"> <div class="reference-title-banner"> <h4 class="title">Scalise 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0063"> <div class="citation-other">Scalise A, Forma O, Happe M, Hahn TW. <span class="citation-title">The CONTOP study: real life experiences from an international study comparing a silver containing hydro‐activated foam dressing with standard wound care</span>. old.ewma.org/fileadmin/user_upload/EWMA/pdf/conference_abstracts/2003/Poster/Poster_81.pdf (accessed 3 February 2017). <a class="crsref citation-link central-link" data-crsref="5748067" href="" ref="info:x-wiley/crsRef/5748067" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0064"> <div class="reference-title-banner"> <h4 class="title">Siavash 2011 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0064"> <div class="citation-journal">Siavash M, Shokri S, Haghighi S, Mohammadi M, Shahtalebi MA, Farajzadehgan Z. <span class="citation-title">The efficacy of topical royal jelly on diabetic foot ulcers healing: a case series</span>. <span class="citation"> Journal of Research in Medical Sciences </span><span class="pubYear">2011</span>;<span class="volume">16</span>(7):904‐9. <a class="crsref citation-link central-link" data-crsref="5748069" href="" ref="info:x-wiley/crsRef/5748069" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/22279458" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+efficacy+of+topical+royal+jelly+on+diabetic+foot+ulcers+healing:+a+case+series&author=M+Siavash&author=S+Shokri&author=S+Haghighi&author=M+Mohammadi&author=MA+Shahtalebi&author=Z+Farajzadehgan&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0065"> <div class="reference-title-banner"> <h4 class="title">Siavash 2015 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0065"> <div class="citation-journal">Siavash M, Shokri S, Haghighi S, Shahtalebi MA, Farajzadehgan Z. <span class="citation-title">The efficacy of topical royal jelly on healing of diabetic foot ulcers: a double‐blind placebo‐controlled clinical trial</span>. <span class="citation"> International Wound Journal </span><span class="pubYear">2015</span>;<span class="volume">12</span>(2):137–42. <a class="crsref citation-link central-link" data-crsref="5748071" href="" ref="info:x-wiley/crsRef/5748071" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/23566071" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+efficacy+of+topical+royal+jelly+on+healing+of+diabetic+foot+ulcers:+a+double%E2%80%90blind+placebo%E2%80%90controlled+clinical+trial+&author=M+Siavash&author=S+Shokri&author=S+Haghighi&author=MA+Shahtalebi&author=Z+Farajzadehgan&publication_year=2015&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0066"> <div class="reference-title-banner"> <h4 class="title">Sibbald 2011 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0066"> <div class="citation-journal">Sibbald RG, Coutts P, Woo KY. <span class="citation-title">Reduction of bacterial burden and pain in chronic wounds using a new polyhexamethylene biguanide antimicrobial foam dressing: clinical trial results</span>. <span class="citation"> Advances in Skin &amp; Wound Care </span><span class="pubYear">2011</span>;<span class="volume">24</span>(2):78‐84. <a class="crsref citation-link central-link" data-crsref="5748073" href="" ref="info:x-wiley/crsRef/5748073" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21242737" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Reduction+of+bacterial+burden+and+pain+in+chronic+wounds+using+a+new+polyhexamethylene+biguanide+antimicrobial+foam+dressing:+clinical+trial+results+&author=RG+Sibbald&author=P+Coutts&author=KY+Woo&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0067"> <div class="reference-title-banner"> <h4 class="title">Song 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0067"> <div class="citation-journal">Song M, Li X, Zhong X. <span class="citation-title">Clinical observation and nursing care of patients with diabetic foot treated with sodium humate in combination with insulin external applying</span>. <span class="citation"> Chinese Nursing Research </span><span class="pubYear">2009</span>;<span class="volume">23</span>(10):862‐4. <a class="crsref citation-link central-link" data-crsref="5748075" href="" ref="info:x-wiley/crsRef/5748075" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Clinical+observation+and+nursing+care+of+patients+with+diabetic+foot+treated+with+sodium+humate+in+combination+with+insulin+external+applying+&author=M+Song&author=X+Li&author=X+Zhong&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0068"> <div class="reference-title-banner"> <h4 class="title">Tardivo 2014 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0068"> <div class="citation-journal">Tardivo JP, Adami F, Correa JA, Pinhal MA, Baptista MS. <span class="citation-title">A clinical trial testing the efficacy of PDT in preventing amputation in diabetic patients</span>. <span class="citation"> Photodiagnosis and Photodynamic Therapy </span><span class="pubYear">2014</span>;<span class="volume">11</span>(3):342‐50. <a class="crsref citation-link central-link" data-crsref="5748077" href="" ref="info:x-wiley/crsRef/5748077" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/24814697" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+clinical+trial+testing+the+efficacy+of+PDT+in+preventing+amputation+in+diabetic+patients+&author=JP+Tardivo&author=F+Adami&author=JA+Correa&author=MA+Pinhal&author=MS+Baptista&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0069"> <div class="reference-title-banner"> <h4 class="title">Tauro 2013 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0069"> <div class="citation-journal">Tauro LF, Shetti P, Dsouza NT, Mohammed S, Sucharitha S. <span class="citation-title">A comparative study of efficacy of topical phenytoin vs conventional wound care in diabetic ulcers</span>. <span class="citation"> International Journal of Molecular Medical Science </span><span class="pubYear">2013</span>;<span class="volume">3</span>(8):65‐71. <a class="crsref citation-link central-link" data-crsref="5748079" href="" ref="info:x-wiley/crsRef/5748079" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparative+study+of+efficacy+of+topical+phenytoin+vs+conventional+wound+care+in+diabetic+ulcers+&author=LF+Tauro&author=P+Shetti&author=NT+Dsouza&author=S+Mohammed&author=S+Sucharitha&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0070"> <div class="reference-title-banner"> <h4 class="title">Tran 2014 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0070"> <div class="citation-journal">Tran TD‐X, Le PT‐B, Pham P. <span class="citation-title">Diabetic foot ulcer treatment by activated platelet rich plasma: a clinical study</span>. <span class="citation"> Biomedical Research and Therapy </span><span class="pubYear">2014</span>;<span class="volume">1</span>(2):37‐42. <a class="crsref citation-link central-link" data-crsref="5748081" href="" ref="info:x-wiley/crsRef/5748081" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diabetic+foot+ulcer+treatment+by+activated+platelet+rich+plasma:+a+clinical+study&author=TD%E2%80%90X+Tran&author=PT%E2%80%90B+Le&author=P+Pham&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0071"> <div class="reference-title-banner"> <h4 class="title">Trial 2010 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0071"> <div class="citation-journal">Trial C, Darbas H, Lavigne JP, Sotto A, Simoneau G, Tillet Y, et al. <span class="citation-title">Assessment of the antimicrobial effectiveness of a new silver alginate wound dressing: a RCT</span>. <span class="citation"> Journal of Wound Care </span><span class="pubYear">2010</span>;<span class="volume">19</span>(1):20‐6. <a class="crsref citation-link central-link" data-crsref="5748083" href="" ref="info:x-wiley/crsRef/5748083" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/20081570" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Assessment+of+the+antimicrobial+effectiveness+of+a+new+silver+alginate+wound+dressing:+a+RCT+&author=H+Darbas&author=JP+Lavigne&author=A+Sotto&author=G+Simoneau&author=Y+Tillet&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0072"> <div class="reference-title-banner"> <h4 class="title">Uribe 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0072"> <div class="citation-journal">Uribe F. <span class="citation-title">Effect of a neutral pH superoxidized solution in the healing of diabetic foot ulcers</span>. <span class="citation"> International Journal of Lower Extremity Wounds </span><span class="pubYear">2007</span>;<span class="volume">6</span>(3):224. [Abstract 117]<a class="crsref citation-link central-link" data-crsref="5748085" href="" ref="info:x-wiley/crsRef/5748085" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+a+neutral+pH+superoxidized+solution+in+the+healing+of+diabetic+foot+ulcers&author=F+Uribe&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0073"> <div class="reference-title-banner"> <h4 class="title">Vandeputte 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0073"> <div class="citation-other">Vandeputte J, Gryson L. <span class="citation-title">Diabetic foot infection controlled by immuno‐modulating hydrogel containing 65% glycerine. Presentation of a clinical trial</span>. Journal of Wound Care<span class="pubYear">1996</span>; Vol. 5, issue 8:9. <a class="crsref citation-link central-link" data-crsref="5748087" href="" ref="info:x-wiley/crsRef/5748087" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diabetic+foot+infection+controlled+by+immuno%E2%80%90modulating+hydrogel+containing+65%+glycerine.+Presentation+of+a+clinical+trial+&author=J+Vandeputte&author=L+Gryson&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0074"> <div class="reference-title-banner"> <h4 class="title">Varga 2014 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0074"> <div class="citation-journal">Varga M, Sixta B, Bem R, Matia I, Jirkovska A, Adamec M. <span class="citation-title">Application of gentamicin‐collagen sponge shortened wound healing time after minor amputations in diabetic patients: a prospective, randomised trial</span>. <span class="citation"> Archives of Medical Science </span><span class="pubYear">2014</span>;<span class="volume">10</span>(2):283‐7. <a class="crsref citation-link central-link" data-crsref="5748089" href="" ref="info:x-wiley/crsRef/5748089" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/24904661" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Application+of+gentamicin%E2%80%90collagen+sponge+shortened+wound+healing+time+after+minor+amputations+in+diabetic+patients:+a+prospective,+randomised+trial+&author=M+Varga&author=B+Sixta&author=R+Bem&author=I+Matia&author=A+Jirkovska&author=M+Adamec&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD011038-bbs2-0075"> <div class="reference-title-banner"> <h4 class="title">Wainstein 2011 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0075"> <div class="citation-journal">Wainstein J, Feldbrin Z, Boaz M, Harman‐Boehm I. <span class="citation-title">Efficacy of ozone–oxygen therapy for the treatment of diabetic foot ulcers</span>. <span class="citation"> Diabetes Technology &amp; Therapeutics </span><span class="pubYear">2011</span>;<span class="volume">13</span>(12):1255‐60. <a class="crsref citation-link central-link" data-crsref="5748091" href="" ref="info:x-wiley/crsRef/5748091" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21751891" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+ozone%E2%80%93oxygen+therapy+for+the+treatment+of+diabetic+foot+ulcers&author=J+Wainstein&author=Z+Feldbrin&author=M+Boaz&author=I+Harman%E2%80%90Boehm&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD011038-bbs1-0003"> <h3 class="title">References to studies awaiting assessment</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD011038-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0004">ongoing studies</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0005">additional references</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0006">other published versions</a></li> </ul> </div> </div> <div class="bibliographies references_awaitingAssessmentStudies" id="CD011038-bbs2-0076"> <div class="reference-title-banner"> <h4 class="title">Fazal 2012 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0076"> <div class="citation-journal">Fazal F. <span class="citation-title">Comparative evaluation of the beneficial effects of phenytoin in diabetic ulcers</span>. <span class="citation"> Australasian Annals of Medicine </span><span class="pubYear">2012</span>;<span class="volume">5</span>(1):55. <a class="crsref citation-link central-link" data-crsref="5748093" href="" ref="info:x-wiley/crsRef/5748093" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparative+evaluation+of+the+beneficial+effects+of+phenytoin+in+diabetic+ulcers&author=F+Fazal&publication_year=2012&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_awaitingAssessmentStudies" id="CD011038-bbs2-0077"> <div class="reference-title-banner"> <h4 class="title">Rehman 2013 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0077"> <div class="citation-journal">Rehman EU, Afzal OM, Ali A, Qureshi RA, Rashid M. <span class="citation-title">Comparison between honey and povidone‐iodine/normal saline dressing for management of Wagner's grade I &amp; II diabetic foot ulcers</span>. <span class="citation"> Pakistan Journal of Medical and Health Sciences </span><span class="pubYear">2013</span>;<span class="volume">7</span>(4):1082‐5. <a class="crsref citation-link central-link" data-crsref="5748095" href="" ref="info:x-wiley/crsRef/5748095" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+between+honey+and+povidone%E2%80%90iodine/normal+saline+dressing+for+management+of+Wagner's+grade+I+&+II+diabetic+foot+ulcers+&author=EU+Rehman&author=OM+Afzal&author=A+Ali&author=RA+Qureshi&author=M+Rashid&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD011038-bbs1-0004"> <h3 class="title">References to ongoing studies</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD011038-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0003">studies awaiting assessment</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0005">additional references</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0006">other published versions</a></li> </ul> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD011038-bbs2-0078"> <div class="reference-title-banner"> <h4 class="title">Heybeck 2012 {published data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0078"> <div class="citation-journal">Heybeck T, Rothenberg G. <span class="citation-title">Utilizing cupron antimicrobial therapeutic socks to help prevent lower limb and foot ulcers in the diabetic patients: a double blind trial of safety and efficacy</span>. <span class="citation"> Foot </span><span class="pubYear">2012</span>;<span class="volume">22</span>(2):108‐9. <a class="crsref citation-link central-link" data-crsref="5748097" href="" ref="info:x-wiley/crsRef/5748097" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Utilizing+cupron+antimicrobial+therapeutic+socks+to+help+prevent+lower+limb+and+foot+ulcers+in+the+diabetic+patients:+a+double+blind+trial+of+safety+and+efficacy+&author=T+Heybeck&author=G+Rothenberg&publication_year=2012&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD011038-bbs2-0079"> <div class="reference-title-banner"> <h4 class="title">NCT01594762 {unpublished data only} </h4> </div> <div class="bibliography-section" id="CD011038-bib-0079"> <div class="citation-other">NCT01594762. <span class="citation-title">Pexiganan versus placebo control for the treatment of mild infections of diabetic foot ulcers (Onestep‐2)</span>. clinicaltrials.gov/ct2/show/NCT01594762 (first received 7 May 2012). <a class="crsref citation-link central-link" data-crsref="5748099" href="" ref="info:x-wiley/crsRef/5748099" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD011038-bbs1-0005"> <h3 class="title">Additional references</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD011038-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0003">studies awaiting assessment</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0004">ongoing studies</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0006">other published versions</a></li> </ul> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0080"> <div class="reference-title-banner"> <h4 class="title">American Diabetes Association 2003</h4> </div> <div class="bibliography-section" id="CD011038-bib-0080"> <div class="citation-journal">American Diabetes Association. <span class="citation-title">Peripheral arterial disease in people with diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2003</span>;<span class="volume">26</span>(12):3333‐41. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14633825" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0081"> <div class="reference-title-banner"> <h4 class="title">Bergin 2006</h4> </div> <div class="bibliography-section" id="CD011038-bib-0081"> <div class="citation-journal">Bergin SM, Wraight P. <span class="citation-title">Silver based wound dressings and topical agents for treating diabetic foot ulcers</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2006</span>, Issue 1. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD005082.pub2" target="_blank"><span>10.1002/14651858.CD005082.pub2</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16437516" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Silver+based+wound+dressings+and+topical+agents+for+treating+diabetic+foot+ulcers&author=SM+Bergin&author=P+Wraight&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0082"> <div class="reference-title-banner"> <h4 class="title">Cooper 2004</h4> </div> <div class="bibliography-section" id="CD011038-bib-0082"> <div class="citation-other">Cooper R. <span class="citation-title">A review of the evidence for the use of topical antimicrobial agents in wound care. World Wide Wounds. February 2004</span>. www.worldwidewounds.com/2004/february/Cooper/Topical‐Antimicrobial‐Agents.html (accessed 3 February 2017). <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0083"> <div class="reference-title-banner"> <h4 class="title">Cutting 2005</h4> </div> <div class="bibliography-section" id="CD011038-bib-0083"> <div class="citation-journal">Cutting KF, White RJ. <span class="citation-title">Criteria for identifying wound infection: revisited</span>. <span class="citation"> Ostomy/Wound Management </span><span class="pubYear">2005</span>;<span class="volume">51</span>:28‐34. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Criteria+for+identifying+wound+infection:+revisited&author=KF+Cutting&author=RJ+White&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0084"> <div class="reference-title-banner"> <h4 class="title">Davies 2004</h4> </div> <div class="bibliography-section" id="CD011038-bib-0084"> <div class="citation-journal">Davies CE, Hill KE, Wilson MJ, Stephens P, Hill CM, Harding KG, et al. <span class="citation-title">Use of 16S ribosomal DNA PCR and denaturing gradient gel electrophoresis for analysis of the microfloras of healing and nonhealing chronic venous leg ulcers</span>. <span class="citation"> Journal of Clinical Microbiology </span><span class="pubYear">2004</span>;<span class="volume">42</span>(8):3549‐57. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15297496" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Use+of+16S+ribosomal+DNA+PCR+and+denaturing+gradient+gel+electrophoresis+for+analysis+of+the+microfloras+of+healing+and+nonhealing+chronic+venous+leg+ulcers+&author=CE+Davies&author=KE+Hill&author=MJ+Wilson&author=P+Stephens&author=CM+Hill&author=KG+Harding&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0085"> <div class="reference-title-banner"> <h4 class="title">Davies 2007</h4> </div> <div class="bibliography-section" id="CD011038-bib-0085"> <div class="citation-journal">Davies CE, Hill KE, Newcombe RG, Stephens P, Wilson MJ, Harding KG, et al. <span class="citation-title">A prospective study of the microbiology of chronic venous leg ulcers to reevaluate the clinical predictive value of tissue biopsies and swabs</span>. <span class="citation"> Wound Repair and Regeneration </span><span class="pubYear">2007</span>;<span class="volume">15</span>(1):17‐22. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17244315" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+prospective+study+of+the+microbiology+of+chronic+venous+leg+ulcers+to+reevaluate+the+clinical+predictive+value+of+tissue+biopsies+and+swabs+&author=CE+Davies&author=KE+Hill&author=RG+Newcombe&author=P+Stephens&author=MJ+Wilson&author=KG+Harding&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0086"> <div class="reference-title-banner"> <h4 class="title">Deeks 2011</h4> </div> <div class="bibliography-section" id="CD011038-bib-0086"> <div class="citation-other">Deeks JJ, Higgins JP, Altman DG, on behalf of the Cochrane Statistical Methods Group. <span class="citation-title">Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</span>. Available from handbook.cochrane.org. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0087"> <div class="reference-title-banner"> <h4 class="title">Delamaire 1997</h4> </div> <div class="bibliography-section" id="CD011038-bib-0087"> <div class="citation-journal">Delamaire M, Maugendre D, Moreno M, Goff MC, Allannic H, Genetet B. <span class="citation-title">Impaired leucocyte functions in diabetic patients</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1997</span>;<span class="volume">14</span>(1):29‐34. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9017350" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Impaired+leucocyte+functions+in+diabetic+patients&author=M+Delamaire&author=D+Maugendre&author=M+Moreno&author=MC+Goff&author=H+Allannic&author=B+Genetet&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0088"> <div class="reference-title-banner"> <h4 class="title">Drucker 2012</h4> </div> <div class="bibliography-section" id="CD011038-bib-0088"> <div class="citation-journal">Drucker CR. <span class="citation-title">Update on topical antibiotics in dermatology</span>. <span class="citation"> Dermatologic Therapy </span><span class="pubYear">2012</span>;<span class="volume">25</span>:6‐11. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/22591495" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Update+on+topical+antibiotics+in+dermatology&author=CR+Drucker&publication_year=2012&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0089"> <div class="reference-title-banner"> <h4 class="title">Game 2016</h4> </div> <div class="bibliography-section" id="CD011038-bib-0089"> <div class="citation-journal">Game FL, Apelqvist J, Attinger C, Hartemann A, Hinchliffe RJ, Löndahl M, et al. International Working Group on the Diabetic Foot (IWGDF). <span class="citation-title">Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review</span>. <span class="citation"> Diabetes/Metabolism Research and Reviews </span><span class="pubYear">2016</span>;<span class="volume">32</span>(1 Suppl):154‐68. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effectiveness+of+interventions+to+enhance+healing+of+chronic+ulcers+of+the+foot+in+diabetes:+a+systematic+review+&author=FL+Game&author=J+Apelqvist&author=C+Attinger&author=A+Hartemann&author=RJ+Hinchliffe&author=M+L%C3%B6ndahl&publication_year=2016&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0090"> <div class="reference-title-banner"> <h4 class="title">Gardner 2001</h4> </div> <div class="bibliography-section" id="CD011038-bib-0090"> <div class="citation-journal">Gardner SE, Frantz RA, Doebbeling BN. <span class="citation-title">The validity of the clinical signs and symptoms used to identify localized chronic wound infection</span>. <span class="citation"> Wound Repair and Regeneration </span><span class="pubYear">2001</span>;<span class="volume">9</span>(3):178‐86. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11472613" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+validity+of+the+clinical+signs+and+symptoms+used+to+identify+localized+chronic+wound+infection+&author=SE+Gardner&author=RA+Frantz&author=BN+Doebbeling&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0091"> <div class="reference-title-banner"> <h4 class="title">Gelmetti 2008</h4> </div> <div class="bibliography-section" id="CD011038-bib-0091"> <div class="citation-journal">Gelmetti C. <span class="citation-title">Local antibiotics in dermatology</span>. <span class="citation"> Dermatologic Therapy </span><span class="pubYear">2008</span>;<span class="volume">21</span>:187‐95. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18564249" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Local+antibiotics+in+dermatology&author=C+Gelmetti&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0092"> <div class="reference-title-banner"> <h4 class="title">GradePro GDT 2015 [Computer program]</h4> </div> <div class="bibliography-section" id="CD011038-bib-0092"> <div class="citation-other">GRADEpro GDT. <span class="citation-title">GRADEpro Guideline Development Tool</span>. McMaster University, <span class="pubYear">2015 (developed by Evidence Prime, Inc.)</span>. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=GRADEpro+Guideline+Development+Tool&author=GDT+GRADEpro&publication_year=2015(developedbyEvidencePrime,Inc.)&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0093"> <div class="reference-title-banner"> <h4 class="title">Guyatt 2008</h4> </div> <div class="bibliography-section" id="CD011038-bib-0093"> <div class="citation-journal">Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck‐Ytter Y, Schünemann HJ. <span class="citation-title">What is 'quality of evidence' and why is it important to clinicians?</span>. <span class="citation"> BMJ </span><span class="pubYear">2008</span>;<span class="volume">336</span>(7651):995‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18456631" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=What+is+'quality+of+evidence'+and+why+is+it+important+to+clinicians?&author=GH+Guyatt&author=AD+Oxman&author=R+Kunz&author=GE+Vist&author=Y+Falck‐Ytter&author=HJ+Schünemann&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0094"> <div class="reference-title-banner"> <h4 class="title">Guyatt 2011</h4> </div> <div class="bibliography-section" id="CD011038-bib-0094"> <div class="citation-journal">Guyatt G, Oxman A, Kunz R, Brozek J, Alonso‐Coello P, Rind D. <span class="citation-title">GRADE guidelines 6. Rating the quality of evidence: imprecision</span>. <span class="citation"> Journal of Clinical Epidemiology </span><span class="pubYear">2011</span>;<span class="volume">64</span>:1283‐93. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21839614" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=GRADE+guidelines+6.+Rating+the+quality+of+evidence:+imprecision&author=G+Guyatt&author=A+Oxman&author=R+Kunz&author=J+Brozek&author=P+Alonso%E2%80%90Coello&author=D+Rind&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0095"> <div class="reference-title-banner"> <h4 class="title">Heggers 1991</h4> </div> <div class="bibliography-section" id="CD011038-bib-0095"> <div class="citation-journal">Heggers JP, Sazy JA, Stenberg BD, Strock LL, McCauley RL, Herndon DN, et al. <span class="citation-title">Bactericidal and wound‐healing properties of sodium hypochlorite solutions: the 1991 Lindberg Award</span>. <span class="citation"> Journal of Burn Care and Rehabilitation </span><span class="pubYear">1991</span>;<span class="volume">12</span>(5):420‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1752875" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Bactericidal+and+wound%E2%80%90healing+properties+of+sodium+hypochlorite+solutions:+the+1991+Lindberg+Award+&author=JP+Heggers&author=JA+Sazy&author=BD+Stenberg&author=LL+Strock&author=RL+McCauley&author=DN+Herndon&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0096"> <div class="reference-title-banner"> <h4 class="title">Heinzelmann 2002</h4> </div> <div class="bibliography-section" id="CD011038-bib-0096"> <div class="citation-journal">Heinzelmann M, Scott M, Lam T. <span class="citation-title">Factors predisposing to bacterial invasion and infection</span>. <span class="citation"> American Journal of Surgery </span><span class="pubYear">2002</span>;<span class="volume">183</span>(2):179‐90. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11918885" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Factors+predisposing+to+bacterial+invasion+and+infection&author=M+Heinzelmann&author=M+Scott&author=T+Lam&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0097"> <div class="reference-title-banner"> <h4 class="title">Higgins 2003</h4> </div> <div class="bibliography-section" id="CD011038-bib-0097"> <div class="citation-journal">Higgins JP, Thompson SG, Deeks JJ, Altman DG. <span class="citation-title">Measuring inconsistency in meta‐analyses</span>. <span class="citation"> BMJ </span><span class="pubYear">2003</span>;<span class="volume">327</span>(7414):557‐60. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12958120" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Measuring+inconsistency+in+meta%E2%80%90analyses&author=JP+Higgins&author=SG+Thompson&author=JJ+Deeks&author=DG+Altman&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0098"> <div class="reference-title-banner"> <h4 class="title">Higgins 2011</h4> </div> <div class="bibliography-section" id="CD011038-bib-0098"> <div class="citation-other">Higgins JP, Green S, editor(s). <span class="citation-title">Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</span>. Available from handbook.cochrane.org. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0099"> <div class="reference-title-banner"> <h4 class="title">Hróbjartsson 2012</h4> </div> <div class="bibliography-section" id="CD011038-bib-0099"> <div class="citation-journal">Hróbjartsson A, Thomsen AS, Emanuelsson F, Tendal B, Hilden J, Boutron I, et al. <span class="citation-title">Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non‐blinded outcome assessors</span>. <span class="citation"> BMJ </span><span class="pubYear">2012</span>;<span class="volume">344</span>:e1119. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/22371859" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Observer+bias+in+randomised+clinical+trials+with+binary+outcomes:+systematic+review+of+trials+with+both+blinded+and+non%E2%80%90blinded+outcome+assessors+&author=A+Hr%C3%B3bjartsson&author=AS+Thomsen&author=F+Emanuelsson&author=B+Tendal&author=J+Hilden&author=I+Boutron&publication_year=2012&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0100"> <div class="reference-title-banner"> <h4 class="title">IDF 2015</h4> </div> <div class="bibliography-section" id="CD011038-bib-0100"> <div class="citation-other">International Diabetes Foundation (IDF). <span class="citation-title">Diabetes Atlas. 7th edition. 2015</span>. www.diabetesatlas.org (accessed 10 February 2017). <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0101"> <div class="reference-title-banner"> <h4 class="title">IWGDF 2015</h4> </div> <div class="bibliography-section" id="CD011038-bib-0101"> <div class="citation-other">International Working Group on the Diabetic Foot (IWGDF). <span class="citation-title">IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Prepared by the IWGDF Working Group on Foot Infections 2015</span>. iwgdf.org/guidelines/guidance‐on‐infection (accessed 3 February 2017). <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0102"> <div class="reference-title-banner"> <h4 class="title">IWGDF 2016</h4> </div> <div class="bibliography-section" id="CD011038-bib-0102"> <div class="citation-other"><span class="citation-title">International Working Group on the Diabetic Foot (IWGDF)</span>. iwgdf.org/ (accessed 10 February 2017). <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0103"> <div class="reference-title-banner"> <h4 class="title">James 2008</h4> </div> <div class="bibliography-section" id="CD011038-bib-0103"> <div class="citation-journal">James GA, Swogger E, Wolcott R, Pulcini E, Secor P, Sestrich J, et al. <span class="citation-title">Biofilms in chronic wounds</span>. <span class="citation"> Wound Repair and Regeneration </span><span class="pubYear">2008</span>;<span class="volume">16</span>(1):37‐44. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18086294" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Biofilms+in+chronic+wounds&author=GA+James&author=E+Swogger&author=R+Wolcott&author=E+Pulcini&author=P+Secor&author=J+Sestrich&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0104"> <div class="reference-title-banner"> <h4 class="title">Jull 2015</h4> </div> <div class="bibliography-section" id="CD011038-bib-0104"> <div class="citation-journal">Jull AB, Cullum N, Dumville JC, Westby MJ, Deshpande S, Walker N. <span class="citation-title">Honey as a topical treatment for wounds</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2015</span>, Issue 3. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD005083.pub4" target="_blank"><span>10.1002/14651858.CD005083.pub4</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/25742878" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Honey+as+a+topical+treatment+for+wounds&author=AB+Jull&author=N+Cullum&author=JC+Dumville&author=MJ+Westby&author=S+Deshpande&author=N+Walker&publication_year=2015&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0105"> <div class="reference-title-banner"> <h4 class="title">Kontopantelis 2012</h4> </div> <div class="bibliography-section" id="CD011038-bib-0105"> <div class="citation-journal">Kontopantelis E, Springate DA, Reeves D. <span class="citation-title">A re‐analysis of the Cochrane Library data: the dangers of unobserved heterogeneity in meta‐analyses</span>. <span class="citation"> PLoS ONE </span><span class="pubYear">2013</span>;<span class="volume">26</span>:e69930. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+re%E2%80%90analysis+of+the+Cochrane+Library+data:+the+dangers+of+unobserved+heterogeneity+in+meta%E2%80%90analyses+&author=E+Kontopantelis&author=DA+Springate&author=D+Reeves&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0106"> <div class="reference-title-banner"> <h4 class="title">Lavery 2006</h4> </div> <div class="bibliography-section" id="CD011038-bib-0106"> <div class="citation-journal">Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. <span class="citation-title">Risk factors for foot infections in individuals with diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2006</span>;<span class="volume">29</span>(6):1288‐93. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16732010" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Risk+factors+for+foot+infections+in+individuals+with+diabetes&author=LA+Lavery&author=DG+Armstrong&author=RP+Wunderlich&author=MJ+Mohler&author=CS+Wendel&author=BA+Lipsky&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0107"> <div class="reference-title-banner"> <h4 class="title">Lefebvre 2011</h4> </div> <div class="bibliography-section" id="CD011038-bib-0107"> <div class="citation-other">Lefebvre C, Manheimer E, Glanville J. <span class="citation-title">Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</span>. Available from handbook.cochrane.org. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0108"> <div class="reference-title-banner"> <h4 class="title">Lio 2004</h4> </div> <div class="bibliography-section" id="CD011038-bib-0108"> <div class="citation-journal">Lio PA, Kaye ET. <span class="citation-title">Topical antibacterial agents</span>. <span class="citation"> Infectious Disease Clinics of North America </span><span class="pubYear">2004</span>;<span class="volume">18</span>:717‐33. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15308283" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Topical+antibacterial+agents&author=PA+Lio&author=ET+Kaye&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0109"> <div class="reference-title-banner"> <h4 class="title">Lipsky 2009</h4> </div> <div class="bibliography-section" id="CD011038-bib-0109"> <div class="citation-journal">Lipsky BA, Hoey C. <span class="citation-title">Topical antimicrobial therapy for treating chronic wounds</span>. <span class="citation"> Clinical Infectious Diseases </span><span class="pubYear">2009</span>;<span class="volume">49</span>(10):1541‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19842981" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Topical+antimicrobial+therapy+for+treating+chronic+wounds&author=BA+Lipsky&author=C+Hoey&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0110"> <div class="reference-title-banner"> <h4 class="title">Lipsky 2012b</h4> </div> <div class="bibliography-section" id="CD011038-bib-0110"> <div class="citation-journal">Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. <span class="citation-title">2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections</span>. <span class="citation"> Clinical Infectious Diseases </span><span class="pubYear">2012</span>;<span class="volume">54</span>(12):e132‐73. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/22619242" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=2012+Infectious+Diseases+Society+of+America+clinical+practice+guideline+for+the+diagnosis+and+treatment+of+diabetic+foot+infections+&author=BA+Lipsky&author=AR+Berendt&author=PB+Cornia&author=JC+Pile&author=EJ+Peters&author=DG+Armstrong&publication_year=2012&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0111"> <div class="reference-title-banner"> <h4 class="title">Lipsky 2013</h4> </div> <div class="bibliography-section" id="CD011038-bib-0111"> <div class="citation-journal">Lipsky BA, Richard JL, Lavigne JP. <span class="citation-title">Diabetic foot ulcer microbiome: one small step for molecular microbiology: one giant leap for understanding diabetic foot ulcers?</span>. <span class="citation"> Diabetes </span><span class="pubYear">2013</span>;<span class="volume">62</span>(3):679‐81. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/23431007" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diabetic+foot+ulcer+microbiome:+one+small+step+for+molecular+microbiology:+one+giant+leap+for+understanding+diabetic+foot+ulcers?+&author=BA+Lipsky&author=JL+Richard&author=JP+Lavigne&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0112"> <div class="reference-title-banner"> <h4 class="title">Lipsky 2016</h4> </div> <div class="bibliography-section" id="CD011038-bib-0112"> <div class="citation-journal">Lipsky BA, Aragón‐Sánchez J, Diggle M, Embil J, Kono S, Lavery L, et al. International Working Group on the Diabetic Foot (IWGDF). <span class="citation-title">IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes</span>. <span class="citation"> Diabetes/Metabolism Research and Reviews </span><span class="pubYear">2016</span>;<span class="volume">32</span>(1 Suppl):45‐74. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=IWGDF+guidance+on+the+diagnosis+and+management+of+foot+infections+in+persons+with+diabetes+&author=BA+Lipsky&author=J+Arag%C3%B3n%E2%80%90S%C3%A1nchez&author=M+Diggle&author=J+Embil&author=S+Kono&author=L+Lavery&publication_year=2016&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0113"> <div class="reference-title-banner"> <h4 class="title">Markakis 2016</h4> </div> <div class="bibliography-section" id="CD011038-bib-0113"> <div class="citation-journal">Markakis K, Bowling FL, Boulton AJ. <span class="citation-title">The diabetic foot in 2015: an overview</span>. <span class="citation"> Diabetes/Metabolism Research and Reviews </span><span class="pubYear">2016</span>;<span class="volume">32</span>(1 Suppl):169‐78. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+diabetic+foot+in+2015:+an+overview&author=K+Markakis&author=FL+Bowling&author=AJ+Boulton&publication_year=2016&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0114"> <div class="reference-title-banner"> <h4 class="title">Nebeker 2004</h4> </div> <div class="bibliography-section" id="CD011038-bib-0114"> <div class="citation-journal">Nebeker JR, Barach P, Samore MH. <span class="citation-title">Clarifying adverse drug events: a clinician’s guide to terminology, documentation, and reporting</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">2004</span>;<span class="volume">140</span>(10):795‐801. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15148066" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Clarifying+adverse+drug+events:+a+clinician%E2%80%99s+guide+to+terminology,+documentation,+and+reporting+&author=JR+Nebeker&author=P+Barach&author=MH+Samore&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0115"> <div class="reference-title-banner"> <h4 class="title">Neely 2009</h4> </div> <div class="bibliography-section" id="CD011038-bib-0115"> <div class="citation-journal">Neely AN, Gardner J, Durkee P, Warden GD, Greenhalgh DG, Gallagher JJ, et al. <span class="citation-title">Are topical antimicrobials effective against bacteria that are highly resistant to systemic antibiotics?</span>. <span class="citation"> Journal of Burn Care and Research </span><span class="pubYear">2009</span>;<span class="volume">30</span>(1):19‐29. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19060725" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Are+topical+antimicrobials+effective+against+bacteria+that+are+highly+resistant+to+systemic+antibiotics?+&author=AN+Neely&author=J+Gardner&author=P+Durkee&author=GD+Warden&author=DG+Greenhalgh&author=JJ+Gallagher&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0116"> <div class="reference-title-banner"> <h4 class="title">O'Meara 2001</h4> </div> <div class="bibliography-section" id="CD011038-bib-0116"> <div class="citation-journal">O’Meara SM, Cullum NA, Majid M, Sheldon TA. <span class="citation-title">Systematic review of antimicrobial agents used for chronic wounds</span>. <span class="citation"> British Journal of Surgery </span><span class="pubYear">2001</span>;<span class="volume">88</span>:4‐21. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11136304" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Systematic+review+of+antimicrobial+agents+used+for+chronic+wounds&author=SM+O%E2%80%99Meara&author=NA+Cullum&author=M+Majid&author=TA+Sheldon&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0117"> <div class="reference-title-banner"> <h4 class="title">O'Meara 2014</h4> </div> <div class="bibliography-section" id="CD011038-bib-0117"> <div class="citation-journal">O’Meara S, Al‐Kurdi D, Ologun Y, Ovington LG, Martyn‐St James M, Richardson R. <span class="citation-title">Antibiotics and antiseptics for venous leg ulcers</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2014</span>, Issue 1. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD003557.pub5" target="_blank"><span>10.1002/14651858.CD003557.pub5</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/24408354" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Antibiotics+and+antiseptics+for+venous+leg+ulcers&author=S+O%E2%80%99Meara&author=D+Al%E2%80%90Kurdi&author=Y+Ologun&author=LG+Ovington&author=M+Martyn%E2%80%90StJames&author=R+Richardson&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0118"> <div class="reference-title-banner"> <h4 class="title">Pecoraro 1990</h4> </div> <div class="bibliography-section" id="CD011038-bib-0118"> <div class="citation-journal">Pecoraro RE, Reiber GE, Burgess EM. <span class="citation-title">Pathways to diabetic limb amputation: basis for prevention</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1990</span>;<span class="volume">13</span>:513‐21. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2351029" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pathways+to+diabetic+limb+amputation:+basis+for+prevention&author=RE+Pecoraro&author=GE+Reiber&author=EM+Burgess&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0119"> <div class="reference-title-banner"> <h4 class="title">Peters 2012</h4> </div> <div class="bibliography-section" id="CD011038-bib-0119"> <div class="citation-journal">Peters EJ, Lipsky BA, Berendt AR, Embil JM, Lavery LA, Senneville E, et al. <span class="citation-title">A systematic review of the effectiveness of interventions in the management of infection in the diabetic foot</span>. <span class="citation"> Diabetes/Metabolism Research and Reviews </span><span class="pubYear">2012</span>;<span class="volume">28</span>(1 Suppl):142‐62. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+systematic+review+of+the+effectiveness+of+interventions+in+the+management+of+infection+in+the+diabetic+foot+&author=EJ+Peters&author=BA+Lipsky&author=AR+Berendt&author=JM+Embil&author=LA+Lavery&author=E+Senneville&publication_year=2012&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0120"> <div class="reference-title-banner"> <h4 class="title">Peters 2016</h4> </div> <div class="bibliography-section" id="CD011038-bib-0120"> <div class="citation-journal">Peters EJ, Lipsky BA, Aragón‐Sánchez J, Boyko EJ, Diggle M, Embil JM, et al. International Working Group on the Diabetic Foot (IWGDF). <span class="citation-title">Interventions in the management of infection in the foot in diabetes: a systematic review</span>. <span class="citation"> Diabetes/Metabolism Research and Reviews </span><span class="pubYear">2016</span>;<span class="volume">32</span>(1 Suppl):145‐53. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Interventions+in+the+management+of+infection+in+the+foot+in+diabetes:+a+systematic+review+&author=EJ+Peters&author=BA+Lipsky&author=J+Arag%C3%B3n%E2%80%90S%C3%A1nchez&author=EJ+Boyko&author=M+Diggle&author=JM+Embil&publication_year=2016&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0121"> <div class="reference-title-banner"> <h4 class="title">Prompers 2007</h4> </div> <div class="bibliography-section" id="CD011038-bib-0121"> <div class="citation-journal">Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, et al. <span class="citation-title">High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2007</span>;<span class="volume">50</span>(1):18‐25. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17093942" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=High+prevalence+of+ischaemia,+infection+and+serious+comorbidity+in+patients+with+diabetic+foot+disease+in+Europe.+Baseline+results+from+the+Eurodiale+study+&author=L+Prompers&author=M+Huijberts&author=J+Apelqvist&author=E+Jude&author=A+Piaggesi&author=K+Bakker&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0122"> <div class="reference-title-banner"> <h4 class="title">RevMan 2014 [Computer program]</h4> </div> <div class="bibliography-section" id="CD011038-bib-0122"> <div class="citation-other">Nordic Cochrane Centre, The Cochrane Collaboration. <span class="citation-title">Review Manager 5 (RevMan 5)</span>. Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, <span class="pubYear">2014</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0123"> <div class="reference-title-banner"> <h4 class="title">Rhoads 2008</h4> </div> <div class="bibliography-section" id="CD011038-bib-0123"> <div class="citation-journal">Rhoads DD, Wolcott RD, Percival SL. <span class="citation-title">Biofilms in wounds: management strategies</span>. <span class="citation"> Journal of Wound Care </span><span class="pubYear">2008</span>;<span class="volume">17</span>:502‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18978690" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Biofilms+in+wounds:+management+strategies&author=DD+Rhoads&author=RD+Wolcott&author=SL+Percival&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0124"> <div class="reference-title-banner"> <h4 class="title">Schünemann 2011a</h4> </div> <div class="bibliography-section" id="CD011038-bib-0124"> <div class="citation-other">Schünemann HJ, Oxman AD, Higgins JP, Vist GE, Glasziou P, Guyatt GH. <span class="citation-title">Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</span>. Available from handbook.cochrane.org. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0125"> <div class="reference-title-banner"> <h4 class="title">Schünemann 2011b</h4> </div> <div class="bibliography-section" id="CD011038-bib-0125"> <div class="citation-other">Schünemann HJ, Oxman AD, Higgins JP, Deeks JJ, Glasziou P, Guyatt GH. <span class="citation-title">Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</span>. Available from handbook.cochrane.org. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0126"> <div class="reference-title-banner"> <h4 class="title">Selva Olid 2015</h4> </div> <div class="bibliography-section" id="CD011038-bib-0126"> <div class="citation-journal">Selva Olid A, Solà I, Barajas‐Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. <span class="citation-title">Systemic antibiotics for treating diabetic foot infections</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2015</span>, Issue 9. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD009061.pub2" target="_blank"><span>10.1002/14651858.CD009061.pub2</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/26337865" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Systemic+antibiotics+for+treating+diabetic+foot+infections&author=A+SelvaOlid&author=I+Sol%C3%A0&author=LA+Barajas%E2%80%90Nava&author=OD+Gianneo&author=X+BonfillCosp&author=BA+Lipsky&publication_year=2015&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0127"> <div class="reference-title-banner"> <h4 class="title">SIGN 2015</h4> </div> <div class="bibliography-section" id="CD011038-bib-0127"> <div class="citation-other">Scottish Intercollegiate Guidelines Network (SIGN). <span class="citation-title">Search filters</span>. www.sign.ac.uk/methodology/filters.html (accessed 8 July 2016). <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0128"> <div class="reference-title-banner"> <h4 class="title">Singh 2005</h4> </div> <div class="bibliography-section" id="CD011038-bib-0128"> <div class="citation-journal">Singh N, Armstrong DG, Lipsky BA. <span class="citation-title">Preventing foot ulcers in patients with diabetes</span>. <span class="citation"> JAMA </span><span class="pubYear">2005</span>;<span class="volume">293</span>(2):217‐28. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15644549" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Preventing+foot+ulcers+in+patients+with+diabetes&author=N+Singh&author=DG+Armstrong&author=BA+Lipsky&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0129"> <div class="reference-title-banner"> <h4 class="title">Vermeulen 2007</h4> </div> <div class="bibliography-section" id="CD011038-bib-0129"> <div class="citation-journal">Vermeulen H, Hattem JM, Storm‐Versloot MN, Ubbink DT. <span class="citation-title">Topical silver for treating infected wounds</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2007</span>, Issue 1. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD005486.pub2" target="_blank"><span>10.1002/14651858.CD005486.pub2</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Topical+silver+for+treating+infected+wounds&author=H+Vermeulen&author=JM+Hattem&author=MN+Storm%E2%80%90Versloot&author=DT+Ubbink&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0130"> <div class="reference-title-banner"> <h4 class="title">von Eiff 2006</h4> </div> <div class="bibliography-section" id="CD011038-bib-0130"> <div class="citation-journal">Eiff C, Peters G, Becker K. <span class="citation-title">The small colony variant (SCV) concept: the role of staphylococcal SCVs in persistent infections</span>. <span class="citation"> Injury </span><span class="pubYear">2006</span>;<span class="volume">37</span>(2 Suppl):S26‐33. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16651068" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+small+colony+variant+(SCV)+concept:+the+role+of+staphylococcal+SCVs+in+persistent+infections+&author=C+Eiff&author=G+Peters&author=K+Becker&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD011038-bbs2-0131"> <div class="reference-title-banner"> <h4 class="title">White 2006</h4> </div> <div class="bibliography-section" id="CD011038-bib-0131"> <div class="citation-journal">White RJ, Cutting K, Kingsley A. <span class="citation-title">Topical antimicrobials in the control of wound bioburden</span>. <span class="citation"> Ostomy/Wound Management </span><span class="pubYear">2006</span>;<span class="volume">52</span>(8):26‐58. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Topical+antimicrobials+in+the+control+of+wound+bioburden&author=RJ+White&author=K+Cutting&author=A+Kingsley&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD011038-bbs1-0006"> <h3 class="title">References to other published versions of this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD011038-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0003">studies awaiting assessment</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0004">ongoing studies</a></li> <li><a class="jump-to" href="#CD011038-bbs1-0005">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_otherVersions" id="CD011038-bbs2-0132"> <div class="reference-title-banner"> <h4 class="title">Lipsky 2014</h4> </div> <div class="bibliography-section" id="CD011038-bib-0132"> <div class="citation-journal">Lipsky BA, Hoey C, Cruciani M, Mengoli C. <span class="citation-title">Topical antimicrobial agents for preventing and treating foot infections in people with diabetes</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2014</span>, Issue 3. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD011038" target="_blank"><span>10.1002/14651858.CD011038</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Topical+antimicrobial+agents+for+preventing+and+treating+foot+infections+in+people+with+diabetes+&author=BA+Lipsky&author=C+Hoey&author=M+Cruciani&author=C+Mengoli&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> </section> <section class="characteristicStudies" id="characteristicStudies"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title"> Characteristics of studies <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="characteristicIncludedStudiesContent" lang=""> <div class="section-header" id="CD011038-sec2-0021"> <h3 class="title">Characteristics of included studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD011038-sec2-0022" class="jump-to">excluded studies</a></li> <li><a href="#CD011038-sec2-0023" class="jump-to">awaiting classification</a></li> <li><a href="#CD011038-sec2-0024" class="jump-to">ongoing studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ahmed 2014 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT</p> <p>Setting: Hospital, 1 centre</p> <p>Country: Pakistan</p> <p>Duration of follow‐up: 8 weeks</p> <p>Duration of treatment: Not noted</p> <p>Funding source: Not reported</p> <p>Unit of analysis: Participant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>60 participants</p> <p>Inclusion criteria: Grade I or II foot ulcer in person with diabetes (grading assessed using Meggitt‐Wagner scale and corresponds to absence of necrosis and osteomyelitis) of more than 4 weeks' duration. Adequate controlled diabetes with fasting blood sugar of 110 to 130 mg/dL on 2 consecutive days prior to recruitment in the study. </p> <p>Exclusion criteria: Patients with a history of hepatic or renal disease, those on corticosteroid therapy, and those with impalpable dorsalis pedis or posterior tibial arteries. </p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported) </p> <p>Group 1: All Wagner grade II ulcers; ulcer area 1107.53 SD: 486.5</p> <p>Group 2: All Wagner grade II ulcers: ulcer area 1310.10 SD: 489.2</p> <p>Infection status at baseline: Not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 30) Pyodine bath and saline and Vaseline gauze dressing</p> <p>Group 2: (n = 30) Phenytoin powder (from capsules, no information on concentration) applied in a thin, uniform layer plus pyodine bath and saline/Vaseline gauze dressing as for Group 1. The amount of powder depended on ulcer area. </p> <p>Additional treatment information: Dressings were changed daily or on alternate days depending on need. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: None reported</p> <p>Secondary review outcomes: None reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "The study patients were divided in two equal groups randomly by lottery method"</p> <p>Comment: Whilst limited information is presented, we assumed that the a lottery approach refers to a random sequence generation. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "No information was provided on who conducted randomisation and if or how allocation was concealed" </p> <p>Comment: No information provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: Flow chart reports 0 lost to follow‐up in either group.</p> <p>Comment: Assumed all participants followed up</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Protocol not obtained, all outcomes stated in methods reported. However, key outcomes not presented; unclear if these were measured. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>None noted.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Apelqvist 1996 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT</p> <p>Setting: Hospital, 1 centre</p> <p>Country: Sweden</p> <p>Duration of follow‐up: 12 weeks</p> <p>Duration of treatment: Not reported</p> <p>Funding source: For‐profit organisation</p> <p>Unit of analysis: Participant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>41 participants</p> <p>Inclusion criteria: Caucasian &gt; 40 years of age with previously known diabetes, an exudating cavity ulcer below the ankle (Wagner grade I or II) with an ulcer area &gt; 1 cm² and systolic toe pressure &gt; 30 mmHg or a systolic ankle pressure &gt; 80 mmHg. </p> <p>Exclusion criteria: Patients with ulcers &gt; 25 cm², deep abscess, osteomyelitis, or gangrene (Wagner grade III to IV). Patients undergoing investigation of the thyroid gland or unlikely to adhere to study protocol. </p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): Not reported </p> <p>Infection status at baseline: Not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 19) Gentamicin solution (Garamycin, Schering‐Plough); streptodornase/streptokinase (Varidase, Lederle); dry saline gauze. </p> <p>Group 2: (n = 22) Cadexomer iodine ointment (Iodosorb) changed once daily during the first week and daily or every second or third day in subsequent weeks. </p> <p>Additional comments: All participants were offered the same basic treatment during the study. Prior to inclusion footwear was corrected or special footwear provided whenever required to relieve local pressure. Oral antibiotics used in signs of infection. If the ulcer was infected, gentamicin solution (80 mg/mL) was prescribed twice daily, streptodornase/streptokinase was used for necrotic lesions.<br> Dry saline gauze used as an absorptive dressing with Vaseline gauze used on dry wounds. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: Proportion of ulcers healed.</p> <p>Secondary review outcomes: Surgical resection; adverse events.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Stratifìcation was based on size and type of ulcer (Wagner grade I to II).</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Computer generated list of randomly permuted blocks of patients, the size of the blocks was unknown to the investigator." </p> <p>Comment: Adequate sequence generation</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No mention of allocation concealment process</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "open‐label"</p> <p>Comment: Assumed staff and participants not blinded to treatment</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "... with blinded photo evaluation ..."</p> <p>Comment: Blinded outcome assessment for healing</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "... with blinded photo evaluation ..."</p> <p>Comment: Blinded outcome assessment for healing</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information was provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Patients were withdrawn from the study in case [sic] of hospitalisation (n = 2), lack of compliance (n = 1), violation of inclusion criteria (n = 2)" </p> <p>Comment: Data presented for 35 participants, suggesting 6 dropped out (study started with 41 participants), for a loss of 15%. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Protocol not obtained, all outcomes stated in methods reported.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>None noted.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bergqvist 2016 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Open‐label RCT</p> <p>Setting: Hospital, 4 centres</p> <p>Country: Gothenburg, Sweden</p> <p>Duration of follow‐up: Up to 24 weeks</p> <p>Duration of treatment: 12 weeks</p> <p>Funding source: Vinnova and RLS Global AB co funded the study</p> <p>Unit of analysis: Participant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>41 participants</p> <p>Inclusion criteria: Type 1 and 2 diabetes, age 18 years or older (67.5 ± 11.8 years in chloramine group; 74.5 ± 12.3 years in control group) and an infected foot for more than 4 weeks. </p> <p>Exclusion criteria: Patients with end‐stage renal disease, impaired blood circulation, or in need of vascular intervention, or a vascular intervention performed less than 3 months before the study, a history of kidney or pancreas transplant, treatment with cortisone &gt; 60 mg daily, chemotherapy or any immune‐modulating agents during the past year, identified conditions, in the ulcer area (e.g. cancer), or generally poor health of the participant and at risk of requirement of hospitalisation. </p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): Not reported </p> <p>Infection status at baseline: Infected</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 19) Standard care alone. Ulcer was cleaned and debrided according to the guidelines of the International Working Group on the Diabetic Foot once weekly. The ulcer was dressed with foam, hydrocolloid, or alginate dressing. In a few cases an adjusted antiseptic agent, silver or polyhexamethylene biguanide, was used. </p> <p>Group 2: (n = 21) Chloramine plus standard care. Trialist applied a preparation containing sodium hypochlorite and amino acid, which are converted to chloramine by mixing the 2 components immediately prior to treatment. The gel was applied to the ulcer once a week. Debridement was done with the gel left on the ulcer surface to provide antibacterial protection for the exposed tissue. </p> <p>Additional comments: Nurses and podiatrist performed cleansing and debridement of the ulcer in both groups at least once weekly for 12 weeks. All participants were given standard care advice on the treatment of diabetes and risk factors. Oral antibiotic treatment was offered if signs of significant infection were observed, particularly affecting underlying tissues or bones. Appropriate off‐loading was considered in all participants. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: Proportion of ulcers healed; time‐to‐event data (partially reported); resolution of signs of infection </p> <p>Secondary review outcomes: Surgical resection; adverse events</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>The original study performed both ITT and PP analyses for efficacy outcomes, but did not state which analysis was used in the report, hence we assumed the numbers reported were completers only. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "patients were randomised in blocks of 4 ..."</p> <p>Comment: Block randomisation is implied.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "in an explorative open randomised controlled multi‐centre study"</p> <p>Comment: No mention of allocation concealment process</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "open‐label"</p> <p>Comment: Assumed staff and participants not blinded to treatment</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "a photo was taken every week after treatment ... the area of ulcer was subsequently measured by an independent observer" </p> <p>Comment: Adequate blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "a photo was taken every week after treatment ... the area of ulcer was subsequently measured by an independent observer" </p> <p>Comment: Adequate blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: It is unclear how the adverse events were assessed.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Chloramine group: Violation of protocol (n = 1 had percutaneous angioplasty; n = 1 was accidentally included in 2 centres; n = 1 lower toe blood pressure &lt; 30 mmHg), 2 ulcer coalesced and unable to assess (n = 1). Control group: lost to follow‐up (n = 1), withdrew informed consent (n = 1) </p> <p>Comment: The dropout rate did not differ significantly between groups; although more people dropped out of the intervention group, the reasons for dropout were mostly not related to the treatment. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Protocol not obtained, all outcomes stated in methods reported.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bowling 2011 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT; prospective, 2‐centre, randomised, controlled, double‐blind, pilot study</p> <p>Setting: Hospital and community, 2 centres</p> <p>Country: UK</p> <p>Duration of follow‐up: 4 weeks</p> <p>Duration of treatment: Weekly treatment for 4 weeks</p> <p>Funding source: For‐profit organisation</p> <p>Unit of analysis: Participant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>20 participants</p> <p>Inclusion criteria: Chronic (4 weeks’ duration), non‐clinically infected foot ulcers (colonised) where necrotic tissue was present and mechanical debridement was indicated. A foot ulcer was defined as a full‐thickness break of the epithelium distal to the medial and lateral malleoli. Only 1 ulcer per participant was included. </p> <p>Exclusion criteria: Ulcers larger than 25 cm², ulcers defined as grade III in the University of Texas classification, osteomyelitis, peripheral arterial disease (absent pulses/ankle‐brachial index &lt; 0.8), prescription use of anticoagulants, immunosuppressive drug treatment, or known allergies to chlorine (present in Dermacyn). Clinically infected wounds were excluded on the grounds of antibiotic use. </p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): </p> <p>Group 1: Ulcer duration (weeks) 13.7 SD: 12.0</p> <p>Group 2: Ulcer duration (weeks) 9.7 SD: 8.1</p> <p>Infection status at baseline: Not infected</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1 (n = 10): Saline solution</p> <p>Group 2 (n = 10): Super‐oxidised aqueous solution</p> <p>Additional comments: Both solutions used with the Versajet lavage system for removing necrotic tissue. Each solution was used with the Versajet lavage system in a clinic treatment room, followed by a wound rinse and a 10‐minute soak with the respective solution. After the soaking, all of the wounds were dressed with a hydrogel dressing that was changed at regular intervals of 3 to 4 days, as specified by the treating physician. Saline or super‐oxidised aqueous solution was applied at every dressing change. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: Proportion of wounds healed (partially reported)</p> <p>Secondary review outcomes: Adverse events</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Ten subjects were randomised to each group using a computer‐generated block randomization scheme" </p> <p>Comment: Adequate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Both medical centers were provided with sealed randomization envelopes for conducting the treatment assignment" </p> <p>Comment: It is unclear if the envelopes were opaque, but we assume it is a reporting issue. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "This was a prospective, two‐center, randomised, controlled, double‐blind, pilot study." </p> <p>Comment: No further information was provided on who was blinded or how the blinding was achieved. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information was provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information was provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information was provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Information not provided</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Protocol not obtained, all outcomes stated in methods reported.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>None noted.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Gottrup 2013 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT</p> <p>Setting: Hospital, 2 centres</p> <p>Country: Denmark</p> <p>Duration of follow‐up: 14 weeks</p> <p>Duration of treatment: Not reported</p> <p>Funding source: For‐profit</p> <p>Unit of analysis: Participant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>39 participants</p> <p>Inclusion criteria: Diabetic patients aged 35 to 80 years with an ulcer of at least 30 days' duration. Ulcer defined as diabetic foot ulcer, Wagner grade II to III. No local or systemic signs of infection with normal leukocyte levels. Patient willing to return to centre for dressing changes and wound evaluation. </p> <p>Exclusion criteria: Known allergies to any of the contents of PROMOGRAN PRISMA (collagen, oxidised regenerated cellulose, or silver oxidised regenerated cellulose); clinical signs of infection; pregnancy or lactating; history of drug misuse or excessive alcohol consumption; currently undergoing chemotherapy; wound is considered to be malignant; peripheral arterial disease or toe pressure 45 mmHg, or both; patient is unable to walk; patient had haemolytic anaemia and/or iron deficiency anaemia and/or malnutrition, severe cardiac and/or hepatic and/or renal and/or pulmonary insufficiency or chronic administration of cortisone for chronic inflammatory disease and/or autoimmune disease. </p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): </p> <p>Group 1: Ulcer duration (months) 16.9 SD: 36.6; wound area (cm²) 4.4 SD: 6.3</p> <p>Group 2: Ulcer duration (months) 12.9 SD: 13.0; wound area (cm²) 2.1 SD: 3.1</p> <p>Infection status at baseline: Not infected</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 15) Foam dressing (Biatain, Coloplast, Humlebæk, Denmark) for moderately exuding wounds and a more absorbent dressing (Mesorb, Mölnlycke Health Care, Gothenburg, Sweden) for highly secreting wounds. </p> <p>Group 2: (n = 24) Silver collagen/oxidised regenerated cellulose dressing (Promogran Prisma, Systagenix Wound Management Ltd., Gatwick, UK). Applied directly to wound. Where there was a low level of wound exudates, the dressing was pre‐wet before applying to the wound. The study protocol suggests that the control dressings were also used in the intervention group, but timing was unclear. </p> <p>Additional comments: The same type of dressings were used in the test and control group and consisted of a foam dressing (Biatain, Coloplast, Humlebæk, Denmark) for moderately exuding wounds and a more absorbent dressing (Mesorb, Mölnlycke Health Care, Gothenburg, Sweden) for highly secreting wounds. The dressings were changed at least twice a week according to the condition of the wound. Patients in both groups were treated with standard wound treatment protocol including debridement and off‐loading, based on specialist clinical evaluation. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: Proportion of wounds healed; wound infection (defined by a clinical specialist evaluation based on the classical infection signs, with no microbiological assessment) </p> <p>Secondary review outcomes: Adverse events</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Randomization was performed independently of the research team using random number tables and group assignment was kept in sealed envelopes until the end of the study" </p> <p>Comment: Adequate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Randomization was performed independently of the research team using random number tables and group assignment was kept in sealed envelopes until the end of the study" </p> <p>Comment: Adequate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No mention of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No mention of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No mention of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No mention of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Figure shows loss of 3 participants at 14 weeks' follow‐up.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Protocol not obtained, all outcomes stated in methods reported.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>None noted.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">He 2016 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT</p> <p>Setting: Outpatients and inpatients admitted to the Department of Burn and Plastic Surgery of Dazhou Central Hospital </p> <p>Country: China</p> <p>Duration of follow‐up: 4 weeks</p> <p>Duration of treatment: 4 weeks</p> <p>Funding source: Not reported</p> <p>Unit of analysis: Not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria: Patients with foot ulcers with over 2 years' history of diabetes and glycated haemoglobin &gt; 6.5%. </p> <p>Exclusion criteria: Patients with severe heart or lung disease, high blood pressure, severe mental illness, required immediate amputation, malnutrition, severe sinusitis, detachment of retina, diabetic ketosis in the last 2 weeks, diabetic ketoacidosis, severe infection, and other patients at high risk of being non‐compliant. </p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): </p> <p>Group 1: Ulcer area 12.34 SD: 3.42 (cm²)</p> <p>Group 2: Ulcer area 11.85 SD: 2.91 (cm²)</p> <p>Infection status at baseline: Not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 40) Routine debridement plus standard care (including blood glucose control, nutritional support, improvement in microcirculation). </p> <p>Group 2: (n = 40) Silver ion dressing plus standard care (including blood glucose control, nutritional support, improve microcirculation). </p> <p>Additional information: Dressing was changed daily in Group 1; dressing was changed daily and silver ion was refreshed once a week in Group 2. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: Proportion of ulcers healed; time to healing (partially reported)</p> <p>Secondary review outcomes: None reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>English abstract; text translated from Chinese.</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "random numbers were generated with computer programme and managed by an assigned team member" </p> <p>Comment: Adequate method of generating random sequence</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "researchers, clinicians and patients do not know the allocation sequence before the trial" </p> <p>Comment: Although we do not know how the trialists concealed the allocation plan, we accept their statement quoted above as true. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "prospective, open, randomised controlled clinical trial"</p> <p>Comment: Open trial with no blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Not stated</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No incomplete outcome data</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: None obvious</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: None obvious</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hwang 2010 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT</p> <p>Setting: Not reported</p> <p>Country: Not reported</p> <p>Duration of follow‐up: Not reported</p> <p>Duration of treatment: Not reported</p> <p>Funding source: Not reported</p> <p>Unit of analysis: Not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria: Patients with foot ulcers with bone and tendon exposure and diabetes.</p> <p>Exclusion criteria: None noted.</p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): Not reported </p> <p>Infection status at baseline: Not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = not reported) Iodine gauze (in the control group, iodine gauze dressings were applied at the time of skin graft and changed 3 times a day thereafter). </p> <p>Group 2: (n = not reported) Hydrofiber dressing with silver (changed every 24 hours).</p> <p>Additional comments: All foot ulcers were surgically debrided prior to initiation of the Hydrofiber dressing with silver or gauze treatment. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: None reported.</p> <p>Secondary review outcomes: None reported.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Conference abstract; no outcome data clearly reported.</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Twenty patients were randomised into either the experimental hydrofibre dressing with silver* group or control iodine gauze group" </p> <p>Comment: Insufficient information to make a low‐risk assessment</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information available</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information available</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information available</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information available</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information available</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information available</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Imran 2015 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT</p> <p>Setting: Department of General Surgery, Pakistan and Bhatti International Trust (BIT) Hospital </p> <p>Country: Pakistan</p> <p>Duration of follow‐up: 17 weeks</p> <p>Duration of treatment: Not reported</p> <p>Funding source: Not reported</p> <p>Unit of analysis: Not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria: All patients &gt; 18 years of age with diabetic foot ulcer (Wagner grade I or II) were selected. </p> <p>Exclusion criteria: Patients with Wagner grade III to V, ankle‐brachial pressure index &lt; 7, venous ulcer or malignant ulcer, uncontrolled diabetes (glycated haemoglobin &gt; 7%), patients with &gt; 1 ulcers, patients with haemoglobin &lt; 10 g/dL, and patients with local signs of infection (presence of pus, initial culture positive) in the wound were excluded from the study. </p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): Not reported </p> <p>Infection status at baseline: Not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 180) Treated with normal saline dressing.</p> <p>Group 2: (n = 195) Treated with honey dressing.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: Proportion of ulcers healed; time to wound healing (partially reported) </p> <p>Secondary review outcomes: Not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "grouping was done by simple randomization method (computer‐generated random numbers)" </p> <p>Comment: Adequate method of random sequence generation</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 16 people dropped out of honey dressing group, and 11 dropped out of saline group. Although not included in the final analysis, the proportion of dropout was balanced between groups and did not compromise the statistical power to detect any potential difference between groups. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: None obvious</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: None noted.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Jacobs 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT</p> <p>Setting: Office of study author (no further details)</p> <p>Country: Not reported</p> <p>Duration of follow‐up: 6 weeks</p> <p>Duration of treatment: 6 weeks</p> <p>Funding source: Not reported</p> <p>Unit of analysis: Participant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>40 participants</p> <p>Inclusion criteria: Wagner grade I or II ulcerations of the foot. Study authors note that all patients included in the study presented with ulcers that were 3 centimetres in diameter or less on the plantar aspect of the foot (unclear if inclusion criteria or not). Currently under care for diabetes. </p> <p>Exclusion criteria: Glycated haemoglobin greater than 10%.</p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): Not clearly reported </p> <p>Infection status at baseline: Not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 20) Silver sulphadiazine cream (no further details).</p> <p>Group 2: (n = 20) Formulation of benzoic acid, 6%; salicylic acid, 3%; and extract of oak bark (<i>Quercus rubra</i>)<i>,</i> 3% (Bensal HP with QRB7), with silver sulfadiazine cream. </p> <p>Additional comments: All participants were treated by off‐loading of weight bearing and shoe pressure from the area of ulceration. Debridement with a scalpel was performed as determined for each participant. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: Proportion of ulcers healed (referred to as "resolved" by study authors) </p> <p>Secondary review outcomes: None reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "A research coordinator randomly assigned patients to receive ..."</p> <p>Comment: No further details provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: As above</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "This was a blinded study"</p> <p>Comment: No further details provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: As above</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: It seems from report that all participants were followed up, as results table contains data for all 40 randomised participants. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Protocol not obtained, all outcomes stated in methods reported.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: None noted.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Jeffcoate 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT</p> <p>Setting: Hospital, 9 centres</p> <p>Country: UK</p> <p>Duration of follow‐up: 24 weeks</p> <p>Duration of treatment: 24 weeks or until healing</p> <p>Funding source: Not‐for‐profit</p> <p>Unit of analysis: Participant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>317 participants</p> <p>Inclusion criteria: Type 1 or 2 diabetes; 18 years of age or older; a foot ulcer present for at least 6 weeks with a cross‐sectional area of between 25 and 2500 mm²; able and willing to give informed consent; reasonably accessible by car to the hospital base; under routine review by the multidisciplinary clinic. </p> <p>Exclusion criteria: Those with a known allergy to any of the trial preparations (including iodine); any ulcer on either foot extending to tendon, periosteum, or bone, infection of bone, soft‐tissue infection requiring treatment with systemic antibiotics; an ulcer on a limb being considered for revascularisation; those chosen for management with a non‐removable cast without a dressing window; gangrene on the affected foot; eschar that was not removable by clinical debridement; those with evidence of a sinus or deep track; those in whom the hallux had been amputated on the affected side (preventing the measurement of toe pressure); those with an ankle‐brachial pressure index of less than 0.7 or toe systolic pressure less than 30 mmHg; ulceration judged to be caused primarily by disease other than diabetes; patients with any other serious disease likely to compromise the outcome of the trial; patients with critical renal disease (creatinine greater than 300 mmol/L); those receiving immunosuppressants, systemic corticosteroid therapy (other than by inhalation), or any other preparation that, in the opinion of the supervising clinician, could have interfered with wound healing; those living at such a distance (generally further than 10 miles) from the clinic as would have made frequent assessment visits inappropriately expensive or impractical, or both; those who withheld consent. </p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): Not reported </p> <p>Infection status at baseline: Not clear</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 108) Non‐adherent dressing, viscose filament gauze (Johnson &amp; Johnson)</p> <p>Group 2: (n = 103) Hydrocolloid (Hydrofiber) dressing (Aquacel, ConvaTec)</p> <p>Group 3: (n = 106) Iodine‐containing dressing (Inadine, Systagenix)</p> <p>Additional comments: Dressings were changed daily, on alternate days or 3 times a week according to need or availability of professional staff, or both. Participants were advised to have a bath or shower as often as they wished, provided the ulcer could be redressed afterwards, and provided the ulcerated foot was not immersed in water for more than 5 minutes. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: Proportion of ulcers healed<br> Secondary review outcomes: Health‐related quality of life (Cardiff Wound Impact Schedule and SF‐36); amputations (minor and major); adverse events (serious and non‐serious) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Randomisation was stratified by both centre and size, using a block size of 9. Randomisation was stratified across the whole population by ulcer area into 3 groups: 25 to 100 mm², 101 to 250 mm², and 251 to 2500 mm². </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Randomisation lists were created using SPSS (SPSS Inc., Version 14), using blinded dressing codes." </p> <p>Comment: Adequate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "The lists were held at Cardiff University and each recruiting centre telephoned a designated number during working hours. They were required to identify the centre and size of wound only." </p> <p>Comment: Adequate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: The study was not blinded to personnel and participants.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Dressings were removed prior to examination by assessors who were not involved in the conduct of the trial and who were blind to the randomisation group." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not clear if infection assessment was blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not clear if adverse event data collection was blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Intention to treat analysis was carried out using the last value carried forward method, with strict adherence to the protocol such that only those who attended for a healing verification visit and reported as still healed at 28 days have been coded as ‘healed’ for the outcome classification."<br> Comment: ITT analysis was done, but imputing missing data attributable to withdrawal of trial participants due to adverse events and protocol violations. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Protocol not obtained, all outcomes stated in methods reported.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: None noted.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Jude 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT</p> <p>Setting: 18 centres ‐ settings not clear</p> <p>Country: UK, France, Germany, and Sweden</p> <p>Duration of follow‐up: 8 weeks</p> <p>Duration of treatment: 8 weeks or until healed</p> <p>Funding source: For‐profit</p> <p>Unit of analysis: Participant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>134 participants.<br> Inclusion criteria: Patients with Type 1 or Type 2 diabetes mellitus (glycated haemoglobin ≤ 12%); serum creatinine ≤ 200 mol/L; neuropathic or neuro‐ischaemic diabetic foot ulcers classed as Wagner grade I or II; all wounds &gt; 1 cm² in area.<br> Exclusion criteria: Patients with known allergies to dressings being investigated; known or suspected malignancy near ulcer; taking systemic antibiotics &gt; 7 days prior to enrolment; inadequate arterial perfusion defined by ankle‐brachial index &lt; 0.8, or great toe systolic blood pressure &lt; 40 mmHg or forefoot transcutaneous oxygen &lt; 30 mmHg (participant supine) or &lt; 40 mmHg (participant sitting). </p> <p>Ulcer characteristics at baseline (e.g. anatomic site, size, number of ulcers, presence of infection, duration of ulceration where reported): </p> <p>Group 1: Ulcer duration (years) 1.4 (SD 2.6); ulcer area (cm²) 4.2 (SD 7.8)</p> <p>Group 2: Ulcer duration (years) 1.2 (SD 2.1); ulcer area (cm²) 4.2 (SD 4.1)</p> <p>Infection status at baseline: Mixed: 22 participants had clinically infected ulcers at baseline, 13 in Group A and 9 in Group B. On enrolment antibiotics were prescribed to 8 participants in Group A and 13 in Group B. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 67) Calcium‐alginate dressing (Algosteril, Smith &amp; Nephew). Manufacturer's instructions were followed, and dressing was moistened before use on dry wounds, and changed on leakage or at evaluation or every 7 days as indicated (except for infected wounds, for which the dressing was changed daily). </p> <p>Group 2 (n = 67): Fibrous‐hydrocolloid (Hydrofiber) dressing with 1.2% ionic silver (Aquacel Ag, ConvaTec). Left in place and changed on leakage or at evaluation or every 7 days as indicated. </p> <p>In both groups, ulcers were cleansed using sterile saline; each dressing was covered with a sterile, non‐adherent foam dressing. </p> <p>Additional comments: Accommodative footwear for non‐plantar ulcers and off‐loading for plantar ulcers delivered as required. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: Proportion of ulcers healed (number of ulcers healed); time to healing (only partially reported)<br> Secondary review outcomes: Adverse events </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "eligible individuals were randomly assigned to receive one of the two dressings according to instructions in a sealed envelope and stratified according to whether or not systemic antibiotics were being administered for treatment of the studied ulcer" </p> <p>Comment: No detailed information provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: See above</p> <p>Comment: It is unclear how allocation was conducted.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "open‐label"</p> <p>Comment: The study was not blinded to personnel and participants.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No information is provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No information is provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No information is provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>65 out of the 67 participants in each study group were rated for wound condition at final evaluation. All included participants were evaluated for safety. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Protocol not obtained, all outcomes stated in methods reported.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>None noted.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Khandelwal 2013 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT</p> <p>Setting: Patients were managed initially on inpatient and then on outpatient basis</p> <p>Country: India</p> <p>Duration of follow‐up: Until healing &gt; 8 weeks</p> <p>Duration of treatment: 10 weeks</p> <p>Funding source: Unclear: the study notes that "financial support was provided by dr. Ram Manohar Lohia Hospital, New Dehli" </p> <p>Unit of analysis: Participant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>60 participants</p> <p>Inclusion criteria: Diabetic foot ulcer of at least 8 weeks' duration ‐ stage III and IV, absence of vascular insufficiency involving large‐ and medium‐sized arteries proximal to the ulcer demonstrated by Doppler study, age ≥ 18 years with Type 1 or 2 diabetes. </p> <p>Exclusion criteria: Patients with uncontrolled diabetes, foot ulcer with established gangrene, compromised vascularity of the particular limb, associated osteomyelitis at site of ulcers, pregnant and lactating females, neoplasm at the local site, patients on any immunosuppressive agents, presence of multiple ulcers, patient HIV seropositive, patients with known drug allergy, presence of concomitant life‐threatening infections, chronic renal insufficiency (serum creatinine &gt; 3 mg/dL), when ear cannot equalise the pressure when congested with cold/hay fever, patients with perforation of ear drum. High‐risk case, i.e. bronchial asthma/emphysema </p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): Not reported </p> <p>Infection status at baseline: Not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 20) Hyperbaric oxygen therapy. Therapy delivered at 2.5 atmospheres absolute for 60 min per sitting for a total of 30 sittings or until the ulcer had healed. Sittings were distributed over a period of 10 weeks. Patients were given either daily or alternate‐day therapy depending on the availability of slot in the facility. The patients in this group were also debrided from time to time but dressed only with normal saline. No antiseptics were used (group not considered further in review). </p> <p>Group 2: (n = 20) Recombinant human platelet‐derived growth factor. The patients in this group were initially<br> debrided surgically and subsequently as well when required. </p> <p>Group 3: (n = 20) Antiseptic treatments (Edinburgh University Solution of Lime (EUSOL), hydrogen peroxide, and povidone iodine). The foot was soaked in EUSOL for 30 min, followed by use of hydrogen peroxide and povidone iodine (no details about concentration). </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcome: Proportion of ulcers healed; time to healing (partially reported)</p> <p>Secondary outcomes: None</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Randomisation methods not specified.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information is provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Open‐label study</p> <p>Comment: Blinding unfeasible due to the differences in setting and formulation of the interventions. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information is provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "6 patients in group 1 (30%), 5 in group 2 (25%) and 1 (5%) in group 3 lost to follow up" </p> <p>Comment: Systematic differences in withdrawal from the study among groups</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: The outcomes reported in the results are not the same as specified in the Material and Methods section. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: None noted.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Landsman 2011 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT</p> <p>Setting: 16 centres, but outpatient or inpatient setting is not specified</p> <p>Country: USA</p> <p>Duration of follow‐up: 4 weeks</p> <p>Duration of treatment: 10 days</p> <p>Funding source: For‐profit funding; "This project was supported by a research grant from Oculus Innovative Sciences." </p> <p>Unit of analysis: Participant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>67 participants</p> <p>Inclusion criteria: &gt; 18 years of age with diabetes mellitus (Type 1 or 2) and a mild diabetic foot infection. Eligible foot ulcers involved skin and deeper soft tissue and were classified by Infectious Diseases Society of America guidelines as mildly infected and by the University of Texas Classification as 1B. Ulcers could be located on the foot and malleolar areas, measured 1 to 9 cm², and were accessible for culture. Adequate circulation to the foot was required. </p> <p>Exclusion criteria: Antibiotic treatment for more than 24 hours within 72 hours of study entry; necrotising fasciitis, deep abscesses in the soft tissue, sinus tracts, gas gangrene, or infected burns, superinfected eczema or other chronic medical conditions; ulcers located on the stump of an amputated extremity; ulcers having a non‐diabetic aetiology; infections complicated by the presence of prosthetic materials and osteomyelitis; pregnancy or risk of pregnancy, breastfeeding; liver disease; neutropenia; hypersensitivity to chlorine or quinolones; patients receiving glucocorticoid or adjuvant therapy with hyperbaric oxygen or topical formulations containing growth factors, antimicrobials, enzymatic debriders, or granulation promoters; disorders of immune function and any medical condition that, in the investigator’s opinion, would require dose modification of levofloxacin to less than 750 mg/d or who had received an investigational agent within 1 month before the baseline evaluation. </p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): Not reported </p> <p>Infection status at baseline: Infected ulcers</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 21) Topical saline solution plus 750 mg levofloxacin once per day.</p> <p>Group 2: (n = 21) Topical Microcyn therapy once per day (not considered in review).</p> <p>Group 3 (n = 25) Topical Microcyn therapy plus 750 mg levofloxacin once per day.</p> <p>Additional comments: Wound cleaning and coverage was performed once a day with 30 mL of either Microcyn Rx or saline. Sterile gauze was saturated with approximately 25 mL of Microcyn Rx or saline, and the excess solution was wrung out. Working from the inside out, the wound was scrubbed gently to remove drainage and exudates. Once the wound bed was prepared, another sterile gauze pad was saturated with an additional 5 mL of Microcyn Rx or saline. Enough of the soaked gauze was applied to fill, but not tightly pack, the wound. The wound was covered with an occlusive dressing after each dressing change. Where necessary, off‐loading was achieved with fixed ankle boots or healing sandals, as indicated by the investigator. Debridement procedures were limited to 3 for the duration of the study. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: Resolution of infection (defined in the paper as "cure" ‐ resolution of all signs and symptoms, including the presence of culturable exudates, warmth, erythema, induration, tenderness, pain, swelling, and a healing wound (as determined by the investigator) after 5 or more days of treatment). </p> <p>Secondary review outcomes: Adverse events</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Randomization was accomplished at each study site by using a manual system and stratified by site". "Envelopes containing group designations opened sequentially" </p> <p>Comment: It is not clear how the randomisation sequence was generated.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Envelopes containing group designations opened sequentially"</p> <p>Comment: It is unclear if the allocation was foreseeable with this method; numbering envelopes would have added extra rigour, and it is not clear if this was done. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Open‐label</p> <p>Comment: Blinding unfeasible due to the differences in setting and formulation of the interventions. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: The study was conducted on an ITT basis with missing = failure; 66 out of 67 participants randomised were evaluated. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Protocol not obtained, all outcomes stated in methods reported.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: None noted.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lipsky 2008a </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT</p> <p>Setting: Predominantly outpatients (with some inpatients) (<i>from study author</i>) </p> <p>Country: USA</p> <p>Duration of follow‐up: 28 to 42 days</p> <p>Duration of treatment: 14 to 28 days</p> <p>Funding source: For‐profit; "Magainin Pharmaceuticals sponsored the studies"</p> <p>Unit of analysis: Participant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>493 participants</p> <p>Inclusion criteria: Men or women aged &gt; 18 years with diabetes mellitus and an infected wound below the malleoli that exceeded 0.5 cm² in area after appropriate debridement. Wounds had to be full‐thickness (i.e. through the epidermis and into or through the dermis, but not involving tendon, bone, or joint capsule). </p> <p>Exclusion criteria: Patients were excluded if they had: an abscess; extensive gangrene; an imminently limb‐threatening infection; evidence of systemic infection (e.g. fever, chills, or hypotension); plain radiograph findings suggestive of osteomyelitis; no palpable dorsalis pedis or posterior tibial pulse or a pedal systolic pressure (by Doppler) of ≤ 40 mmHg on the affected limb; requirement for renal dialysis; need for immunosuppressive medication; or hypersensitivity to either study medication. </p> <p>Infection was defined by the presence of purulent drainage or ≥ 2 of the following: erythema, warmth, pain or tenderness, or oedema or induration. The diabetic foot infection had to be severe enough to require antibiotic therapy, but it had to be amenable to outpatient treatment. </p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): </p> <p>Group 1: Ulcer area (mm²) 131.5 (no SD reported)</p> <p>Group 2: Ulcer area (mm²) 117.3 (no SD reported)</p> <p>Infection status at baseline: Infected ulcers</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 246) Ofloxacin (200 mg) oral tablets and a topical placebo (vehicle) cream. </p> <p>Additional comments: Investigators performed appropriate local wound care, including any necessary debridement and pressure off‐loading of the infected site, and they obtained wound tissue specimens for aerobic and anaerobic culture at enrolment, and at follow‐up, when material was available. </p> <p>Group 2: (n = 247) Topical pexiganan cream (1% or 2%) and placebo oral tablets.</p> <p>Each treatment administered twice daily.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary outcomes: None reported in useable format</p> <p>Secondary outcomes: Surgical resection; adverse events</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Some information about study methods was available from corresponding author. Classed as study 303 in paper </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote "Computer generated random sequence" (<i>from study author</i>) </p> <p>Comment: Adequate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "After completion of required screening procedures eligible patients received a sequentially assigned randomization number. Each investigational centre received a unique set of randomization numbers." (<i>from study author</i>) </p> <p>Comment: Adequate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "double blind. Patients were instructed to take 2 tablets (either 200 mg of active ofloxacin orally twice daily and to apply a cream (either active pexiganan acetate or placebo, sufficient to form a dime thick layer) twice daily directly onto the ulcer and to dress the wound with sterile, dry gauze. Patients randomised to treatment with pexiganan received placebo tablets, and those randomised to ofloxacin treatment received placebo cream" </p> <p>Comment: Blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "assessors were also blinded to treatment" (<i>from study author</i>) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "assessors were also blinded to treatment" (<i>from study author</i>) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Figure in paper shows that all participants had clinical data analysed in ITT. There were more missing data for microbial analysis, but we did not consider these in the review. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Healing data did not seem to be reported.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: None noted.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lipsky 2008b </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT</p> <p>Setting: Predominantly outpatients (with some inpatients) (<i>from study author</i>) </p> <p>Country: USA</p> <p>Duration of follow‐up: 28 to 42 days</p> <p>Duration of treatment: 14 to 28 days</p> <p>Funding source: For‐profit</p> <p>Unit of analysis: Participant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>342 participants</p> <p>Inclusion criteria: Men or women aged &gt; 18 years with diabetes mellitus and an infected wound below the malleoli that exceeded 0.5 cm² in area after appropriate debridement. Wounds had to be full‐thickness (i.e. through the epidermis and into or through the dermis, but not involving tendon, bone, or joint capsule). </p> <p>Exclusion criteria: Patients were excluded if they had an abscess, extensive gangrene, an imminently limb‐threatening infection, evidence of systemic infection (e.g. fever, chills, or hypotension), plain radiograph findings suggestive of osteomyelitis, no palpable dorsalis pedis or posterior tibial pulse or a pedal systolic pressure (by Doppler) of ≤ 40 mmHg on the affected limb, requirement for renal dialysis, need for immunosuppressive medication, or hypersensitivity to either study medication. </p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): Not reported </p> <p>Infection status at baseline: Infected ulcers</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 171) Ofloxacin (200 mg) oral tablets and a topical placebo (vehicle) cream. </p> <p>Group 2: (n = 171) Topical pexiganan cream (1%) and placebo oral tablets.</p> <p>Additional comments: Investigators performed appropriate local wound care, including any necessary debridement and pressure off‐loading of the infected site, and they obtained wound tissue specimens for aerobic and anaerobic culture at enrolment, and at follow‐up, when material was available. </p> <p>Each treatment administered twice daily.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary outcomes: None reported in useable format</p> <p>Secondary outcomes: Surgical resection; adverse events</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Some information about study methods was available from corresponding author.</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote "Computer generated random sequence" (<i>from study author</i>) </p> <p>Comment: Adequate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "20 or more clinical study centres received sufficient randomization numbers to complete approximately 224 patients at each site. The investigators were blinded as to the treatment group assignment throughout the study. After completion of required screening procedures eligible patients received a sequentially assigned randomization number. Each investigational centre received a unique set of randomization numbers." (<i>from study author</i>) </p> <p>Comment: Adequate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "double blind. Patients were instructed to take 2 tablets (either 200 mg of active ofloxacin orally twice daily and to apply a cream (either active pexiganan acetate or placebo, sufficient to form a dime thick layer) twice daily directly onto the ulcer and to dress the wound with sterile, dry gauze. Patients randomised to treatment with pexiganan received placebo tablets, and those randomised to ofloxacin treatment received placebo cream" </p> <p>Comment: Blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "assessors were also blinded to treatment" (<i>from study author</i>) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "assessors were also blinded to treatment" (<i>from study author</i>) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Figure in paper shows that all participants had clinical data analysed in ITT. There were more missing data for microbial analysis, but we did not consider these in the review. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Healing data did not seem to be reported.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: None noted.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lipsky 2012a </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT (2:1 randomisation ratio)</p> <p>Setting: Diabetic foot clinics (mainly inpatients) (<i>from study author</i>) </p> <p>Country: USA and UK</p> <p>Duration of follow‐up: Outcome assessment planned for 2 weeks after cessation of treatment for a total study duration of 42 days </p> <p>Duration of treatment: At least 7 days and for a maximum of 28 days</p> <p>Funding source: For‐profit; "This study was funded in whole by Innocoll Technologies Ltd." </p> <p>Unit of analysis: Participant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>56 participants</p> <p>Inclusion criteria: Diabetic patients aged 18 to 80 years with a single, moderately infected lower extremity ulcer. </p> <p>Exclusion criteria: Patients who had received any antimicrobial therapy in the preceding 2 weeks; those with ischaemia of the lower limb; and, at institutional review board request, patients with a glycated haemoglobin level of ≥ 10.0%. </p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): Not reported </p> <p>Infection status at baseline: Infected ulcers</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 38) Systemic antibiotic therapy alone (a daily oral or intravenous dose of 750 mg of levofloxacin or alternative antimicrobial therapy, as determined by susceptibility testing). </p> <p>Group 2: (n = 18) Daily topical application of the gentamicin‐collagen sponge combined with systemic antibiotic therapy (a daily oral or intravenous dose of 750 mg of levofloxacin or alternative antimicrobial therapy, as determined by susceptibility testing). </p> <p>Additional comments: Participants in both arms also received standard diabetic wound management, including sharp surgical debridement at each visit where appropriate, pressure off‐loading as applicable, and daily dressing changes using a non‐adherent, moisture‐permeable gauze dressing followed by a second saline‐moistened gauze dressing. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: Resolution of infection</p> <p>Secondary review outcomes: Adverse events</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information presented.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "patients were randomised in a 2:1 ratio to the treatment or control group using a interactive voice response system" </p> <p>Comment: Confirmed centralised randomisation</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "open‐label"</p> <p>Comment: The authors chose not to administer placebo collagen sponges to participants in the control group due to the concern that a placebo sponge could potentially harbour bacteria and bias the results in favour of the active treatment. Consequently, to reduce the complexity of this pilot study, they chose an open‐label design. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "assessors were also blinded to treatment" (<i>from study author</i>) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "assessors were also blinded to treatment" (<i>from study author</i>) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote "of the 56 randomised subjects, 20 (12 in group 1 and 8 in group 2) were deemed ineligible; three more subjects in the study group discontinued (1 because of adverse events, 1 because of protocol non‐compliance and 1 lost to follow up)." "we defined a modified ITT population to use of efficacy analyses to include only the 36 eligible patients" </p> <p>Comment: 41% of participants were not included in analysis.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: All outcomes reported as outlined in methods. Protocol not obtained.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: None noted.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Martinez‐De Jesus 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT</p> <p>Setting: Outpatient clinic</p> <p>Country: Mexico</p> <p>Duration of follow‐up: 20 weeks</p> <p>Duration of treatment: Minimum of 10 days</p> <p>Funding source: Not reported</p> <p>Unit of analysis: Participant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>45 participants</p> <p>Inclusion criteria: Type 2 diabetes; older than 18 years of age; infected, deep wounds at or distal to the malleoli; presence of malodour, active periwound cellulites; loss of protective sensation; and at least 1 Dopplerable pedal pulse. </p> <p>Exclusion criteria: Severe arterial disease; ankle‐brachial index below 0.5; a diagnosis of osteomyelitis; total gangrene of the study foot or forefoot; severe cardiovascular or renal failure; and severe neurological problems. </p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): </p> <p>Group 1: Ulcer duration (weeks) 15.1 (SD 16.3)</p> <p>Group 2: Ulcer duration (weeks) 13.7 (SD 24.0)</p> <p>Infection status at baseline: Infected ulcers</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 16) Povidone iodine and saline. Povidone iodine was used after debridement. When the infection resolved and formation of granulation tissue was observed, the participant was switched to a surgical soap (Dermo Clean) with saline rinse to minimise the cytotoxic effects of povidone iodine. If clinical signs of infection returned, the use of povidone iodine was resumed. </p> <p>Group 2: (n = 21) Neutral pH super‐oxidised aqueous solution. Participants received an initial 15‐ to 20‐minute immersion of the affected foot. Following appropriate debridement, the affected foot soak was repeated either weekly or biweekly. </p> <p>Additional comments: All participants were treated using an outpatient ambulatory model, which included appropriate surgical debridement, administration of aggressive parenteral/intramuscular broad‐spectrum antibiotic therapy, appropriate off‐loading, and strict glycaemic control. Systemic antibiotics were given for a minimum of 10 days to all participants in both groups. Antibiotics were used for more that 10 days if clinical signs of infection continued to be present. All participants received pentoxyphylline at a dose of 1200 mg/day as a haemorheologic. All participants in both groups were instructed to reduce weight bearing on the affected foot by using a wheelchair or crutches and by resting as much as possible. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: Resolution of infection</p> <p>Secondary review outcomes: None</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "patient randomised using randomly alternate assignment"</p> <p>Comment: It was not clear whether process was random ‐ could also describe alternation.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "patient randomised using randomly alternate assignment"</p> <p>Comment: The description is not entirely clear, but allocation could have been foreseeable.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Patients were blinded about [<i>sic</i>] the differences in treatment." </p> <p>Comment: Adequate blinding for participants but not personnel</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Outcomes reported for all participants.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: All outcomes reported as outlined in methods. Protocol not obtained.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: None noted.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ramos Cuevas 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT</p> <p>Setting: Diabetic foot clinic</p> <p>Country: Mexico</p> <p>Duration of follow‐up: 20 weeks</p> <p>Duration of treatment: Until healing</p> <p>Funding source: Indas S. A. Laboratory, distributor of Cicactiv (zinc hyaluronate)</p> <p>Unit of analysis: Participant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>50 participants</p> <p>Inclusion criteria: People with foot ulcer and diabetes</p> <p>Exclusion criteria: Not reported</p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): Not reported as a summary measure </p> <p>Infection status at baseline: Not reported (based on translated material)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1 (n = 25): Conventional treatment (no further details provided)</p> <p>Group 2 (n = 25): Zinc hyaluronate</p> <p>Additional comments: Not reported (based on translated material)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: Proportion of ulcers healed; time to healing (partially reported)</p> <p>Secondary review outcomes: None</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "... were assigned randomly ..."</p> <p>Comment: No further information reported.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No details reported.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "open label"</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "open label"</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Figure in paper shows that all participants had clinical data analysed in ITT. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: All outcomes reported as outlined in methods. Protocol not obtained.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: None obvious</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Shukrimi 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT</p> <p>Setting: Hospital university centre</p> <p>Country: Malaysia</p> <p>Duration of follow‐up: Not stated</p> <p>Duration of treatment: Between 7 and 26 days</p> <p>Funding source: Not reported</p> <p>Unit of analysis: Participant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>30 participants. Non‐insulin‐dependent diabetes mellitus patients with Wagner grade II ulcers admitted to the hospital for surgery </p> <p>Inclusion criteria: age between 35 and 65 years, transcutaneous oxygen tension of more than 30 mmHg, and serum albumin level of more than 35 g/dL. </p> <p>Exclusion criteria: Multiple medical comorbidity, corticosteroid therapy, neutrophil count less than 2000/mm<sup>₃</sup>. </p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): Not stated </p> <p>Infection status at baseline: Not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1 (n = not stated): Standard dressing group (povidone iodine solution 10%).</p> <p>Group 2 (n = not stated): Honey dressing group.</p> <p>Additional comments: 30 consecutive patients were randomised, but number of participants in each group not reported. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: Time to healing (partially reported)</p> <p>Secondary review outcomes: None</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "The patients were randomised into two study arms"</p> <p>Comment: Randomisation methods were not specified.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "The patients were randomised into two study arms"</p> <p>Comment: Randomisation methods were not specified.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Not blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "all the wounds were assessed every other day by a surgeon blinded to the material of dressing" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 30 participants were randomised, but no further information on the number of participants in each group and for each outcome. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: All outcomes reported as outlined in methods. Protocol not obtained.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: None noted.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Tom 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT; prospective, randomised, double‐blind, placebo‐controlled clinical trial</p> <p>Setting: Foot clinic at the Veterans Affairs Medical Center, San Diego</p> <p>Country: USA</p> <p>Duration of follow‐up: 16 weeks</p> <p>Duration of treatment: 4 weeks</p> <p>Funding source: Supported by OrthoNeutrogena</p> <p>Unit of analysis: Some participants had more than 1 ulcer (22 participants with 24 ulcers) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>24 participants</p> <p>Inclusion criteria: Lower extremity ulcer and a diagnosis of diabetes mellitus</p> <p>Exclusion criteria: Patients unable to give informed consent; had a known bleeding disorder; were pregnant at the time of enrolment; had infected ulcers or nearby tissues; or had lower extremity ulcers due to large artery disease (by clinical examination or abnormal ankle‐brachial index, or both) </p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): Not reported </p> <p>Infection status at baseline: Not infected</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1 (n = 11): Placebo (normal saline solution that was coloured the same as the topical tretinoin). </p> <p>Group 2 (n = 13): Topical 0.05% tretinoin solution (Retin‐A; Ortho Pharmaceutical Corp, Raritan, NJ). </p> <p>The randomly assigned solution was applied directly to the wound bed and left in contact for 10 minutes every day; it was then rinsed off with normal saline. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: Proportion of ulcers healed; time to healing (partially reported)</p> <p>Secondary review outcomes: None</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>24 participants included, 22 participants analysed (13 + 11 ulcers)</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "randomization was performed by an uninvolved third party who used a computer‐generated random sequence to balance the numbers of the 2 treatment groups" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Each newly enrolled patient was assigned a topical solution in ascending order"</p> <p>Comment: Not clear if the sequence was foreseeable with this method</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "all dispensed bottles of solutions were identical in appearance (identified by number only), and neither the investigators nor the patients were aware of the treatment group to which patients were assigned until the study was completed" </p> <p>Comment: The double‐blind appears to have been respected.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>As above</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: All outcomes reported as outlined in methods. Protocol not obtained.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 24 participants were randomised; 22 completed the study and were considered for the outcomes, 20 with 1 foot ulcer and 2 with 2 foot ulcers. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Some participants had multiple ulcers, but this was not accounted for.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ullal 2014 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT; randomised, controlled, open study</p> <p>Setting: Unclear</p> <p>Country: India</p> <p>Duration of follow‐up: Not reported (not clear)</p> <p>Duration of treatment: 2 months</p> <p>Funding source: Not stated</p> <p>Unit of analysis: Not stated</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>4 participants</p> <p>Inclusion criteria: People with diabetes having grade I or II foot ulcer</p> <p>Exclusion criteria: Unclear</p> <p>Infection at baseline: Unclear</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1 (n = 2): Povidone iodine and metronidazole 1% gel dressing.</p> <p>Group 2 (n = 2): Honey and metronidazole 1% gel dressing.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary outcomes: Proportion of ulcers healed</p> <p>Secondary outcomes: Adverse events</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "a randomised, controlled, open study"</p> <p>Comment: Unclear how randomisation was achieved</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "open study"</p> <p>Comment: No mention of allocation concealment process</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Open study, no blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Open study, no blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No incomplete outcome data</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: None obvious</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: None observed.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Viswanathan 2011 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RCT; single‐centre, open‐label, phase III, comparative study</p> <p>Setting: Diabetes Research Centre</p> <p>Country: India</p> <p>Duration of follow‐up: 20 weeks</p> <p>Duration of treatment: Not clear</p> <p>Funding source: Cholayil Products and Services, Koyambedu, Chennai, India provided the polyherbal cream with their formulation. </p> <p>Unit of analysis: Participant</p> <p>Participants enrolled between August 2008 and February 2009</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>40 participants</p> <p>Inclusion criteria: Consecutive Type 2 diabetes patients who presented with an ulcer up to Wagner's grade III classification (grade I, superficial ulcer; grade II, deep ulcer probing to tendon, capsule, or bone; grade III, deep ulcer with abscess, osteomyelitis, or joint sepsis). </p> <p>Exclusion criteria: People who had clinical signs of severe infection; wound that had exposed bone; unwillingness to participate in the study were excluded. </p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): "There was no significant difference in the location of the wound between the groups. The distribution of ulcers according to Wagner's grade was also similar in both the study groups. Wagner grade I and II foot ulcers were viable and grade III ulcers were non‐viable tissues" </p> <p>Infection status at baseline: Unclear; severe infections were excluded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Group 1 (n = 20): Polyherbal formulation wound cream<i>: Glycyrrhiza glabra</i>, <i>Musa × paradisiaca</i>,<i>Curcuma longa</i>,<i>Pandanus</i>,<i>Aloe vera</i>,<i>Cocos nucifera</i> oil. </p> <p>Group 2 (n = 20): Silver sulphadiazine cream.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: Proportion of ulcers healed (partially reported); time to healing (partially reported) </p> <p>Secondary review outcomes: Adverse events</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Not blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Wound healing </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: No information provided.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Infection/resolution of infection </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Secondary outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: Rate of ulcer healing not reported.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Of the 40 patients enrolled in this study, 38 adhered to the protocol (group 1; n = 19 and group 2; n = 19). One patient in group 1 was excluded from the study because of severe infection and one patient in group 2 died during the study period (unrelated cause)" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: None noted.</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ITT: intention‐to‐treat<br> PP: per protocol<br> RCT: randomised controlled trial<br> SD: standard deviation </p> </div> </div> </p> </section> <section class="characteristicsOfExcludedStudies" lang=""> <div class="section-header" id="CD011038-sec2-0022"> <h3 class="title">Characteristics of excluded studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD011038-sec2-0021" class="jump-to">included studies</a></li> <li><a href="#CD011038-sec2-0023" class="jump-to">awaiting classification</a></li> <li><a href="#CD011038-sec2-0024" class="jump-to">ongoing studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reason for exclusion</p> </td> </tr> </thead> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0023">Abidia 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant intervention (hyperbaric oxygen therapy)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0024">Ajmeer 2015</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant study population (mixed wounds)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0025">Al‐Ebous 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant intervention (all antibiotics were administered intervenously)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0026">Alzahrani 2013</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant study population</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0027">Bahar 2015</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0028">Belcaro 2010</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant study population (mixed wound types)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0029">Braumann 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0030">Braumann 2011</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0031">Dalla Paola 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0032">Della Marchina 1997</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant study population (mixed wound types)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0033">Driver 2015</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant intervention</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0034">Dwivedi 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0035">Gao 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No outcome data available on request</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0036">Gibbons 2015</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0037">Hadi 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant study population</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0038">Kamaratos 2014</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0039">Kapur 2011</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant study population</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0040">Kastelan 1998</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0042">Li 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant intervention</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0043">Li 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant intervention (no topical treatment tested)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0044">Li 2011</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant intervention</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0045">Lipsky 2015</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant intervention (no topical treatment tested)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0046">Lishner 1985</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0047">Londahl 2013</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant intervention (BioLight, combination of pulsating monochromatic light)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0041">Lázaro‐Martínez 2014</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant intervention (no topical treatment tested)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0048">Mahmoud 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0049">Martinez‐Sanchez 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant intervention (ozone therapy)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0050">Mikhaloĭko 2014</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant intervention (no topical treatment tested)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0051">Minatel 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant intervention (phototherapy)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0052">Monami 2012</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant intervention (photosensitiser compound)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0053">Morley 2012</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant intervention (cationic photosensitisers)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0054">Motta 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant study population (mixed wound types)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0055">Münter 2006</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0056">Otvos 2015</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0057">Panahi 2015</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant study population (mixed population; only 18 diabetic patients included, separate data not available) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0058">Paquette 2001</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0059">Piaggesi 2010</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant study population</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0060">Reyzelman 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant study population</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0061">Rhaiem 1998</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant study population (mixed population, number with diabetes and foot ulcers not reported) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0062">Santomauro 2015</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant intervention</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0063">Scalise 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0064">Siavash 2011</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0065">Siavash 2015</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0066">Sibbald 2011</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant study population (mixed population, number with diabetes and foot ulcers not reported) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0067">Song 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0068">Tardivo 2014</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0069">Tauro 2013</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0070">Tran 2014</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0071">Trial 2010</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant study population (mixed population, data for people with diabetes and foot ulcers not available) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0072">Uribe 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0073">Vandeputte 1997</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Antimicrobial treatment not the only systematic difference between trial arms</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0074">Varga 2014</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant study population</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD011038-bbs2-0075">Wainstein 2011</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not relevant intervention (ozone therapy)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>RCT: randomised controlled trial</p> </div> </div> </p> </section> <section class="characteristicsOfAwaitingStudies" lang=""> <div class="section-header" id="CD011038-sec2-0023"> <h3 class="title">Characteristics of studies awaiting assessment [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD011038-sec2-0021" class="jump-to">included studies</a></li> <li><a href="#CD011038-sec2-0022" class="jump-to">excluded studies</a></li> <li><a href="#CD011038-sec2-0024" class="jump-to">ongoing studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Fazal 2012 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RCT</p> <p>Setting: Hospital</p> <p>Country: India</p> <p>Duration of follow‐up: Not reported</p> <p>Duration of treatment: 14 days</p> <p>Funding source: Not reported</p> <p>Unit of analysis: Participant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>50 participants</p> <p>Inclusion criteria: Diabetic ulcer of the foot</p> <p>Exclusion criteria: Not reported</p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported): Not reported </p> <p>Infection status at baseline: Not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 25) 5% w/v povidone iodine solution twice daily for 14 days.</p> <p>Group 2: (n = 25) Phenytoin‐soaked suspension (20 mg/cm²) total body surface area; frequency not reported. </p> <p>Additional comments: After 14 days all participants were subject to split‐thickness skin graft. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: Time to healing</p> <p>Secondary review outcomes: None reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Available only as a conference abstract (authors contacted for further information; awaiting response) </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Rehman 2013 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RCT</p> <p>Setting: Surgical unit, hospital, 1 centre</p> <p>Country: Pakistan</p> <p>Duration of follow‐up: 2 weeks</p> <p>Duration of treatment: 2 weeks</p> <p>Funding source: Not reported</p> <p>Unit of analysis: Participant</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>60 participants</p> <p>Inclusion criteria: Wagner grade I or II diabetic ulcers.</p> <p>Exclusion criteria: Patients not consenting to study, having features of systemic infection and other comorbidities. </p> <p>Ulcer characteristics at baseline (size of ulcer, number of ulcers, duration of ulceration where reported)): Size of ulcer after surgical debridement measured at baseline, but data not reported. </p> <p>Infection status at baseline: Not reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: Honey‐soaked dressing (local honey used ‐ no further information).</p> <p>Group 2: Povidone iodine/normal saline dressing.</p> <p>Additional comments: Dressing changed once a day.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Primary review outcomes: Proportion of ulcers healed</p> <p>Secondary review outcomes: None</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contacted author for randomisation methods</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>RCT: randomised controlled trial</p> </div> </div> </p> </section> <section class="characteristicsOfOngoingStudies" lang=""> <div class="section-header" id="CD011038-sec2-0024"> <h3 class="title">Characteristics of ongoing studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD011038-sec2-0021" class="jump-to">included studies</a></li> <li><a href="#CD011038-sec2-0022" class="jump-to">excluded studies</a></li> <li><a href="#CD011038-sec2-0023" class="jump-to">awaiting classification</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Heybeck 2012 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Double‐blind, multicentre trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Diabetic patients with foot ulcers</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Normal diabetic socks versus (experimental group) copper‐impregnated socks</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quality of life, healing, odour</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ABSTRACT ONLY, ONGOING</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">NCT01594762 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A randomized, double‐blind, multicenter, superiority, placebo‐controlled phase 3 study of pexiganan cream 0.8% applied twice daily for 14 days in the treatment of adults with mild infections of diabetic foot ulcers </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventional RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mild infected ulcer in diabetic patients, full‐ or partial‐thickness ulcer on the foot distal to the malleoli with a surface area ≥ 1 cm² after the wound has undergone appropriate debridement </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Pexiganan versus placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>28 days clinical response, 28 days microbiological response, incidence and severity of adverse events </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2014</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> </p> </section> </section> <section class="dataAndAnalyses" id="dataAndAnalyses"> <section class="dataAndAnalyses" lang="en"> <div class="section-header section-collapse-header" id="CD011038-sec1-0011"> <h2 class="title section-collapse-title">Data and analyses<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <div class="table" id="CD011038-tbl-0006"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Topical antimicrobial dressing compared with non‐antimicrobial dressing</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Proportion of wounds healed <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>945</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.28 [1.12, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD011038-fig-00101"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-001-01.png?filename=nCD011038-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20Topical%20antimicrobial%20dressing%20compared%20with%20non%E2%80%90antimicrobial%20dressing%2C%20Outcome%201%20Proportion%20of%20wounds%20healed.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.1</div> </div> <hr class="top"><img data-id="CD011038-fig-00101" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-001-01.png" alt="Comparison 1 Topical antimicrobial dressing compared with non‐antimicrobial dressing, Outcome 1 Proportion of wounds healed."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Topical antimicrobial dressing compared with non‐antimicrobial dressing, Outcome 1 Proportion of wounds healed. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Short term follow up</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>80</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.6 [1.00, 2.57]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Medium term follow‐up</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>865</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.26 [1.10, 1.44]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Incidence of infection: medium term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>173</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.34 [0.04, 3.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD011038-fig-00102"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-001-02.png?filename=nCD011038-CMP-001-02.ppt&amp;title=1.2&amp;caption=Comparison%201%20Topical%20antimicrobial%20dressing%20compared%20with%20non%E2%80%90antimicrobial%20dressing%2C%20Outcome%202%20Incidence%20of%20infection%3A%20medium%20term%20follow%E2%80%90up.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.2</div> </div> <hr class="top"><img data-id="CD011038-fig-00102" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-001-02.png" alt="Comparison 1 Topical antimicrobial dressing compared with non‐antimicrobial dressing, Outcome 2 Incidence of infection: medium term follow‐up."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Topical antimicrobial dressing compared with non‐antimicrobial dressing, Outcome 2 Incidence of infection: medium term follow‐up. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Surgical resection: medium term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>317</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.33 [0.04, 2.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD011038-fig-00103"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-001-03.png?filename=nCD011038-CMP-001-03.ppt&amp;title=1.3&amp;caption=Comparison%201%20Topical%20antimicrobial%20dressing%20compared%20with%20non%E2%80%90antimicrobial%20dressing%2C%20Outcome%203%20Surgical%20resection%3A%20medium%20term%20follow%E2%80%90up.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.3</div> </div> <hr class="top"><img data-id="CD011038-fig-00103" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-001-03.png" alt="Comparison 1 Topical antimicrobial dressing compared with non‐antimicrobial dressing, Outcome 3 Surgical resection: medium term follow‐up."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Topical antimicrobial dressing compared with non‐antimicrobial dressing, Outcome 3 Surgical resection: medium term follow‐up. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>134</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.96 [0.62, 1.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD011038-fig-00104"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-001-04.png?filename=nCD011038-CMP-001-04.ppt&amp;title=1.4&amp;caption=Comparison%201%20Topical%20antimicrobial%20dressing%20compared%20with%20non%E2%80%90antimicrobial%20dressing%2C%20Outcome%204%20Adverse%20events.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.4</div> </div> <hr class="top"><img data-id="CD011038-fig-00104" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-001-04.png" alt="Comparison 1 Topical antimicrobial dressing compared with non‐antimicrobial dressing, Outcome 4 Adverse events."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Topical antimicrobial dressing compared with non‐antimicrobial dressing, Outcome 4 Adverse events. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD011038-tbl-0007"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Topical antimicrobial agent (non‐dressing) compared with non‐antimicrobial topical agent (non‐dressing)</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Proportion of wounds healed: medium term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>112</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.82 [0.56, 14.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD011038-fig-00201"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-002-01.png?filename=nCD011038-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20Topical%20antimicrobial%20agent%20%28non%E2%80%90dressing%29%20compared%20with%20non%E2%80%90antimicrobial%20topical%20agent%20%28non%E2%80%90dressing%29%2C%20Outcome%201%20Proportion%20of%20wounds%20healed%3A%20medium%20term%20follow%E2%80%90up.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.1</div> </div> <hr class="top"><img data-id="CD011038-fig-00201" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-002-01.png" alt="Comparison 2 Topical antimicrobial agent (non‐dressing) compared with non‐antimicrobial topical agent (non‐dressing), Outcome 1 Proportion of wounds healed: medium term follow‐up."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Topical antimicrobial agent (non‐dressing) compared with non‐antimicrobial topical agent (non‐dressing), Outcome 1 Proportion of wounds healed: medium term follow‐up. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Resolution of infection: medium term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>40</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.16 [0.54, 2.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD011038-fig-00202"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-002-02.png?filename=nCD011038-CMP-002-02.ppt&amp;title=2.2&amp;caption=Comparison%202%20Topical%20antimicrobial%20agent%20%28non%E2%80%90dressing%29%20compared%20with%20non%E2%80%90antimicrobial%20topical%20agent%20%28non%E2%80%90dressing%29%2C%20Outcome%202%20Resolution%20of%20infection%3A%20medium%20term%20follow%E2%80%90up.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.2</div> </div> <hr class="top"><img data-id="CD011038-fig-00202" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-002-02.png" alt="Comparison 2 Topical antimicrobial agent (non‐dressing) compared with non‐antimicrobial topical agent (non‐dressing), Outcome 2 Resolution of infection: medium term follow‐up."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Topical antimicrobial agent (non‐dressing) compared with non‐antimicrobial topical agent (non‐dressing), Outcome 2 Resolution of infection: medium term follow‐up. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Surgical resection: medium term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>34</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.67 [0.47, 5.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD011038-fig-00203"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-002-03.png?filename=nCD011038-CMP-002-03.ppt&amp;title=2.3&amp;caption=Comparison%202%20Topical%20antimicrobial%20agent%20%28non%E2%80%90dressing%29%20compared%20with%20non%E2%80%90antimicrobial%20topical%20agent%20%28non%E2%80%90dressing%29%2C%20Outcome%203%20Surgical%20resection%3A%20medium%20term%20follow%E2%80%90up.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.3</div> </div> <hr class="top"><img data-id="CD011038-fig-00203" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-002-03.png" alt="Comparison 2 Topical antimicrobial agent (non‐dressing) compared with non‐antimicrobial topical agent (non‐dressing), Outcome 3 Surgical resection: medium term follow‐up."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Topical antimicrobial agent (non‐dressing) compared with non‐antimicrobial topical agent (non‐dressing), Outcome 3 Surgical resection: medium term follow‐up. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD011038-tbl-0008"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">One topical antimicrobial agent compared with an alternative topical antimicrobial agent</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Proportion of wounds healed <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD011038-fig-00301"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-003-01.png?filename=nCD011038-CMP-003-01.ppt&amp;title=3.1&amp;caption=Comparison%203%20One%20topical%20antimicrobial%20agent%20compared%20with%20an%20alternative%20topical%20antimicrobial%20agent%2C%20Outcome%201%20Proportion%20of%20wounds%20healed.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.1</div> </div> <hr class="top"><img data-id="CD011038-fig-00301" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-003-01.png" alt="Comparison 3 One topical antimicrobial agent compared with an alternative topical antimicrobial agent, Outcome 1 Proportion of wounds healed."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 One topical antimicrobial agent compared with an alternative topical antimicrobial agent, Outcome 1 Proportion of wounds healed. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Medium term follow‐up</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Unknown follow‐up period</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Resolution of infection: medium term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD011038-fig-00302"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-003-02.png?filename=nCD011038-CMP-003-02.ppt&amp;title=3.2&amp;caption=Comparison%203%20One%20topical%20antimicrobial%20agent%20compared%20with%20an%20alternative%20topical%20antimicrobial%20agent%2C%20Outcome%202%20Resolution%20of%20infection%3A%20medium%20term%20follow%E2%80%90up.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.2</div> </div> <hr class="top"><img data-id="CD011038-fig-00302" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-003-02.png" alt="Comparison 3 One topical antimicrobial agent compared with an alternative topical antimicrobial agent, Outcome 2 Resolution of infection: medium term follow‐up."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 One topical antimicrobial agent compared with an alternative topical antimicrobial agent, Outcome 2 Resolution of infection: medium term follow‐up. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Surgical resection: medium term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>41</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.93 [0.53, 7.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD011038-fig-00303"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-003-03.png?filename=nCD011038-CMP-003-03.ppt&amp;title=3.3&amp;caption=Comparison%203%20One%20topical%20antimicrobial%20agent%20compared%20with%20an%20alternative%20topical%20antimicrobial%20agent%2C%20Outcome%203%20Surgical%20resection%3A%20medium%20term%20follow%E2%80%90up.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.3</div> </div> <hr class="top"><img data-id="CD011038-fig-00303" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-003-03.png" alt="Comparison 3 One topical antimicrobial agent compared with an alternative topical antimicrobial agent, Outcome 3 Surgical resection: medium term follow‐up."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 One topical antimicrobial agent compared with an alternative topical antimicrobial agent, Outcome 3 Surgical resection: medium term follow‐up. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD011038-tbl-0009"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">Topical antimicrobial agent compared with systemic antimicrobial agent</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Resolution of infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>102</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.51 [0.91, 2.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD011038-fig-00401"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-004-01.png?filename=nCD011038-CMP-004-01.ppt&amp;title=4.1&amp;caption=Comparison%204%20Topical%20antimicrobial%20agent%20compared%20with%20systemic%20antimicrobial%20agent%2C%20Outcome%201%20Resolution%20of%20infection.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.1</div> </div> <hr class="top"><img data-id="CD011038-fig-00401" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-004-01.png" alt="Comparison 4 Topical antimicrobial agent compared with systemic antimicrobial agent, Outcome 1 Resolution of infection."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 Topical antimicrobial agent compared with systemic antimicrobial agent, Outcome 1 Resolution of infection. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Short‐term follow‐up</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>46</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.54 [0.69, 3.45]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Medium term follow‐up</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>56</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.49 [0.79, 2.82]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Surgical resection: medium term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>835</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.22 [0.51, 2.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD011038-fig-00402"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-004-02.png?filename=nCD011038-CMP-004-02.ppt&amp;title=4.2&amp;caption=Comparison%204%20Topical%20antimicrobial%20agent%20compared%20with%20systemic%20antimicrobial%20agent%2C%20Outcome%202%20Surgical%20resection%3A%20medium%20term%20follow%E2%80%90up.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.2</div> </div> <hr class="top"><img data-id="CD011038-fig-00402" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-004-02.png" alt="Comparison 4 Topical antimicrobial agent compared with systemic antimicrobial agent, Outcome 2 Surgical resection: medium term follow‐up."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 Topical antimicrobial agent compared with systemic antimicrobial agent, Outcome 2 Surgical resection: medium term follow‐up. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>937</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.91 [0.78, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD011038-fig-00403"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-004-03.png?filename=nCD011038-CMP-004-03.ppt&amp;title=4.3&amp;caption=Comparison%204%20Topical%20antimicrobial%20agent%20compared%20with%20systemic%20antimicrobial%20agent%2C%20Outcome%203%20Adverse%20events.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.3</div> </div> <hr class="top"><img data-id="CD011038-fig-00403" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-004-03.png" alt="Comparison 4 Topical antimicrobial agent compared with systemic antimicrobial agent, Outcome 3 Adverse events."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 Topical antimicrobial agent compared with systemic antimicrobial agent, Outcome 3 Adverse events. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Short‐term follow‐up</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>891</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.90 [0.78, 1.05]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 Medium term follow‐up</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>46</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.08 [0.49, 2.40]</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD011038-tbl-0010"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 5.</span>&nbsp;<span class="table-title">Topical antimicrobial agent compared with growth factor</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Proportion of wounds healed: Medium term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>40</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.5 [0.28, 0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD011038-fig-00501"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-005-01.png?filename=nCD011038-CMP-005-01.ppt&amp;title=5.1&amp;caption=Comparison%205%20Topical%20antimicrobial%20agent%20compared%20with%20growth%20factor%2C%20Outcome%201%20Proportion%20of%20wounds%20healed%3A%20Medium%20term%20follow%E2%80%90up.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 5.1</div> </div> <hr class="top"><img data-id="CD011038-fig-00501" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-005-01.png" alt="Comparison 5 Topical antimicrobial agent compared with growth factor, Outcome 1 Proportion of wounds healed: Medium term follow‐up."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 5 Topical antimicrobial agent compared with growth factor, Outcome 1 Proportion of wounds healed: Medium term follow‐up. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> </section> </section> <div class="figures-list"> <div class="figure" id="CD011038-fig-0001"> <img data-id="CD011038-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-AFig-FIG01.png" alt="Study flow diagram."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-fig-0001" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-AFig-FIG01.png?filename=nCD011038-AFig-FIG01.ppt&amp;title=1&amp;caption=Study%20flow%20diagram.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-AFig-FIG01.png">Open in new tab</a></div> </div> <div class="figure" id="CD011038-fig-0002"><img data-id="CD011038-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-AFig-FIG02.png" alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-fig-0002" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-AFig-FIG02.png?filename=nCD011038-AFig-FIG02.ppt&amp;title=2&amp;caption=Risk%20of%20bias%20summary%3A%20review%20authors%27%20judgements%20about%20each%20risk%20of%20bias%20item%20for%20each%20included%20study.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-AFig-FIG02.png">Open in new tab</a></div> </div> <div class="figure" id="CD011038-fig-0003"><img data-id="CD011038-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-AFig-FIG03.png" alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-fig-0003" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-AFig-FIG03.png?filename=nCD011038-AFig-FIG03.ppt&amp;title=3&amp;caption=Risk%20of%20bias%20graph%3A%20review%20authors%27%20judgements%20about%20each%20risk%20of%20bias%20item%20presented%20as%20percentages%20across%20all%20included%20studies.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-AFig-FIG03.png">Open in new tab</a></div> </div> <div class="figure" id="CD011038-fig-00101"><img data-id="CD011038-fig-00101" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-001-01.png" alt="Comparison 1 Topical antimicrobial dressing compared with non‐antimicrobial dressing, Outcome 1 Proportion of wounds healed."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Topical antimicrobial dressing compared with non‐antimicrobial dressing, Outcome 1 Proportion of wounds healed. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#CD011038-fig-00101" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-001-01.png?filename=nCD011038-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20Topical%20antimicrobial%20dressing%20compared%20with%20non%E2%80%90antimicrobial%20dressing%2C%20Outcome%201%20Proportion%20of%20wounds%20healed.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-001-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD011038-fig-00102"><img data-id="CD011038-fig-00102" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-001-02.png" alt="Comparison 1 Topical antimicrobial dressing compared with non‐antimicrobial dressing, Outcome 2 Incidence of infection: medium term follow‐up."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Topical antimicrobial dressing compared with non‐antimicrobial dressing, Outcome 2 Incidence of infection: medium term follow‐up. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#CD011038-fig-00102" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-001-02.png?filename=nCD011038-CMP-001-02.ppt&amp;title=1.2&amp;caption=Comparison%201%20Topical%20antimicrobial%20dressing%20compared%20with%20non%E2%80%90antimicrobial%20dressing%2C%20Outcome%202%20Incidence%20of%20infection%3A%20medium%20term%20follow%E2%80%90up.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-001-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD011038-fig-00103"><img data-id="CD011038-fig-00103" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-001-03.png" alt="Comparison 1 Topical antimicrobial dressing compared with non‐antimicrobial dressing, Outcome 3 Surgical resection: medium term follow‐up."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Topical antimicrobial dressing compared with non‐antimicrobial dressing, Outcome 3 Surgical resection: medium term follow‐up. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#CD011038-fig-00103" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-001-03.png?filename=nCD011038-CMP-001-03.ppt&amp;title=1.3&amp;caption=Comparison%201%20Topical%20antimicrobial%20dressing%20compared%20with%20non%E2%80%90antimicrobial%20dressing%2C%20Outcome%203%20Surgical%20resection%3A%20medium%20term%20follow%E2%80%90up.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-001-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD011038-fig-00104"><img data-id="CD011038-fig-00104" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-001-04.png" alt="Comparison 1 Topical antimicrobial dressing compared with non‐antimicrobial dressing, Outcome 4 Adverse events."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Topical antimicrobial dressing compared with non‐antimicrobial dressing, Outcome 4 Adverse events. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#CD011038-fig-00104" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-001-04.png?filename=nCD011038-CMP-001-04.ppt&amp;title=1.4&amp;caption=Comparison%201%20Topical%20antimicrobial%20dressing%20compared%20with%20non%E2%80%90antimicrobial%20dressing%2C%20Outcome%204%20Adverse%20events.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-001-04.png">Open in new tab</a></div> </div> <div class="figure" id="CD011038-fig-00201"><img data-id="CD011038-fig-00201" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-002-01.png" alt="Comparison 2 Topical antimicrobial agent (non‐dressing) compared with non‐antimicrobial topical agent (non‐dressing), Outcome 1 Proportion of wounds healed: medium term follow‐up."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Topical antimicrobial agent (non‐dressing) compared with non‐antimicrobial topical agent (non‐dressing), Outcome 1 Proportion of wounds healed: medium term follow‐up. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#CD011038-fig-00201" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-002-01.png?filename=nCD011038-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20Topical%20antimicrobial%20agent%20%28non%E2%80%90dressing%29%20compared%20with%20non%E2%80%90antimicrobial%20topical%20agent%20%28non%E2%80%90dressing%29%2C%20Outcome%201%20Proportion%20of%20wounds%20healed%3A%20medium%20term%20follow%E2%80%90up.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-002-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD011038-fig-00202"><img data-id="CD011038-fig-00202" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-002-02.png" alt="Comparison 2 Topical antimicrobial agent (non‐dressing) compared with non‐antimicrobial topical agent (non‐dressing), Outcome 2 Resolution of infection: medium term follow‐up."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Topical antimicrobial agent (non‐dressing) compared with non‐antimicrobial topical agent (non‐dressing), Outcome 2 Resolution of infection: medium term follow‐up. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#CD011038-fig-00202" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-002-02.png?filename=nCD011038-CMP-002-02.ppt&amp;title=2.2&amp;caption=Comparison%202%20Topical%20antimicrobial%20agent%20%28non%E2%80%90dressing%29%20compared%20with%20non%E2%80%90antimicrobial%20topical%20agent%20%28non%E2%80%90dressing%29%2C%20Outcome%202%20Resolution%20of%20infection%3A%20medium%20term%20follow%E2%80%90up.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-002-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD011038-fig-00203"><img data-id="CD011038-fig-00203" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-002-03.png" alt="Comparison 2 Topical antimicrobial agent (non‐dressing) compared with non‐antimicrobial topical agent (non‐dressing), Outcome 3 Surgical resection: medium term follow‐up."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Topical antimicrobial agent (non‐dressing) compared with non‐antimicrobial topical agent (non‐dressing), Outcome 3 Surgical resection: medium term follow‐up. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#CD011038-fig-00203" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-002-03.png?filename=nCD011038-CMP-002-03.ppt&amp;title=2.3&amp;caption=Comparison%202%20Topical%20antimicrobial%20agent%20%28non%E2%80%90dressing%29%20compared%20with%20non%E2%80%90antimicrobial%20topical%20agent%20%28non%E2%80%90dressing%29%2C%20Outcome%203%20Surgical%20resection%3A%20medium%20term%20follow%E2%80%90up.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-002-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD011038-fig-00301"><img data-id="CD011038-fig-00301" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-003-01.png" alt="Comparison 3 One topical antimicrobial agent compared with an alternative topical antimicrobial agent, Outcome 1 Proportion of wounds healed."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 One topical antimicrobial agent compared with an alternative topical antimicrobial agent, Outcome 1 Proportion of wounds healed. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#CD011038-fig-00301" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-003-01.png?filename=nCD011038-CMP-003-01.ppt&amp;title=3.1&amp;caption=Comparison%203%20One%20topical%20antimicrobial%20agent%20compared%20with%20an%20alternative%20topical%20antimicrobial%20agent%2C%20Outcome%201%20Proportion%20of%20wounds%20healed.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-003-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD011038-fig-00302"><img data-id="CD011038-fig-00302" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-003-02.png" alt="Comparison 3 One topical antimicrobial agent compared with an alternative topical antimicrobial agent, Outcome 2 Resolution of infection: medium term follow‐up."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 One topical antimicrobial agent compared with an alternative topical antimicrobial agent, Outcome 2 Resolution of infection: medium term follow‐up. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#CD011038-fig-00302" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-003-02.png?filename=nCD011038-CMP-003-02.ppt&amp;title=3.2&amp;caption=Comparison%203%20One%20topical%20antimicrobial%20agent%20compared%20with%20an%20alternative%20topical%20antimicrobial%20agent%2C%20Outcome%202%20Resolution%20of%20infection%3A%20medium%20term%20follow%E2%80%90up.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-003-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD011038-fig-00303"><img data-id="CD011038-fig-00303" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-003-03.png" alt="Comparison 3 One topical antimicrobial agent compared with an alternative topical antimicrobial agent, Outcome 3 Surgical resection: medium term follow‐up."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 One topical antimicrobial agent compared with an alternative topical antimicrobial agent, Outcome 3 Surgical resection: medium term follow‐up. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#CD011038-fig-00303" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-003-03.png?filename=nCD011038-CMP-003-03.ppt&amp;title=3.3&amp;caption=Comparison%203%20One%20topical%20antimicrobial%20agent%20compared%20with%20an%20alternative%20topical%20antimicrobial%20agent%2C%20Outcome%203%20Surgical%20resection%3A%20medium%20term%20follow%E2%80%90up.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-003-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD011038-fig-00401"><img data-id="CD011038-fig-00401" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-004-01.png" alt="Comparison 4 Topical antimicrobial agent compared with systemic antimicrobial agent, Outcome 1 Resolution of infection."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Topical antimicrobial agent compared with systemic antimicrobial agent, Outcome 1 Resolution of infection. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#CD011038-fig-00401" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-004-01.png?filename=nCD011038-CMP-004-01.ppt&amp;title=4.1&amp;caption=Comparison%204%20Topical%20antimicrobial%20agent%20compared%20with%20systemic%20antimicrobial%20agent%2C%20Outcome%201%20Resolution%20of%20infection.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-004-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD011038-fig-00402"><img data-id="CD011038-fig-00402" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-004-02.png" alt="Comparison 4 Topical antimicrobial agent compared with systemic antimicrobial agent, Outcome 2 Surgical resection: medium term follow‐up."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Topical antimicrobial agent compared with systemic antimicrobial agent, Outcome 2 Surgical resection: medium term follow‐up. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#CD011038-fig-00402" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-004-02.png?filename=nCD011038-CMP-004-02.ppt&amp;title=4.2&amp;caption=Comparison%204%20Topical%20antimicrobial%20agent%20compared%20with%20systemic%20antimicrobial%20agent%2C%20Outcome%202%20Surgical%20resection%3A%20medium%20term%20follow%E2%80%90up.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-004-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD011038-fig-00403"><img data-id="CD011038-fig-00403" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-004-03.png" alt="Comparison 4 Topical antimicrobial agent compared with systemic antimicrobial agent, Outcome 3 Adverse events."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Topical antimicrobial agent compared with systemic antimicrobial agent, Outcome 3 Adverse events. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#CD011038-fig-00403" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-004-03.png?filename=nCD011038-CMP-004-03.ppt&amp;title=4.3&amp;caption=Comparison%204%20Topical%20antimicrobial%20agent%20compared%20with%20systemic%20antimicrobial%20agent%2C%20Outcome%203%20Adverse%20events.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-004-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD011038-fig-00501"><img data-id="CD011038-fig-00501" src="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-005-01.png" alt="Comparison 5 Topical antimicrobial agent compared with growth factor, Outcome 1 Proportion of wounds healed: Medium term follow‐up."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Topical antimicrobial agent compared with growth factor, Outcome 1 Proportion of wounds healed: Medium term follow‐up. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#CD011038-fig-00501" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/ppt/CDSR/CD011038/image_n/nCD011038-CMP-005-01.png?filename=nCD011038-CMP-005-01.ppt&amp;title=5.1&amp;caption=Comparison%205%20Topical%20antimicrobial%20agent%20compared%20with%20growth%20factor%2C%20Outcome%201%20Proportion%20of%20wounds%20healed%3A%20Medium%20term%20follow%E2%80%90up.&amp;citation=Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2017, 6. Art. No.: CD011038. DOI: http://dx.doi.org/10.1002/14651858.CD011038.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD011038.pub2/media/CDSR/CD011038/image_n/nCD011038-CMP-005-01.png">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD011038-tbl-0001" class="summary-of-findings framed"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span>&nbsp;<span class="table-title">Antimicrobial dressings compared with non‐antimicrobial dressings</span></div> <tbody> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Antimicrobial dressings compared with non‐antimicrobial dressings</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> Foot ulcers in people with diabetes </p> <p><b>Settings:</b> Mixed </p> <p><b>Intervention:</b> Antimicrobial dressings </p> <p><b>Comparison:</b> Standard dressings </p> </td> </tr> <tr class="table-header separated"> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>№ of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with standard dressings</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with antimicrobial dressings</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Proportion of wounds healed</b> </p> <p>Up to 24 weeks' follow‐up</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>425 per 1000</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>544 per 1000</b> <br> (476 to 616) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 1.28</b> (1.12 to 1.45) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>945 participants</p> <p>(5 studies)</p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> <b>low</b><sup>1</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>On average, use of an antimicrobial dressing compared with a non‐antimicrobial dressing may increase the number of ulcers healed over a medium‐term follow‐up period. </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Risk difference:</b> 119 more healed wounds per 1000 (51 more to 191 more) </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Incidence of infection</b> </p> <p>Up to 24 weeks' follow‐up</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>183 per 1000</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>62 per 100</b> (7 to 567) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 0.34</b> (0.04 to 3.10) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>173 participants (2 studies)</p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br> <b>very low</b><sup>2</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>On average, it is unclear whether or not use of an antimicrobial dressing compared with a non‐antimicrobial dressing reduces the incidence of ulcer infection over a medium‐term follow‐up period. </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Risk difference:</b> 121 fewer infections per 1000 (176 fewer to 384 more) </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Resolution infection</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Not reported for this comparison</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>This outcome was not reported for this comparison.</p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> <p>Up to 24 weeks' follow‐up</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>388 per 1000</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>373 per 1000</b> (241 to 574) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 0.96</b> (0.62 to 1.48) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>134 participants</p> <p>(1 study)</p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br> <b>very low</b><sup>3</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>It is uncertain whether use of an antimicrobial dressing affects the risk of adverse events compared with use of a non‐antimicrobial dressing over a medium‐term follow‐up period. </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Risk difference:</b> 16 fewer adverse events per 1000 (147 fewer to 186 more) </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>N/A:</b> not applicable; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b> <br> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br> <b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br> <b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br> <b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded twice for risk of bias due to one study (with the highest weighting in the meta‐analysis) being at unclear risk of selection bias and three studies being at high risk of performance bias (36% weighting in analysis), although the studies were at unclear or low risk of detection bias for this outcome.<br> <sup>2</sup>Downgraded twice for imprecision due to sample size and low number of events. 95% CIs span both benefits and harms. Downgraded once due to inconsistency: I² = 60%. Downgraded once due to risk of performance bias.<br> <sup>3</sup>Downgraded twice for imprecision due to sample size and low number of events. 95% CIs span both benefits and harms. Downgraded once due to risk of performance bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span>&nbsp;<span class="table-title">Antimicrobial dressings compared with non‐antimicrobial dressings</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-tbl-0001" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD011038-tbl-0002" class="summary-of-findings framed"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span>&nbsp;<span class="table-title">Topical antimicrobial agents (non‐dressing) compared with non‐antimicrobial topical agents (non‐dressing)</span></div> <tbody> <tr class="separated"> <td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Topical antimicrobial agents (non‐dressing) compared with non‐antimicrobial topical agents (non‐dressing)</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> Foot ulcers in people with diabetes<br> <b>Setting:</b> Mixed<br> <b>Intervention:</b> Topical antimicrobial agent<br> <b>Comparison:</b> Non‐antimicrobial treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>№ of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with non‐antimicrobial treatment</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with topical antimicrobial treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Proportion of wounds healed</b> </p> <p>Up to 24 weeks' follow‐up</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>241 per 1000</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>679 per 1000</b> (135 to 1000) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 2.82</b> (0.56 to 14.23) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>112 participants</p> <p>(3 studies)</p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br> <b>very low</b><sup>1</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>The average effect of antimicrobial agents compared with non‐antimicrobial treatment is uncertain over a medium‐term follow‐up period. </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Risk difference</b>: 438 more healed wounds per 1000 (106 fewer to 1000 more) </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Incidence of infection</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Not reported for this comparison</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>This outcome was not reported for this comparison.</p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Resolution of infection</b> </p> <p>Up to 24 weeks' follow‐up</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>368 per 1000</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>427 per 1000</b> (199 to 925) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 1.16</b> (0.54 to 2.51) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>40 participants</p> <p>(1 study)</p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> <b>low</b><sup>2</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>It is unclear whether use of an antimicrobial topical agent has an effect on risk of infection over a medium‐term follow‐up period. </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Risk difference</b>: 59 more resolved infections per 1000 (169 fewer to 556 more) </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> <p>Up to 24 weeks' follow‐up</p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Not estimable</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>81 participants</p> <p>(2 studies)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br> <b>very low</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2 studies reported adverse event data. We were unable to extract per‐participant data for 1 study. The second study stated that no adverse events were reported in each arm. We judged this as very low‐certainty evidence. </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br> <br> <b>CI:</b> confidence interval; <b>N/A:</b> not applicable; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b> <br> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded twice for risk of bias with two studies at high risk of detection bias, which is of particular concern when healing is being assessed, and one study not accounting for a small number of participants with multiple ulcers in their trial. Downgraded twice for imprecision: small sample size and small number of events. Downgraded once for inconsistency: one small study reported all wounds healed in one arm and few wounds healed in the other. These data are adding heterogeneity to the analysis.<br> <sup>2</sup>Downgraded twice for imprecision: small sample size and small number of events. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span>&nbsp;<span class="table-title">Topical antimicrobial agents (non‐dressing) compared with non‐antimicrobial topical agents (non‐dressing)</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-tbl-0002" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD011038-tbl-0003" class="summary-of-findings framed"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span>&nbsp;<span class="table-title">One topical antimicrobial agent compared with an alternative topical antimicrobial agent</span></div> <tbody> <tr class="separated"> <td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>One topical antimicrobial agent compared with another topical antimicrobial agent</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> Foot ulcers in people with diabetes<br> <b>Setting:</b> Mixed<br> <b>Intervention:</b> Topical antimicrobial agent<br> <b>Comparison:</b> Alternative topical antimicrobial agent </p> </td> </tr> <tr class="table-header separated"> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>№ of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with topical antimicrobial agent</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with alternative topical antimicrobial agent</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Proportion of wounds healed</b> </p> <p>Up to 24 weeks' follow‐up</p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Data were not pooled due to the 3 studies evaluating different interventions.</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>85 participants (3 studies)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br> <b>very low</b><sup>1</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>It is generally uncertain whether 1 topical treatment has an increased likelihood of healing compared with the alternative treatment. We judged this as very low‐certainty evidence ‐ downgraded twice for imprecision and once for risk of bias. </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Incidence of infection</b> </p> <p>Up to 24 weeks' follow‐up</p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Not reported for this comparison</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>This outcome was not reported for this comparison.</p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Resolution of infection</b> </p> <p>Up to 24 weeks' follow‐up</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>625 per 1000</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>906 per 1000</b> (606 to 1000) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 1.45</b> (0.97 to 2.17) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>37 participants (1 study)</p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br> <b>very low</b><sup>2</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>It is uncertain whether 1 specific type of topical antimicrobial agent has a different effect on resolution of infection than another over a medium‐term follow‐up period. </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Risk difference:</b> 281 more resolved infections per 1000 (19 fewer to 731 more) </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> <p>Up to 24 weeks' follow‐up</p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Not estimable</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>41 participants</p> <p>(1 study)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br> <b>very low</b><sup>3</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The 1 study noted that no events were reported in either group.</p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br> <br> <b>CI:</b> confidence interval; <b>N/A:</b> not applicable; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b> <br> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded twice for imprecision: small sample size and small number of events. Downgraded for risk of performance and detection bias.<br> <sup>2</sup>Downgraded twice for imprecision: small sample size and small number of events. Downgraded once for high risk of selection bias.<br> <sup>3</sup>Downgraded twice for imprecision: small sample size and small number of events. Downgraded once for high risk of performance bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span>&nbsp;<span class="table-title">One topical antimicrobial agent compared with an alternative topical antimicrobial agent</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-tbl-0003" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD011038-tbl-0004" class="summary-of-findings framed"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span>&nbsp;<span class="table-title">Topical antimicrobial agent compared with systemic antimicrobial agent</span></div> <tbody> <tr class="separated"> <td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Topical antimicrobial agent compared with systemic antimicrobial agent</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> Foot ulcers in people with diabetes<br> <b>Setting:</b> Mixed<br> <b>Intervention:</b> Topical antimicrobial agent<br> <b>Comparison:</b> Systemic antibiotic </p> </td> </tr> <tr class="table-header separated"> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>№ of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with systemic antibiotic agent</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with topical antimicrobial agent</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Proportion of wounds healed</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Not reported for this comparison</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome not reported for this comparison.</p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Incidence of infection</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Not reported for this comparison</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome not reported for this comparison.</p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Resolution of infection</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>333 per 1000</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>503 per 1000</b> (303 to 830) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 1.51</b> (0.91 to 2.49) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>102 participants (2 studies)</p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br> <b>very low</b><sup>1</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>It is uncertain whether the effects of topical antimicrobial treatment on resolution of infection differ from those of systemic antibiotics. </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Risk difference</b>: 170 more resolved infections per 1000 (30 fewer to 497 more) </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>450 per 1000</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>409 per 1000</b> (351 to 477) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 0.91</b> (0.78 to 1.06) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>937 participants</p> <p>(4 studies)</p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>⊕⊕⊕⊝</p> <p><b>moderate</b><sup>2</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>On average, there is probably little difference in the risk of adverse events between the systemic antibiotics and topical antimicrobial treatments compared here. </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Risk difference</b>: 40 fewer adverse events per 1000 (99 fewer to 27 more) </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br> <br> <b>CI:</b> confidence interval; <b>N/A:</b> not applicable; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b> <br> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded twice for imprecision: small sample size and small number of events. Downgraded once for risk of performance bias.<br> <sup>2</sup>Downgraded once for risk of performance bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span>&nbsp;<span class="table-title">Topical antimicrobial agent compared with systemic antimicrobial agent</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-tbl-0004" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD011038-tbl-0005" class="summary-of-findings framed"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span>&nbsp;<span class="table-title">Topical antimicrobial agent compared with growth factor</span></div> <tbody> <tr class="separated"> <td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Topical antimicrobial agent compared with growth factor</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> Foot ulcers in people with diabetes<br> <b>Setting:</b> Mixed<br> <b>Intervention:</b> Topical antimicrobial agent<br> <b>Comparison:</b> Growth factor </p> </td> </tr> <tr class="table-header separated"> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>№ of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with growth factor</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with topical antimicrobial</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Proportion of wounds healed</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>800 per 1000</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>400 per 1000</b> (224 to 712) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 0.50</b> (0.28 to 0.89) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>40 participants</p> <p>(1 study)</p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br> <b>very low</b><sup>1</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>It is uncertain whether treatment with growth factor affects the risk of healing when compared with antiseptic dressing. </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Risk difference:</b> 400 fewer resolved infections 576 fewer to 88 fewer </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Incidence of infection</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Not reported for this comparison</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome not reported for this comparison.</p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Resolution of infection</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Not reported for this comparison</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome not reported for this comparison.</p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Not reported for this comparison</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome not reported for this comparison.</p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br> <br> <b>CI:</b> confidence interval; <b>N/A:</b> not applicable; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b> <br> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded once for imprecision: small sample size and small number of events ‐ optimal information size not met and results are fragile. Downgraded twice for risk of performance and attrition bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span>&nbsp;<span class="table-title">Topical antimicrobial agent compared with growth factor</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-tbl-0005" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD011038-tbl-0011"> <div class="table-heading"><span class="table-label">Table 1.</span>&nbsp;<span class="table-title">Infectious Diseases Society of America and International Working Group on the Diabetic Foot classification of diabetic foot infection</span></div> <tbody> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Clinical manifestation of infection</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b> PEDIS grade</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>IDSA infection <br> severity</b> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No symptoms or signs of infection</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Uninfected</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Infection present, as defined by the presence of at least 2 of the following items:</p> <p> <ul id="CD011038-lst1-0027"> <li> <p>local swelling or induration</p> </li> <li> <p>erythema</p> </li> <li> <p>local tenderness or pain</p> </li> <li> <p>local warmth</p> </li> <li> <p>purulent discharge (thick, opaque‐to‐white or sanguineous secretion)</p> </li> </ul> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Local infection involving only the skin and the subcutaneous tissue (without involvement of deeper tissues and without systemic signs as described below). If erythema, must be &gt; 0.5 cm to ≤ 2 cm around the ulcer.<br> Exclude other causes of an inflammatory response of the skin (e.g. trauma, gout, acute Charcot neuro‐osteoarthropathy, fracture, thrombosis, venous stasis) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mild</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Local infection (as described above) with erythema &gt; 2 cm, or involving structures deeper than skin and subcutaneous tissues (e.g. abscess, osteomyelitis, septic arthritis, fasciitis), and no systemic inflammatory response signs (as described below) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Moderate</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Local infection (as described above) with the signs of SIRS, as manifested by ≥ 2 of the following: </p> <p> <ul id="CD011038-lst1-0028"> <li> <p>temperature &gt; 38°C or &lt; 36°C</p> </li> <li> <p>heart rate &gt; 90 beats/min</p> </li> <li> <p>respiratory rate &gt; 20 breaths/min or PaCO<sub>2</sub> &lt; 32 mmHg </p> </li> <li> <p>white blood cell count &gt; 12,000 or &lt; 4000 cells/μL or ≥ 10% immature (band) forms</p> </li> </ul> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Severe*</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>Abbreviations: IDSA, Infectious Diseases Society of America; PaCO<sub>2</sub>, partial pressure of arterial carbon dioxide; PEDIS, perfusion, extent/size, depth/tissue loss, infection, and sensation; SIRS, systemic inflammatory response syndrome </p> <p>*Ischaemia may increase the severity of any infection, and the presence of critical ischaemia often makes the infection severe. Systemic infection may sometimes manifest with other clinical findings, such as hypotension, confusion, vomiting, or evidence of metabolic disturbances, such as acidosis, severe hyperglycaemia, and new‐onset azotaemia. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span>&nbsp;<span class="table-title">Infectious Diseases Society of America and International Working Group on the Diabetic Foot classification of diabetic foot infection</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-tbl-0011" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD011038-tbl-0012"> <div class="table-heading"><span class="table-label">Table 2.</span>&nbsp;<span class="table-title">Topical antiseptic products available for treating chronic wounds</span></div> <tbody> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Product and formulations</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Formulations</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bacterial spectrum</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Advantages</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Disadvantages</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Cost<sup>a</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Indications<sup>b</sup> and comments</b> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Acetic acid</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.25%, 0.5%, and 1% solutions</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Bactericidal against most gram‐positive and gram‐negative organisms, including <i>Pseudomonas aeruginosa</i> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Inexpensive; shown to eliminate <i>P aeruginosa</i> colonisation from burn </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cytotoxic in vitro although maybe not in vivo; limited activity against biofilm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No longer as widely used as in the past</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cadexomer iodine</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Gel,<sup>c</sup> ointment, and dressing </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Polysaccharide starch lattice; active agent is slowly released free iodine; broad spectrum of activity (same as iodine) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reduced local toxicity compared to iodine; elemental iodine released on exposure to exudate </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Application may cause stinging and erythema, but less tissue damage than other iodine products; effect may not persist, and efficacy may be reduced in body fluids. </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Indicated for use in cleaning wet ulcers and wounds and reducing microbial load in the wound environment </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cetrimide</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Solution, 40%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Active against bacteria and fungi; not active against <i>P aeruginosa</i> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>May be less toxic to wound tissues than other antiseptics</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>May be corrosive and is potentially harmful if swallowed</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not available in the USA</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Chlorhexidine</p> <p>gluconate</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Solution, 2% and 4%; liquid, 2% and 4%; hand rinse, 0.5%; wipes, 0.5%; sponge/brush, 4%; and foam, 4% </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Active against gram‐positive bacteria (e.g. <i>Staphylococcus aureus</i>) and gram‐negative bacteria, including <i>P aeruginosa</i> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Persistent activity up to 6 h after application; few adverse effects</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Hypersensitivity, including anaphylaxis, generalised</p> <p>urticaria, bronchospasm, cough, dyspnoea, wheezing, and malaise; may cause serious injury to the eye and middle ear; avoid contact with face or head; some resistance reported </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2% chlorhexidine indicated as surgical hand scrub, hand wash, skin and wound cleanser; polyhexanide is a similar, newer biguanide. </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Hexachlorophene</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Liquid, 3%; foam, 0.23% with 56% alcohol</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Biguanide that is bacteriostatic against <i>Staphylococcus</i> species and other gram‐positive bacteria </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>May retain residual effect on skin for several days</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rapidly absorbed and may result in toxic blood levels; application to burns has resulted in neurotoxicity and death; may cause central nervous system stimulation and convulsions, dermatitis, and photosensitivity reactions </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$$$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not recommended for routine use on wounds due to potential toxicity</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Iodine compounds and iodine tincture<sup>c</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Solution (aqueous) 2% and 2.4%; and tincture (44% to 50% alcohol) 2% and 2.4%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Microbicidal against bacteria, fungi, viruses, spores, protozoa, and yeasts</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Broad spectrum</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Highly toxic if ingested or significantly absorbed; do not use with occlusive dressings; causes pain and stains skin and clothing; use cautiously in people with thyroid disorders </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Iodine compounds are now rarely used for wound management; cadexomer iodine and povidone iodine products are less toxic. </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Povidone iodine<sup>c</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ointment, 1%, 4.7%, 10%; solution, 1% and 10%; also wash, scrub, cleanser, gel, aerosol, gauze pad, swab, and other forms </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Broad spectrum includes <i>S aureus</i> and enterococci; active ingredient is liberated free iodine; shares spectrum but is less potent than iodine </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Less irritating to skin and allergenic than iodine. Can be covered with dressings. Clinically significant resistance very rare </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Antibacterial action requires at least 2 min contact; may cause stinging and erythema; effect may not persist, and efficacy may be reduced in body fluids; prolonged use may cause metabolic acidosis; stains skin and clothing; possible interaction with starches in dressings </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Indicated for perioperative skin cleansing and for cleansing and prevention of infection in superficial burns, incisions, and other superficial wounds </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Sodium hypochlorite</p> <p>(Dakin’s solution</p> <p>and EUSOL)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Solution, 0.0125%, 0.125%, 0.25%, and 0.5%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Vegetative bacteria, viruses, and some spores and fungi</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Inexpensive</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No known systemic toxicity. May require prolonged contact for antibacterial action; inactivated by pus; toxic to fibroblasts and keratinocytes, and may cause pain or lyse blood clots </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A concentration of 0.025% is both bactericidal and non‐toxic to tissues (<a href="./references#CD011038-bbs2-0095">Heggers 1991</a>). </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Hydrogen peroxide<sup>c</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Solution, 1% and 3%; and cream, 1%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Oxidizing agent active against many gram‐positive and gram‐negative bacteria</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Broad‐spectrum, bactericidal, inexpensive; no known 1q11</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>May cause some discomfort</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Commonly used, but few clinical studies</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Silver nitrate</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Solution 0.5%, 10%, 25%, and 50%; ointment, 10%; and swabs, 25% to 50%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Silver ions are bactericidal against a broad spectrum of gram‐positive and gram‐negative bacteria. </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low cost; easily applied</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Painful on application; stains tissues; may delay healing; concentrations 10.5% cause cauterisation; inactivated by wound exudates and chlorine </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Previously widely used, but now largely replaced by other compounds, including newer silver dressings </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Silver dressings</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>At least 6 approved products with different properties</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Slowly released silver ions have broad spectrum, including MRSA and VRE.</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Provide sustained levels of active silver ions; microbial resistance is rare; less painful and few adverse effects than silver nitrate; variety of products adaptable to different types of wounds; infrequent application required </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Levels of silver ions at wound interface not well defined; may cause silver staining of tissues; may delay epithelialisation; relatively expensive; few published comparative trials </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Should not substitute for non‐medicated dressings for uninfected wounds; may be useful for subclinically infected, highly colonised wounds or for wounds being prepared for skin grafting </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>Abbreviations: EUSOL, Edinburgh University Solution of Lime; MRSA, methicillin‐resistant <i>Staphylococcus aureus</i>; VRE, vancomycin‐resistant enterococci. </p> <p><sup>a</sup>Costs are approximate in USD per day for treating 100‐square centimetre wound, as follows: $, &lt; USD 3; $$, USD 3 to 15; and $$$, &gt; USD 15. <br> <sup>b</sup>US Food and Drug Administration–approved indications. <br> <sup>c</sup>Available without prescription. Modified from <a href="./references#CD011038-bbs2-0109">Lipsky 2009</a>. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span>&nbsp;<span class="table-title">Topical antiseptic products available for treating chronic wounds</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-tbl-0012" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD011038-tbl-0013"> <div class="table-heading"><span class="table-label">Table 3.</span>&nbsp;<span class="table-title">Topical antibiotic products available for treating chronic wounds</span></div> <tbody> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Product and<br> formulations</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Formulations</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bacterial spectrum</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Advantages</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Disadvantages</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Cost<sup>a</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Indications<sup>b</sup> and comments</b> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Bacitracin c</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ointment, 500 units/g; and powder combinations with neomycin, polymyxin B, and zinc</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Many gram‐positive organisms, including aerobic staphylococci and streptococci, corynebacteria, anaerobic cocci, and clostridia; inactive against most gram‐negative organisms </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Activity not impaired by blood, pus, necrotic tissue, or large bacterial inocula; resistance is rare but increasing among staphylococci; no cross‐resistance with other antibiotics; minimal absorption </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>May cause allergic reactions, contact dermatitis, and (rarely) anaphylactic reactions; may lead to overgrowth of drug‐resistant organisms, including fungi </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Widely used for many years; indicated for prevention of infection in minor skin wounds</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Fusidic acid</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cream, 2%; ointment, 2%; and gel, 2%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>Staphylococcus aureus</i>, streptococci (in topical concentrations), corynebacteria, and clostridia </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Penetrates intact and damaged skin as well as crust and cellular debris</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Occasional hypersensitive reactions; resistance among staphylococci is emerging; must apply 3 times daily </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not available in the USA</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Gentamicin</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cream, 0.1%; and ointment, 0.1%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Streptococci, staphylococci, <i>Pseudomonas aeruginosa</i>, <i>Enterobacter aerogenes</i>, <i>Escherichia coli</i>, <i>Proteus vulgaris</i>, and <i>Klebsiella pneumoniae</i> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Broad spectrum; inexpensive</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Must be applied 3 to 4 times daily; may drive resistance to an agent used systemically</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Indicated for primary skin infections (pyodermas) and secondary skin infections, including infected excoriations, and for bacterial superinfections </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mafenide acetate</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Solution, 5%; and cream, 85 mg/g</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A sulfonamide that is bacteriostatic against many gram‐negative organisms, including <i>P aeruginosa</i>, and some gram‐positive organisms, but minimal activity against staphylococci and some obligate anaerobes </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Remains active in the presence of pus and serum, and its activity is not affected by acidity of environment </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Systemic absorption may occur; drug and metabolites may inhibit carbonic anhydrase, potentially causing metabolic acidosis; use cautiously in patients with renal impairment; pain on application; hypersensitive reactions. </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$$$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Indicated as adjunctive therapy in second‐ and third‐degree burns; may be used in rapidly progressing bacterial necrotising fasciitis; limited use in other wounds </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Metronidazole</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cream, 0.75%; gel, 1%; lotion, 0.75%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Many clinically important anaerobic bacteria</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>May reduce odour associated with anaerobic infections; application only 1 to 2 times daily </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Relatively expensive; systemic formulations available; could drive resistance to these</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$–$$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Indicated for inflammatory papules and pustules of rosacea</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mupirocin and mupirocin calcium</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ointment, 2%; for mupirocin calcium, cream, 2.15%; and nasal ointment,<br> 2.15% (equivalent to 2% mupirocin) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Gram‐positive aerobes, including <i>S aureus</i> (most MRSA), <i>Staphylococcus epidermidis</i>, <i>Staphylococcus saprophyticus</i>, and streptococci (groups A, B, C, and G) but not enterococci, some gram‐negative aerobes (not <i>P aeruginosa</i>), corynebacteria, and obligate anaerobes </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Minimal potential for allergic reactions</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rare local burning and irritation; applying ointment to large wounds in azotaemic patients can cause accumulation of polyethylene glycol; long‐term use can lead to resistance among staphylococci, which is increasing </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Indicated for topical treatment of impetigo and eradication of nasal colonisation with <i>S aureus</i> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Neomycin sulfate<sup>c</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Powder; cream, 0.5%; combinations with polymyxin B and pramoxine, and ointment, 0.5%; combinations with bacitracin, polymyxin B, lidocaine, and pramoxine </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Good for gram‐negative organisms but not <i>P aeruginosa</i>; active against some gram‐positive<br> bacteria, including <i>S aureus</i>, but<br> streptococci are generally resistant; inactive<br> against obligate anaerobes </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low cost; applied only 1 to 3 times daily; may<br> enhance re‐epithelialisation </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Topical powder in wound irrigating solution<br> may cause systemic toxicity (FDA banned); use other formulations cautiously on large wounds, especially with azotaemia; hypersensitive reaction in 1% to 6%, often with chronic use or history of allergies. </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Use of topical powder alone or in solution is not recommended; cream and ointment, in combination with other agents, are indicated for prevention of infection in minor skin injuries. </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Nitrofurazone</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Solution, 0.2%; ointment, 0.2%; and cream, 0.2%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Broad gram‐positive and gram‐negative activity,<br> including <i>S aureus</i> and streptococci, but not <i>P aeruginosa</i> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Used mainly for burn wounds</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Hypersensitive reactions; polyethylene glycols (in some formulations) may be absorbed and can cause problems in azotaemic patients </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Indicated as adjunctive to prevent infections in people with second‐ and third‐degree<br> burns </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Polymyxin B<sup>c</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cream, 5000 units/g or<br> 10,000 units/g, in combination<br> with other agents </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Bactericidal against many gram‐negative organisms,<br> including <i>P aeruginosa</i>; minimal activity against gram‐positive bacteria; activity may be neutralised by divalent cations </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Inexpensive</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Some hypersensitive and neurological or<br> renal adverse reactions reported; may show cross‐reaction with bacitracin. </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Only available in combination with other agents, including bacitracin and neomycin;<br> indicated for prevention </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Retapamulin</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ointment, 1%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Active against staphylococci (but uncertain<br> for MRSA) and streptococci and some obligate<br> anaerobes </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>May be active against some mupirocin‐resistant <i>S aureu</i>s strains; broader activity than mupirocin </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not evaluated for use on mucosal surfaces; may cause local irritation</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$$$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Indicated for impetigo due to <i>S aureus</i> (methicillin‐susceptible only) or <i>Streptococcus pyogenes</i> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Silver sulphadiazine</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cream, 1%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A sulfonamide; the released silver ions are the primary active ingredient; active against many gram‐positive and gram‐negative organisms, including <i>P aeruginosa</i> <br> . </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Applied only once or twice daily; soothing<br> application; low rate of hypersensitive reaction </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Potential cross‐reaction with other sulphonamides; may rarely cause skin staining</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Indicated as adjunctive treatment to prevent<br> infections in people with second‐ and third‐degree burns </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Sulfacetamide Na+</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Lotion, 10%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Bacteriostatic against many gram‐positive and gram‐negative pathogens</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Broad spectrum; can be combined with sulphur</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Systemic absorption and rarely severe side<br> effects occur with application to large, denuded areas; hypersensitive reactions<br> may occur. </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>$$$</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Indicated for secondary bacterial skin infections<br> due to susceptible organisms and for acne vulgaris in adults </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>There are no published studies supporting the use of topical erythromycin, clindamycin, aminoglycosides other than neomycin, gramicidin, or tetracyclines for treating chronically infected wounds. </p> <p>Abbreviations: FDA, US Food and Drug Administration; MRSA, methicillin‐resistant <i>Staphylococcus aureus</i>. </p> <p><sup>a</sup>Costs are approximate in USD per day for treating 100‐square centimetre wound, as follows: $, &lt; USD 3; $$, USD 3 to 15; and $$$, &gt; USD 15. <br> <sup>b</sup>FDA‐approved indications.<br> <sup>c</sup>Available without prescription. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span>&nbsp;<span class="table-title">Topical antibiotic products available for treating chronic wounds</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-tbl-0013" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD011038-tbl-0014"> <div class="table-heading"><span class="table-label">Table 4.</span>&nbsp;<span class="table-title">Information from trial registry</span></div> <tbody> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b> Title (comparator) </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b> Current status</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b> Relevant outcomes listed</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b> Database</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b> Results (# enrolled)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b> Listed contact</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b> Company and any further information received</b> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Phase IIa Randomised, Placebo Controlled Trial to Investigate Antimicrobial Photodynamic Therapy in Chronic Leg Ulcers and Diabetic Foot Ulcers (placebo = “cream”) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Prematurely ended (date unclear)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Photodynamic therapy using the combined effect of 3,7‐bis(N,N‐dibutylamino) phenothiazin‐5‐ium bromide (PPA904) and light; measure reduction of bacterial content of diabetic foot ulcers </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ClincialTrialsRegister.eu</p> <p>EudraCT number: 2005‐001363‐58</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>None (not listed)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>None listed.</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Photopharmacia</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (OneStep‐1 and 2) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Completed (August 2016)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1°: clinical response (resolution of infection);</p> <p>2°: microbiological response; safety</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ClinicalTrials.gov; <a href="./references#CD011038-bbs2-0079">NCT01594762</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No results (200 for each of the 2 trials) reported on website.</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Robert Deluccia, Dipexium</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Dipexium Pharmaceuticals, Inc.</p> <p>Multicentre study; all sites</p> <p>outpatient centre in USA</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comparison of Resin Salve and Octenidine in Patients with Neuropathic Diabetic Foot Ulcers (comparator: octenidine dihydrochloride‐impregnated gauze) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Completed (May 2015)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Investigate healing rate and healing time of neuropathic diabetic foot ulcer in people suffering from infected fore‐ or mid‐foot ulceration. 2°: eradication of bacteria; wound healing and infection </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ClinicalTrials.gov;</p> <p>NCT02169167</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No results on website (n = 35)</p> <p>(see addendum in “comments”)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Janne J Jokinen</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Salve prepared from</p> <p>Norway spruce (Repolar Ltd.)</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Clinical Outcomes for Diabetic Foot Ulcers Treated With Clostridial Collagenase (SANTYL®) Ointment or With a Comparator Product Containing Silver (investigator choice of silver) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Running until January 2017 (last updated November 2016)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomly assigned to apply SANTYL or a topical treatment containing silver to their to foot ulcer. 1°: mean change in ulcer area at end of treatment; 2°: target ulcer infection rate </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ClinicalTrials.gov; NCT02581488</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No results (102)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Jaime E Dickerson, PhD (Smith &amp; Nephew)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>(Smith &amp; Nephew)</p> <p>Information from the sponsor received end of December 2016 stated that the trial is not yet complete but last participant out will be achieved in the next week. The trial enrolled its target number of participants, with the last participant completed December 2016. The evaluability will be carried out prior to the scheduled database lock in January 2017. As intention‐to‐treat is the analysis set for primary inference, it is anticipated that all participants will be included. Final study report is timed for April 2017 (15 December 2016). </p> <p>Waiting for further information to assess eligibility for review</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomized, Controlled Study to Investigate the Efficacy and Safety of a Topical Gentamicin‐Collagen Sponge in Combination with Systemic Antibiotic Therapy in Diabetic Patients With a Moderate or Severe Foot Ulcer Infection </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Recruiting (as of September 2013)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1°: "clinical cure" at the test of cure; 2°: clinical response; time to clinical cure; eradication of baseline pathogen </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ClinicalTrials.gov; NCT01951768</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No results (estimate 144)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ilker Uckay, MD; Hospital of the University of Geneva</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Innocoll, Inc.</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comparison of the Efficacy of Standard Treatment Associated with Phage Therapy Versus Standard Treatment Plus Placebo for Diabetic Foot Ulcers Monoinfected by <i>Staphylococcus aureus</i>: a Randomized, Multi‐centre, Controlled, 2‐parallel‐group, Double‐blind, Superiority Trial </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting January 2017</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1°: reduction in wound surface area;</p> <p>2°: safety; changes in resistance and virulence of <i>S aureus</i> isolates; production of anti‐phage antibodies </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ClinicalTrials.gov; NCT026647401</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No results (estimate 60)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Albert Sotto, MD, PhD</p> <p>+33.(0)6.09.56.66.55</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Centre Hospitalier Universitaire de Nīmes; Pherecydes Pharma.</p> <p>Per correspondence from Prof Sotto on 8 January 2017, National Agency for the Safety of Medicines and Health Products requested “pre‐clinical phase complements”, causing a postponement of the start of the clinical trial. </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A Phase I/IIa, Randomized Double Blind, Placebo‐Controlled, Dose Escalating Study to Evaluate the Safety and Tolerability of Topically Applied Bisphosphocin Nu‐3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes Mellitus (placebo) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Enrolling by invitation only (last verified April 2016)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Diabetic foot ulcers; infection localised to area of ulcer and mild.</p> <p>1° outcome: treatment‐related adverse events, safety</p> <p>2°: microbiological activity evaluated by wound assessments, presence of pathogenic bacteria </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ClinicalTrials.gov; NCT02737722</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No results (estimate 30)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Paul DiTullio, MSc</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Lakewood‐Amedex, Inc.</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A Phase II, Randomized, Parallel, Double‐blind, Placebo‐controlled Study to Assess Prevention of Infection Using a Topical Gentamicin‐Collagen Sponge in Diabetic Patients With Uninfected Lower Extremity Skin Ulcers (placebo sponge) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Terminated (last verified March 2012)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1° outcome: uninfected diabetic foot ulcers that remain free of signs/symptoms of infection to end of study </p> <p>2°: days to wound closure; time to any signs/symptoms of infection; decrease in wound area; pathogen burden in infected wounds </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ClinicalTrials.gov; NCT00658957</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No results (49)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>David Prior, PhD; Chesapeake Foot and Ankle Center, Pasadena (MD), USA</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Innocoll Pharmaceuticals</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A Phase 3 Randomized, Placebo‐Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin‐Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer (COACT 1 and 2) (placebo is no sponge) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Last updated June 2016</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Sponge is adjunctive treatment to systemic antibiotic therapy.</p> <p>1° outcome: per cent of participants with a clinical outcome of clinical cure (resolution of all clinical signs and symptoms of infection) ˜10 days after end of treatment; </p> <p>2° outcomes: baseline pathogen eradication; re‐infection; time to clinical cure; amputation; ulcer closure </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ClinicalTrials.gov:</p> <p>NCT02447172</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No results posted.</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Nigel Jones, VP, Global Clinical Operations, Innocoll Pharmaceuticals</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Innocoll Pharmaceuticals</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study of the Efficacy of Topical Application of Royal Jelly and Panthenol (PedyPhar® Ointment) on the Diabetic Foot Ulcers, an Open Label, Randomized, Non‐placebo‐controlled Study (active comparator panthenol ointment) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Terminated; (last updated February 2015)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Diabetic foot ulcers at any stage after proper surgical treatment (if needed)</p> <p>1° outcome: healing of ulcer;</p> <p>2°: reduction of infection in ulcer site; local reaction possibly related to study drug </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ClinicalTrials.gov; NCT01531517</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No results (estimate 120; 47 enrolled)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>(?)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>European Egyptian Pharmaceutical Industries</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Platelet Rich Fibrin in Combination With Topical Antibiotics or Antiseptics in the Treatment of Chronic Wounds ‐ a Prospective, Randomized, Active Controlled, Double Blind Pilot Trial With an Observer‐blinded Control Group (3 platelet rich fibrin arms &amp; 1 active comparator (Acticoat)) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Recruiting (last verified January 2016)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>People with infected chronic wounds (unclear if diabetic foot)</p> <p>1° outcome: reduction of wound area; 2°: number requiring systemic antimicrobial therapy; C‐reactive protein level; wound volume; occurrence of drug‐resistant bacteria </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ClinicalTrials.gov; NCT02652169</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No results (estimate 120)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Florian Thalhammer, Medical University of Vienna; 0043140400 ext 44400; <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="e6808a89948f8788c8928e878a8e878b8b8394a68b838293888f918f8388c88785c88792">[email&#160;protected]</a></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Medical University of Vienna</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Double Blind, Randomized, Placebo Controlled Clinical Trial for the Treatment of Diabetic Foot Ulcers, Using a Nitric Oxide Releasing Patch: PATHON </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Completed (last verified November 2012)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1° outcome: per cent reduction in ulcer size;</p> <p>2°: complete cure of any infection; development of infection during treatment; adverse events </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ClinicalTrials.gov; NCT00428727</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No results (?)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Fundación Cardiovascular de Colombia</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>(?)</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A Phase I/II, Open Label, Controlled Study to Evaluate the Safety and Efficacy of AppliGel‐G (Gentamicin Sulfate Topical Gel) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers in Patients With Type 1 and Type 2 Diabetes (comparator oral ciprofloxacin and doxycycline alone) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Terminated (last verified May 2015)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>For mild to moderately infected diabetic foot ulcers</p> <p>1°: complete wound clearing of infection</p> <p>2°: incidence infection cleared; wound volume and area change</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ClinicalTrials.gov; NCT02036528</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No results</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Royer Biomedical, Inc.</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Royer Biomedical, Inc.</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A Randomised, Double‐blind, Dose‐response, Placebo‐controlled, Multicenter, Phase IIA Clinical Study to Evaluate the Efficacy and Safety of Topical Application of G.68.y/EtOH in Patients with Type 1 or Type 2 Diabetes With Infected Foot Ulcers (placebo topical gel) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Completed</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Enrolling patients with infected “grade 2 PEDIS” diabetic foot ulcers</p> <p>1°: reduction of bacterial load</p> <p>2°: maintenance of efficacy; tolerability and safety</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>EudraCT number: 2010‐019598‐13</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No results (plan for 60)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="135a3d505c41475a535e5c5f47565d5a5552415e523d5a47">[email&#160;protected]</a></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Molteni</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial to Assess Safety and Efficacy of Topical MBN‐101 (BisEDT ) in Patients With Moderate/ Severe Diabetic Foot Infections (placebo – vehicle‐controlled) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not yet open for participant recruitment (last update March 2016)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Part I, participants will be enrolled into 1 of 3 escalating dose cohorts at a ratio of 3:1 (active to placebo). In Part II, participants will be randomised in a 1:1 ratio (active to placebo) based on the optimal dose demonstrated in Part I. People with infected foot ulcer </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ClinicalTrials.gov; NCT02723539</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No results (plan for 88)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Department of Vascular Surgery, Rigshospitalet</p> <p>Copenhagen, Denmark, 2100</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Microbion Corporation</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>Abbreviations: PEDIS, perfusion, extent/size, depth/tissue loss, infection, and sensation</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span>&nbsp;<span class="table-title">Information from trial registry</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-tbl-0014" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD011038-tbl-0015"> <div class="table-heading"><span class="table-label">Table 5.</span>&nbsp;<span class="table-title">Overview of included studies</span></div> <tbody> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b> Intervention 1</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b> Intervention 2</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b> Foot ulcer grade</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b> Infection status at baseline</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b> Follow‐up</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b> Review‐relevant</b> </p> <p><b> outcomes with reportable data</b> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0001">Ahmed 2014</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 30) Pyodine bath and saline and vaseline gauze dressing</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 2: (n = 30) Phenytoin powder</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Grade I or II</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8 weeks</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>None reported</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0002">Apelqvist 1996</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 19) Gentamicin solution</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 2: (n = 22) Cadexomer iodine ointment</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Grade I or II</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12 weeks</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p> <ol id="CD011038-lst1-0029"> <li> <p>Proportion of ulcers healed</p> </li> <li> <p>Surgical resection</p> </li> <li> <p>Adverse events</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0003">Bergqvist 2016</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 19) Standard care</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 2: (n = 21) Chloramine plus standard care</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Infected</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>24 weeks</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p> <ol id="CD011038-lst1-0030"> <li> <p>Proportion of ulcers healed</p> </li> <li> <p>Resolution of infection</p> </li> <li> <p>Surgical resection</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0004">Bowling 2011</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 10) Saline solution</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 2: (n = 10) Super‐oxidised aqueous solution</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Grade I or II</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not infected</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4 weeks</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p> <ol id="CD011038-lst1-0031"> <li> <p>Adverse events</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0005">Gottrup 2013</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 15) Foam dressing</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 2: (n = 24) Silver collagen/oxidised regenerated cellulose dressing</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Grade II or III</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not infected</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14 weeks</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p> <ol id="CD011038-lst1-0032"> <li> <p>Proportion of ulcers healed</p> </li> <li> <p>Incidence of wound infection</p> </li> <li> <p>Adverse events</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0006">He 2016</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 40) Routine debridement plus standard care (including blood glucose control, nutritional support, improve microcirculation </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 2: (n = 40) Silver ion dressing plus standard care</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4 weeks</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p> <ol id="CD011038-lst1-0033"> <li> <p>Proportion of ulcers healed</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0007">Hwang 2010</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = not reported) Iodine gauze</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 2: (n = not reported) Hydrofiber dressing with silver</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ulcers with bone and tendon exposure</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0008">Imran 2015</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 180) Saline dressing</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 2: (n = 195) Honey dressing</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Grade I or II</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17 weeks</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p> <ol id="CD011038-lst1-0034"> <li> <p>Proportion of ulcers healed</p> </li> <li> <p>Time to healing</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0009">Jacobs 2008</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 20) Silver sulphadiazine cream</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 2: (n = 20) Formulation of benzoic acid, 6%; salicylic acid, 3%; and extract of oak bark (<i>Quercus rubra),</i> 3% (Bensal HP with QRB7), with silver sulphadiazine cream </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Grade I or II</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6 weeks</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p> <ol id="CD011038-lst1-0035"> <li> <p>Proportion of ulcers healed</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0010">Jeffcoate 2009</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 108) Non‐adherent dressing, viscose filament gauze</p> <p>Group 2: (n = 103) Hydrocolloid (Hydrofiber) dressing</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 3: (n = 106) Iodine‐containing dressing</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>24 weeks</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p> <ol id="CD011038-lst1-0036"> <li> <p>Proportion of ulcers healed</p> </li> <li> <p>Health‐related quality of life (Cardiff Wound Impact Schedule and SF‐36)</p> </li> <li> <p>Surgical resection (amputations (minor and major))</p> </li> <li> <p>Adverse events (serious and non‐serious)</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0011">Jude 2007</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 67) Calcium‐alginate dressing</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 2: (n = 67) Fibrous‐hydrocolloid (Hydrofiber) dressing with 1.2% ionic silver</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Grade I or II</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mixed infected and not infected</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8 weeks</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p> <ol id="CD011038-lst1-0037"> <li> <p>Proportion of ulcers healed</p> </li> <li> <p>Incidence of wound infection</p> </li> <li> <p>Adverse events</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0012">Khandelwal 2013</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 20) Hyperbaric oxygen therapy (not considered further)</p> <p>Group 2: (n = 20) Recombinant human platelet‐derived growth factor</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 3: (n = 20) Antiseptic treatments (EUSOL, hydrogen peroxide, and povidone iodine)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Grade III or IV</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>More than 8 weeks</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p> <ol id="CD011038-lst1-0038"> <li> <p>Proportion of ulcers healed</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0013">Landsman 2011</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 21) Topical saline solution plus 750 mg levofloxacin once per day</p> <p>Group 2: (n = 21) Super‐oxidised aqueous solution (topical Microcyn) alone (not considered)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 3: (n = 21) super‐oxidised aqueous solution (topical Microcyn) therapy plus 750 mg levofloxacin once per day </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Eligible foot ulcers involved skin and deeper soft tissue</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Infected</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4 weeks</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p> <ol id="CD011038-lst1-0039"> <li> <p>Resolution of infection</p> </li> <li> <p>Adverse events</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0014">Lipsky 2008a</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 246) Ofloxacin (200 mg) oral tablets and a topical placebo (vehicle) cream </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 2: (n = 247) Topical pexiganan cream (1% or 2%) and placebo oral tablets</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Infected</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Up to 42 days</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p> <ol id="CD011038-lst1-0040"> <li> <p>Surgical resection</p> </li> <li> <p>Adverse events</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0015">Lipsky 2008b</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 171) Ofloxacin (200 mg) oral tablets and a topical placebo (vehicle) cream </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 2: (n = 171) Topical pexiganan cream (1%) and placebo oral tablets</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Full‐thickness wounds</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Infected</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Up to 42 days</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p> <ol id="CD011038-lst1-0041"> <li> <p>Surgical resection</p> </li> <li> <p>Adverse events</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0016">Lipsky 2012a</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 38) Systemic antibiotic therapy alone</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 2: (n = 18) Daily topical application of the gentamicin‐collagen sponge combined with systemic antibiotic therapy </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Infected</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Up to 42 days</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p> <ol id="CD011038-lst1-0042"> <li> <p>Resolution of infection</p> </li> <li> <p>Adverse events</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0017">Martinez‐De Jesus 2007</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 16) Povidone iodine and saline</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 2: (n = 21) Neutral pH super‐oxidised aqueous solution</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Infected</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20 weeks</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p> <ol id="CD011038-lst1-0043"> <li> <p>Resolution of infection</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0018">Ramos Cuevas 2007</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 25) Conventional treatment (no further details translated)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 2: (n = 25) Zinc hyaluronate</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20 weeks</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p> <ol id="CD011038-lst1-0044"> <li> <p>Proportion of ulcers healed</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0019">Shukrimi 2008</a> </p> <p>(30 participants randomised, but number in each group not specified)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: Standard‐dressing group (povidone iodine solution 10%) (n not reported)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 2: Honey dressing group (n not reported)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Grade II</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No useable data</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0020">Tom 2005</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: Normal saline solution, 11 ulcers (in 10 participants)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 2: Tretinoin group, 13 ulcers (in 12 participants)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16 weeks</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p> <ol id="CD011038-lst1-0045"> <li> <p>Proportion of ulcers healed</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0021">Ullal 2014</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 2) Povidone iodine and metronidazole 1% gel dressing</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 2: (n = 2) Honey and metronidazole 1% gel dressing</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Grade I and II</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p> <ol id="CD011038-lst1-0046"> <li> <p>Proportion of ulcers healed</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0022">Viswanathan 2011</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: (n = 19) Polyherbal formulation</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 2: (n = 19) silver sulphadiazine cream</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Grade I, II, and III</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20 weeks</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No useable data</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>Abbreviations: EUSOL, Edinburgh University Solution of Lime</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span>&nbsp;<span class="table-title">Overview of included studies</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-tbl-0015" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD011038-tbl-0016"> <div class="table-heading"><span class="table-label">Table 6.</span>&nbsp;<span class="table-title">Outcomes</span></div> <tbody> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Resolution of infection</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Incidence of wound infection</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Time to healing</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Proportion of wounds healed</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Microbial counts</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Health‐related quality of life</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Need for surgical resection, including partial or complete lower limb amputation</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Safety (adverse events)</b> </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0001">Ahmed 2014</a> </p> <p>Group 1: (n = 30)</p> <p>Povidone iodine bath and saline Vaseline gauze dressing</p> <p>Group 2: (n = 30) Phenytoin powder plus povidone iodine bath and saline Vaseline gauze dressing </p> <p>Not infected at baseline</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0002">Apelqvist 1996</a> </p> <p>Group 1: (n = 19) Gentamicin solution</p> <p>Group 2: (n = 22) Cadexomer iodine ointment</p> <p>Baseline infection status not reported.</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1:</p> <p>2/18</p> <p>Group 2:</p> <p>5/17</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Surgical resection was reported:</p> <p>Group 1: 5/19</p> <p>Group 2: 3/22</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study reports that no adverse</p> <p>reactions related to the topical treatment were documented.</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0003">Bergqvist 2016</a> </p> <p>Group 1: (n = 19) Standard care alone</p> <p>Group 2: (n = 21) Chloramine plus standard care</p> <p>Infected at baseline</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: 7/15</p> <p>Group 2: 9/13</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Time‐to‐event data presented with no reported hazard ratio. Given the small number of participants and events, no further attempts were made to calculate time‐to‐event values. </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>Healed at 24 weeks</i> </p> <p>Group 1: 9/17</p> <p>Group 2: 10/17</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Vascular procedure or amputation</p> <p>Group 1: 3/17</p> <p>Group 2: 5/17</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Adverse event data reported but unable to get a per‐participant value, as it is noted that some participants had more than 1 event. </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0004">Bowling 2011</a> </p> <p>Group 1: (n = 10) Saline solution</p> <p>Group 2: (n = 10) Super‐oxidised aqueous solution</p> <p>Not infected at baseline</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study notes that 15% of the study ulcers</p> <p>were healed, but this information not reported by group.</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The bacterial load in the wound bed was defined as</p> <p>scattered (0/+), light (+), medium (++), or heavy (+++).</p> <p>At week 4 there was a reduction of</p> <p>33% in the bacterial load versus baseline.</p> <p><i>Figure presented but difficult to interpret data by group.</i> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No safety concerns were reported in either the</p> <p>super‐oxidised aqueous solution group or the saline</p> <p>group; no adverse reactions were recorded.</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0005">Gottrup 2013</a> </p> <p>Group 1: (n = 15) Foam dressing</p> <p>Group 2: (n = 24) Silver collagen/oxidised regenerated cellulose dressing</p> <p>Not infected at baseline</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>Wound infection</i> </p> <p>Group 1: 4/13</p> <p>Group 2: 0/23</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>Healed by week 14</i> </p> <p>Group 1: 4/13</p> <p>Group 2: 12/23</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Limited details of adverse events (in addition to infection data already recorded). There were no reported adverse events related to the use of collagen/oxidised regenerated cellulose/silver dressing, and 5 cases of adverse events (no further details) related to foam dressing. </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0006">He 2016</a> </p> <p>Group 1: (n = 40) Routine debridement plus standard care</p> <p>Group 2: (n = 40) Silver ion dressing plus standard care</p> <p>Baseline infection status not reported.</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean wound healing time in days:</p> <p>Group 1: 47.4 ± 11.5</p> <p>Group 2: 31.3 ± 8.2</p> <p>Mean granulation tissue occurrence time in days:</p> <p>Group 1: 10.8 ± 1.9</p> <p>Group 2: 6.4 ± 0.72</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: 15/40</p> <p>Group 2: 24/40</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0007">Hwang 2010</a> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0008">Imran 2015</a> </p> <p>Group 1: (n = 180) Treated with normal saline dressing</p> <p>Group 2: (n = 195) Treated with honey dressing</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Median healing time in honey group is 18 days (IQR is 6 to 120), and in the saline group is 29 days (IQR 7 to 120). </p> <p>Data do not seem to have been calculated using correct time‐to‐event approaches and were not considered further. </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: 97/169</p> <p>Group 2: 136/179</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0009">Jacobs 2008</a> </p> <p>Group 1: (n = 20) Silver sulphadiazine</p> <p>Group 2: (n = 20) Formulation of benzoic acid, 6%; salicylic acid, 3%; and extract of oak bark (<i>Quercus rubra</i>), 3% (Bensal HP with QRB7), with silver sulphadiazine cream </p> <p>Baseline infection status not reported.</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>Healed by week 6</i> </p> <p>Group 1: 6/20</p> <p>Group 2: 8/20</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0010">Jeffcoate 2009</a> </p> <p>Group 1: (n = 108) Non‐adherent dressing, viscose filament gauze (Johnson &amp; Johnson)</p> <p>Group 2: (n = 103) Hydrocolloid (Hydrofiber) dressing (Aquacel, ConvaTec)</p> <p>Group 3: (n = 106) Iodine‐containing dressing (Inadine, Systagenix)</p> <p>Baseline infection status not reported.</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>Number of infected ulcers at 24 weeks:</i> not reported by group </p> <p>Study reports the number of episodes of infection listed as serious adverse events, but it is unclear if foot infections, and not clear how many people had how many infection events. </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>Mean time to healing in days (SD) (fixed at max of 168 days</i>)<br> Group 1: 130.7 (52.4) </p> <p>Group 2: 125.8 (55.9)</p> <p>Group 3: 127.8 (54.2)</p> <p><i>Not all ulcers healed, so mean is inappropriate measure of time to healing.</i> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>Number of ulcers healed at 24 weeks:</i> <br> Group 1: 41/108 </p> <p>Group 2: 46/103</p> <p>Group 3: 48/106</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>Mean Cardiff Wound Impact Schedule score at 24 weeks (SD)</i> </p> <p>Group 1: Physical functioning: 68.9 (19.1). Social functioning: 69.8 (23.5). Well‐being: 50.2 (21.1) </p> <p>Group 2: Physical functioning: 71.4 (19.5). Social functioning: 70.3 (25.4). Well‐being: 53.1 (19.9)<br> Group 3: Physical functioning: 67.1 (23.6). Social functioning: 69.7 (24.1). Well‐being: 51.0 (22.3) </p> <p><i>Other</i> <br> Study also reports mean and SD for each of the 8 domains of the SF‐36. There was no significant difference between the groups for any domain. </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>Minor amputations (below ankle):</i> <br> Group 1: 1/108<br> Group 2: 3/103<br> Group 3: 1/106<br> <i>Major amputations (above knee)</i> <br> Group 1: 1/108 </p> <p>Group 2: 1/103<br> Group 3: 0/106 </p> <p>n not clear; assumed to be all participants</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>Non‐serious adverse events</i> <br> Group 1: 244/108 </p> <p>Group 2: 227/103</p> <p>Group 3: 239/106</p> <p><i>Serious adverse events</i> <br> Group 1: 35/108 </p> <p>Group 2: 28/103</p> <p>Group 3: 37/106</p> <p>Not clear how many participants had how many events, but seems to be more than 1 per person; data not analysed further </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0011">Jude 2007</a> </p> <p>Group 1: (n = 67) Calcium‐alginate dressing</p> <p>Group 2: (n = 67) Fibrous‐hydrocolloid (Hydrofiber) dressing with 1.2% ionic silver</p> <p>Mixed wound infection status at baseline</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: 11/67</p> <p>Group 2: 8/67</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Time to 100% healing also reported, but this is only for a subset of those that healed, so not a useful pan‐study measure. Not reported </p> <p>Mean time to healing in days</p> <p>Group 1: 52.6 ± 1.8</p> <p>Group 2: 57.7 ± 1.7</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>Number of ulcers healed in 8 weeks</i> <br> Group 1: 15/67<br> Group 2: 21/67 </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: 26/67 participants experienced adverse event. Death = 1; Infection = 8. 13 participants discontinued treatment due to adverse event. </p> <p>Group 2: 25/67 participants experienced 1 or more events. Death = 1; Infection = 14. 8 participants discontinued treatment due to adverse event. </p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0012">Khandelwal 2013</a> </p> <p>Group 1: (n = 20) Hyperbaric oxygen therapy (not considered in review)</p> <p>Group 2: (n = 20) Recombinant human platelet‐derived<br> growth factor </p> <p>Group 3: (n = 20) Antiseptic dressings</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>Mean time to healing in weeks (standard error)</i> </p> <p>Group 1: 6.83 (2.5)</p> <p>Group 2:</p> <p>7.6 (2.5)</p> <p>Group 3: 6.75 (2.7)</p> <p><i>Not all ulcers healed, so mean is inappropriate measure of time to healing.</i> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>Number of ulcers healed</i> </p> <p>Group 1: 12/20</p> <p>Group 2: 16/20</p> <p>Group 3: 8/20</p> <p>Review authors calculated figures from graph.</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not recorded</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0013">Landsman 2011</a> </p> <p>Group 1: (n = 21) Levofloxacin plus saline</p> <p>Group 2: (n = 21) Super‐oxidised aqueous solution alone (not considered)</p> <p>Group 3: (n = 25) Levofloxacin plus super‐oxidised aqueous solution</p> <p>Ulcers infected at baseline.</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: 6/21</p> <p>Group 2: 11/21</p> <p>Group 3: 11/25</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mentioned, but data not presented.</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>Adverse events (number of participants with 1 or more event)</i> </p> <p>Group 1: 7/21</p> <p>Group 2: 7/21</p> <p>Group 3: 9/25</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0014">Lipsky 2008a</a> </p> <p>Group 1: (n = 246) Ofloxacin</p> <p>Group 2: (n = 247) Pexiganan</p> <p>Ulcers infected at baseline.</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> <p>Resolution ("cure") and improvement data presented together, so unclear how many participants had resolution. </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See below ‐ results presented by study authors cumulatively for these 2 studies only.</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>Adverse events (number of participants with &gt; 1 adverse event)</i> </p> <p>Group 1: 109/246</p> <p>Group 2: 98/247</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0015">Lipsky 2008b</a> </p> <p>Group 1: (n = 171) Ofloxacin</p> <p>Group 2: (n = 171) Pexiganan</p> <p>Ulcers infected at baseline.</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> <p>Resolution ("cure") and improvement data presented together, so unclear how many participants had resolution. </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: 9/417</p> <p>Group 2: 11/418 (cumulative of two RCTs reported in single paper)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>Adverse events (number of participants with &gt; 1 adverse event)</i> </p> <p>Group 1: 84/171</p> <p>Group 2: 76/171</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0016">Lipsky 2012a</a> </p> <p>Group 1: (n = 18) Systemic antibiotic therapy alone</p> <p>Group 2: (n = 38) Topical application of the gentamicin‐collagen sponge + systemic antibiotic therapy </p> <p>Ulcers infected at baseline.</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Resolution of infection by 7 days</p> <p>Group 1: 7/18</p> <p>Group 2: 22/38</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>Adverse events (number of participants with 1 or more events)</i> </p> <p>Group 1: 5/18</p> <p>Group 2: 11/38</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0017">Martinez‐De Jesus 2007</a> </p> <p>Group 1: (n = 16) Standard management with</p> <p>chemical</p> <p>antiseptics such as soap or povidone iodine</p> <p>Group 2: (n = 21) Super‐oxidised aqueous solution</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>Advances from</i> </p> <p><i>infection to granulating tissue:</i> </p> <p>Group 1: 10/16</p> <p>Group 2: 19/21</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0018">Ramos Cuevas 2007</a> </p> <p>Group 1: (n = 25) Conventional treatment (no further details translated)</p> <p>Group 2: (n = 25) Zinc hyaluronate</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported/translated</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported/translated</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean time to healing in weeks (not clear if standard deviation or standard error presented)</p> <p>Group 1: Only 2 ulcers healed; no time‐to‐event data reported</p> <p>Group 2: 7.80 (3.49) with all ulcers healing</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: 2/25</p> <p>Group 2: 25/25</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported/translated</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported/translated</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported/translated</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported/translated</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0019">Shukrimi 2008</a> </p> <p>Group 1: Standard‐dressing group (povidone iodine solution 10%)</p> <p>Group 2: Honey dressing group</p> <p>30 participants randomised, but number in each group not specified.</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Time to healing in days</p> <p>Group 1: 15.4 days (range 9 to 36 days)</p> <p>Group 2: 14.4 days (range 7 to 26 days)</p> <p>Comment: mean and range, but no measure of variation provided.</p> <p>Unclear how many participants in each group and how many ulcers healed, thus if this measure is a valid time‐to‐healing measure </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0020">Tom 2005</a> </p> <p>Group 1: Normal saline solution, 11 ulcers (in 10 participants)</p> <p>Group 2: Tretinoin group, 13 ulcers (in 12 participants)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data presented as time‐to‐event figure with no further data. Given the small number of participants and events, we have not tried to analyse further. </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><i>16 weeks</i> </p> <p>Group 1: 2/10</p> <p>Group 2: 6/12</p> <p>Unclear if ulcers were healed in the same or different participants; for the analysis we have assumed in different participants </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0021">Ullal 2014</a> </p> <p>Group 1: (n = 2) Povidone iodine and metronidazole 1% gel dressing</p> <p>Group 2: (n = 2) Honey and metronidazole 1% gel dressing</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group 1: 0/2</p> <p>Group 2: 2/2</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> </tr> <tr> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD011038-bbs2-0022">Viswanathan 2011</a> </p> <p>Group 1: (n = 19) Polyherbal formulation</p> <p>Group 2: (n = 19) Silver sulphadiazine cream</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"Number of days taken for healing of the wound:</p> <p>Group 1: 43.1 ± 26.8 Group 2: 43.6 ± 30.7"</p> <p>Not clear what sort of analysis was conducted</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Healing was defined as complete epithelialisation either by secondary intention or by split skin graft. However, figures are not reported. </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"the microbiological investigations were not done"</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"There were no adverse events reported in both the groups."</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>Abbreviations: IQR, interquartile range; SD, standard deviation</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span>&nbsp;<span class="table-title">Outcomes</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/full#CD011038-tbl-0016" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD011038-tbl-0006" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Topical antimicrobial dressing compared with non‐antimicrobial dressing</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Proportion of wounds healed <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>945</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.28 [1.12, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Short term follow up</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>80</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.6 [1.00, 2.57]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Medium term follow‐up</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>865</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.26 [1.10, 1.44]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Incidence of infection: medium term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>173</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.34 [0.04, 3.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Surgical resection: medium term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>317</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.33 [0.04, 2.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>134</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.96 [0.62, 1.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Topical antimicrobial dressing compared with non‐antimicrobial dressing</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#CD011038-tbl-0006" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD011038-tbl-0007" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Topical antimicrobial agent (non‐dressing) compared with non‐antimicrobial topical agent (non‐dressing)</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Proportion of wounds healed: medium term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>112</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.82 [0.56, 14.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Resolution of infection: medium term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>40</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.16 [0.54, 2.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Surgical resection: medium term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>34</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.67 [0.47, 5.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Topical antimicrobial agent (non‐dressing) compared with non‐antimicrobial topical agent (non‐dressing)</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#CD011038-tbl-0007" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD011038-tbl-0008" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">One topical antimicrobial agent compared with an alternative topical antimicrobial agent</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Proportion of wounds healed <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Medium term follow‐up</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Unknown follow‐up period</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Resolution of infection: medium term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Surgical resection: medium term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>41</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.93 [0.53, 7.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">One topical antimicrobial agent compared with an alternative topical antimicrobial agent</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#CD011038-tbl-0008" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD011038-tbl-0009" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">Topical antimicrobial agent compared with systemic antimicrobial agent</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Resolution of infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>102</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.51 [0.91, 2.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Short‐term follow‐up</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>46</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.54 [0.69, 3.45]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Medium term follow‐up</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>56</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.49 [0.79, 2.82]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Surgical resection: medium term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>835</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.22 [0.51, 2.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>937</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.91 [0.78, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Short‐term follow‐up</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>891</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.90 [0.78, 1.05]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 Medium term follow‐up</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>46</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.08 [0.49, 2.40]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">Topical antimicrobial agent compared with systemic antimicrobial agent</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#CD011038-tbl-0009" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD011038-tbl-0010" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 5.</span>&nbsp;<span class="table-title">Topical antimicrobial agent compared with growth factor</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Proportion of wounds healed: Medium term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>40</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.5 [0.28, 0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span>&nbsp;<span class="table-title">Topical antimicrobial agent compared with growth factor</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD011038.pub2/references#CD011038-tbl-0010" class="tableList">Navigate to table in Review</a></div> </div> </div> <section class="translation-notes-modal" style="display: none" data-modal-title="Translation notes" data-modal-class="translation-notes" data-ok-btn-selector=".ok-btn"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011038-note-1204">Deutsch</a> </li> <li class="section-language"> <a class="" href="fr#CD011038-note-1208">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD011038-note-1207">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD011038-note-1205">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD011038-note-1206">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="za#CD011038-note-1209">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" id="citeProcText" data-load-error="Unable to load citation data"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a href="#" class="addthis_button_citeulike at300b btn btn-link">CiteULike</a></li> <li><a href="#" class="addthis_button_mendeley at300b btn btn-link">Mendeley</a></li> <li><a href="#" class="citation-btn-refworks at300b btn btn-link" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <h4>Copy or download citation</h4> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button type="button" class="btn btn-link">Plain text</button></li> <li class="citation-option" data-option="endnote"><button type="button" class="btn btn-link">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button type="button" class="btn btn-link">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button type="button" class="btn btn-link">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button type="button" class="btn btn-link">BibteX</button></li> </nav> <div class="citation-content"> <pre id="citationContent" tabindex="0" data-load-error="Unable to load citation data"></pre> </div> <div class="clearfix"> <form class="download-citation-form" method="GET" target="citation-download-iframe" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=citation-citeproc&p_p_cacheability=cacheLevelPage&p_p_col_id=column-1&p_p_col_count=1"> <input type="hidden" id="siteId" name="siteId" value="" /> <input type="hidden" id="downloadType" name="downloadType" value="" /> <input type="hidden" id="style" name="style" value="" /> <input type="hidden" id="articleId" name="articleId" value="" /> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay" /><input name="p_p_lifecycle" type="hidden" value="2" /><input name="p_p_state" type="hidden" value="normal" /><input name="p_p_mode" type="hidden" value="view" /><input name="p_p_resource_id" type="hidden" value="citation-download" /><input name="p_p_cacheability" type="hidden" value="cacheLevelPage" /><input name="p_p_col_id" type="hidden" value="column-1" /><input name="p_p_col_count" type="hidden" value="1" /> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withAbstract"> <input class="checkbox" type="checkbox" name="withAbstract" /> <span class="checkbox-label">Include abstract</span> </label> </div> </form> <iframe title="Citation download frame" name="citation-download-iframe" src="" style="display: none; visibility: hidden" aria-hidden="true"></iframe> </div> </div> </div> </div> <div class="print-modal" style="display: none;" data-modal-title="Print this review"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input title="Select/deselect all" type="checkbox" class="print-options-select-all" checked="checked" /> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i class="fa fa-print" aria-hidden="true"></i> Print</button> </div> </div> <div class="download-stats-data-modal" style="display: none;" data-modal-title="Download statistical data"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <p> Downloaded data can only be viewed using <a class="external" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/tools/review-production-tools/revman-5" target="_blank">Review Manager software.</a> </p> <p> Please note that: <ul> <li>data are only available for Cochrane Reviews that contain one or more forest plots; and</li> <li>data in the downloaded RevMan file are editable and therefore the review data can be amended without warning.</li> </ul> </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input type="hidden" name="content-disposition" value="attachment" /> <input type="hidden" name="mime-type" value="application/octet-stream" /> <p class="print-options-controls"> <input type="checkbox" class="download-stats-data-toc-check-box" aria-label="I agree to these terms and conditions" /> <span class="checkbox-label" aria-hidden="true">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i class="fa fa-download" aria-hidden="true"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" style="display:none;" data-modal-title="Share this review"> <div class="add-this"> <div class="addthis_toolbox addthis_default_style addthis_32x32_style"> <nav class="stacked-nav-list"> <li> <a href="#" class="addthis_button_twitter at300b" title="Tweet">Twitter</a> </li> <li> <a href="#" class="addthis_button_mendeley at300b" target="_blank" title="Mendeley">Mendeley</a> </li> <li> <a href="#" class="addthis_button_facebook at300b" title="Facebook">Facebook</a> </li> <li> <a href="#" class="addthis_button_linkedin at300b" target="_blank" title="LinkedIn">LinkedIn</a> </li> <li> <a href="#" class="addthis_button_email at300b" target="_blank" title="Email">Email</a> </li> <li> <a href="#" class="addthis_button_whatsapp at300b" target="_blank" title="WhatsApp">WhatsApp</a> </li> <li class="clearfix"> <a href="#" class="addthis_button_more btn primary pull-right" target="_blank" title="View more"> <i class="fa fa-plus" aria-hidden="true"></i> View more</a> </li> </ul> </div> </div> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button type="button" class="btn btn-link" id="figureOptionBtn">Figures</button></li> <li class="table-options-btn-container"><button type="button" class="btn btn-link" id="tableOptionBtn">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div id="figureThumbnails" class="figure-thumbnails is-visible"></div> <div id="tableThumbnails" class="table-thumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a href="#" class="figure-viewer-menu-toggle"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-table-show-text="Show table list" data-table-hide-text="Hide table list" data-figure-show-text="Show thumbnails" data-figure-hide-text="Hide thumbnails">Hide thumbnails</span> </a> <a href="#" class="figure-viewer-zoomin"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a href="#" class="figure-viewer-zoomout"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a href="#" class="figure-viewer-nav previous"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a href="#" class="figure-viewer-nav next"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_  portlet-static portlet-static-end kaleo-designer-portlet " id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a title="Cochrane logo" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/">
<img class="footer-logo logo-part-1" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-1.png" alt="Cochrane logo" /> <img class="footer-logo logo-part-2" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-2.png" alt="" /> </a> </div> <nav class="footer-links"> <ul class="root"> <li class="footer-item"> <a class="footer-item-link" href="/about-cochrane1">About Cochrane</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/evidence" target="_blank">Cochrane.org</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank">Who we are</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NJYXT5SPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Get involved</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX665WNWTYE63PMNYXG4DTMFYGKLUQPJUB/" target="_blank">Consumer Network</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-funders-and-partners" target="_blank">Partners</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYXZ5DQPF4XT7LNF3SX8Z5IPJRX63JPN73GH/" target="_blank">Colloquium</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news" target="_blank">In the news</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/publications">Publications</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="/library">Cochrane Library</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/" target="_blank">Library Homepage</a> </li> <li class="footer-item"> <a class="footer-item-link" href="cdsr/about-cdsr" target="_blank">Cochrane Reviews (CDSR)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/central" target="_blank">Trials (CENTRAL)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cca/about" target="_blank">Cochrane Clinical Answers</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/cochrane-library-app" target="_blank">Cochrane Library App</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cdsr/journal-club" target="_blank">Journal Club</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/podcasts" target="_blank">Podcasts</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/community">Community</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Community</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MF3GG4DJMVYGG55DNB3GC5UFF3YYE3D/" target="_blank">Archie log-in</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/PS3GC4LPNFYGPLUDN7SXR6UBN3TT655TMH/" target="_blank">Training and support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/NWTYI4DQMS3T6Z5QMNVHEZLPMVYG86UH/" target="_blank">Methods</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/help" target="_blank">Software</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news/jobs" target="_blank">Jobs and opportunities</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/contact-us">Contact Us</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/contact" target="_blank">General enquiries</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/help/contact-us" target="_blank">Cochrane Library support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/chief-executive-officers-office/team" target="_blank">Chief Executive Officer</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/editorial-methods/team" target="_blank">Editor in Chief</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-global-community" target="_blank">Cochrane groups</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/media" target="_blank">Media</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/accessibility" target="_blank">Accessibility</a> </li> </ul> </li> </ul> </nav> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/advertisers">Advertisers & Agents</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Help & Support</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/terms-and-conditions">Terms & Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright &copy; 2000 - 2020 by <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUYNFXGK8JPMNYXN/" class="">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br /> Review our <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUYNFXGK8JPMNYXN/en-gb/privacy"><strong>Privacy Policy</strong></a> </p> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MW4T675JNSTYTLUDN7XB/"><img class="logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_wiley-footer-logo.png" alt="Wiley logo" /></a> </div> </div> <span class="wiley-semi-circle"></span> </div> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" style="display: none" data-modal-title="Feature in English only" data-modal-class="english-only-modal"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script src="/cochrane-theme/vendor/ie9.js?t=1581422282000" type="text/javascript"></script> <!--<![endif]--> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/theme.js?t=1581422282000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/checkout.js"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MN3G865UNWRYE43NMNTG6LUDPJYYG65TMWUC655TMH/widget/v2.0/widget.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MRZXE8DIHB4XC63SNWYHPN3PMNXG87LEM33G85UVF3YGK7A/assets/embed.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718173000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718249000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718249000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718173000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011038\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011038\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011038\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011038\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011038\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011038\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011038\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011038\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011038\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011038\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011038\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011038\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011038\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011038\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011038\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011038\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011038\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011038\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581422282000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a href="#" class="rh-nav-close-btn"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a href="#" class="rh-nav-open-btn"> <span>Review tools & navigation</span> </a> </div> <iframe title="Print frame" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" aria-hidden="true"></iframe> <div class="mobile-navigation"> <div class="close-container"> <a href="#" class="main-nav-back-btn" aria-label="Navigate back"><i class="fa fa-chevron-left"></i></a> <a href="#" class="main-nav-close-btn" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="ymag__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=EfT7x5RD&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011038.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011038.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<a href="/en/browse-by-topic" class="btn secondary">Browse </a>
<a href="/en/advanced-search" class="btn secondary advanced-search-button">Advanced search</a>
</div>
<div class="menu-items parent">
<ul>
<li class="nav-root-item parent">
<a href="#" title="Select language" class="language-selection-title-link">
<span class="mobile-nav-language-title">Select your preferred language</span><span class="icon fa fa-caret-down"></span>
<ul class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="fdkn__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div id="active-content-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div id="active-portal-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="/en/cdsr/doi/10.1002/14651858.CD011038.pub2/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD011038.pub2/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</ul>
</a>
</li>
<li class="parent">
<a class="mobile-link signin" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011038.pub2%2Freferences" data-redirect="false" rel="nofollow">
Sign In
</a>
</li>
</ul>
<div class="menu-items-footer">
<div class="utility-links">
<a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/" class="cochrane-link" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
<div class="basic-login-form-content" style="display: none;" data-modal-title="Sign in">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="dbam__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1583243614585" /> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x2f;references" /> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value="" /> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true" /> <input checked class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onClick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true" /> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user-registration" target="_blank" class="btn secondary">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=0&p_p_state=normal&p_p_mode=view&_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" style="display: none;" data-modal-title="Institutional login">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="obft__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text">
</div>
<button class="btn primary" type="submit" name="button">Go</button>
</div>
<div id="institutionLookupErrorDiv" class="message error" style="display:none">
'<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
</div>
</div>
<input type="hidden" id="entityId" name="entityId" value="">
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="joiu__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1583243614588" /> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD011038&#x2e;pub2&#x2f;references" /> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value="" /> </div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true" /> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" style="display: none;" data-modal-title="Unlock the potential of Cochrane evidence">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="wpdq__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text"> </div> <button class="btn primary" type="submit" name="button">Go</button> </div> <div id="institutionLookupErrorDiv" class="message error" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input type="hidden" id="entityId" name="entityId" value=""> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'> <input type="hidden" name="openlabel" id="openlabel" value='Open access'> </div> </section> </div> </div>  <script>window.urlTitle="/cdsr/doi/10.1002/14651858.CD011038.pub2";addthis_config={pubid:"ra-593597d01cdf9a55",ui_508_compliant:true};addthis_share={url:window.location.href,title:document.title};</script> <script src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-593597d01cdf9a55"></script> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> </body> </html> 